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CD4+ T helper (Th) lymphocytes are vital for integrating immune responses by 
orchestrating the function of other immune cell types.  Naïve Th cells can differentiate into 
different effector subsets that are characterized by their cytokine profile and immune regulatory 
functions.  These subsets include Th1, Th2, Th17, natural and inducible regulatory T cells 
(nTreg and iTreg respectively), among others.  We focused our investigation on two Th 
lineages, Th17 and regulatory T cells, with opposing functions in the immune system.  These 
subsets have been suggested to be reciprocally regulated since they both require TGF- for 
their development.  We investigated the role of the Treg-associated master transcription factor 
Foxp3, and found that Foxp3 inhibits Th17 cell generation by preventing the transcriptional 
activity of the two main Th17-specific transcription factors, nuclear orphan receptors ROR 
and RORt.  At the molecular level, we identified two different functional domains in Foxp3 
required for such inhibition: the LQALL sequence in exon 2 and the TIP60/HDAC7 binding 
domain.  These domains could be crucial to either prevent the association of the nuclear 
receptors to coactivators or to recruit histone deacetylases to ROR- or RORt-target genes.  
Since TGF- is a common cytokine required for the commitment towards both Th lineages, we 
 vii
determined the role of the TGF--dependent signaling pathway in the generation of each 
subset.  By using mice with deficiencies in signaling molecules downstream of TGF-, we 
found that while Smad2, Smad3 and Smad4 are required for the generation of iTreg cells, only 
Smad2 is indispensable for the induction of IL-17-producing cells, suggesting that TGF- 
induces these T helper lineages through differential signaling pathways.  Thus, our findings 
describe novel transcriptional regulatory mechanisms that control the generation of two T 
helper lineages with opposing functions.  These findings could provide novel therapeutic 
targets to treat diseases where the balance of these T cells is dysregulated, such as in 
autoimmunity, chronic infectious diseases and cancer. 
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CHAPTER I - INTRODUCTION 
 
The immune system has evolved to not only recognize and fight against invading pathogens, but 
also to generate immunological memory.  For this particular response, the adaptive branch of the 
immune system plays a crucial role.  Within the adaptive immune response, CD4+ T helper (Th) cells 
are vital for integrating immune responses by orchestrating the function of other immune cell types from 
either the adaptive or innate immune system, and thus have a major role in cancer, autoimmune and 
infectious diseases. 
Commitment towards the T cell lineage occurs in the thymus.  Once a hematopoietic precursor 
exits the bone marrow and enters the thymus, it loses the potential to become non-T hematopoietic cell 
types (lineage exclusion) and adopts T cell-properties (reviewed in (Rothenberg et al., 2010)).  After a 
cell commits to the T cell fate, it undergoes positive and negative selection, so that T cells expressing a 
T cell receptor (TCR) with intermediate affinity towards major histocompatibility complexes (MHC) are 
selected (reviewed in (Starr et al., 2003)).  Having succeeded at these stages, naive CD4+ T helper cells 
exit the thymus and migrate to the periphery.  These naïve Th cells circulate through the body and home 
to lymph nodes until they become activated.  Upon activation, naïve CD4+ Th cells are able to 
differentiate into effector cells that are characterized by their cytokine profile and immune regulatory 
functions.  This differentiation process depends on several factors including the strength of the signals 
induced through the TCR, costimulatory molecules and the cytokines present in the microenvironment 
during T cell activation.  These cytokines are mainly produced by cells from the innate immune system, 
especially from antigen-presenting cells (APCs) upon recognition of pathogen associated molecular 
patterns (PAMPs) by pattern recognition receptors (PRRs) (Hsieh et al., 1993; Seder et al., 1993).  Thus, 
the type of effector CD4+ Th cell induced will ultimately depend on the activation status of the innate 
immune cells, the type of PRRs activated, and the balance between the different cytokines present in the 
local microenvironment.  In the present chapter we will discuss the different T helper lineages identified 
and focus on the cytokine and transcription factors that control the commitment towards Th cell types, 
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in particular Th17 and regulatory T cells.  Then, throughout this dissertation, we will determine the 
requirement of several transcription factors that regulate the differentiation to two Th lineages: Th17 
and regulatory T cells. 
 
I.1. T helper cell differentiation: Th1-Th2 paradigm 
 
More than twenty years ago, it became evident that naïve Th cells, once activated, could adopt 
two destinies: support B cell activation and humoral immunity or macrophage activation and thus cell-
mediated immunity (CMI).  This lead Mosmann and Coffman to propose the Th1-Th2 paradigm 
(Mosmann et al., 1986; Mosmann and Coffman, 1989) where Th1 cells induced delayed type 
hypersensitivity (DTH) and CMI responses and Th2 cells promoted humoral/allergic immune responses.  
The identification of these two T cell lineages demonstrated that CD4+ Th cells are heterogeneous and 
capable of adopting differential fates depending on the microenvironment during T cell activation, 
indicating a previously unidentified versatility of the adaptive immune system.  
By analysis of the cytokine profile produced by these cells, it was established that Th1 cells 
produce mainly interferon gamma (IFN-and tumor necrosis factor alpha (TNF-IFN-induces 
macrophage activation and is thus crucial for the host immune defense against intracellular pathogens, 
and also mediates immunoglobulin G2a (IgG2a) class switching in B cells.  By contrast, Th2 cells 
produce interleukin (IL)-4, IL-5 and IL-13, which mediate immunoglobulin class switching in B cells 
(class switch to IgG1 and IgE), induce recruitment of eosinophils and lead to mucosal activation.  
Furthermore, Th2 cells are important in the host immune responses against extracellular bacteria as well 
as parasites. 
Commitment towards Th1 or Th2 cell fate depends on many factors including signals induced 
by costimulatory molecules, type of antigen presenting cells priming T cells, and most importantly, 
cytokines present in the local microenvironment during the T cell activation.  It has been demonstrated 
that Th1 cell generation depends on IL-12, produced by macrophages or dendritic cells upon recognition 
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of pathogen associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs) (Hsieh et 
al., 1993; Seder et al., 1993).  Th2 development, on the other hand, depends on IL-4 (Hsieh et al., 1992; 
Seder et al., 1992) which is produced by Th2 cells, eosinophils, mast cells, NKT cells and basophils 
(reviewed in (Paul, 2010)).  Indeed, it has been recently demonstrated that Th2 priming in vivo requires 
antigen presentation by basophils which also produce IL-4 and thymic stromal lymphopoietin (TSLP) 
(Perrigoue et al., 2009; Sokol et al., 2009; Yoshimoto et al., 2009).  Then, IL-4 produced by Th2 cells 
can act in a positive feedback loop to further induce Th2 cell development.  
Once the key molecules driving differentiation of Th1 and Th2 cells were identified, molecular 
approaches were designed to investigate the transcription factors involved in the commitment towards 
each cell lineage.  Since Th1/Th2 differentiation requires cytokines belonging to the class I cytokine 
superfamily (reviewed in (Leonard and O'Shea, 1998)), the role of Signal Transducers and Activators of 
Transcription (STATs) was determined.  It has been demonstrated that development of Th1 cells 
requires T cell receptor (TCR) and STAT1 signal transductions.  IFN- produced by NK cells in 
response to IL-12 secreted by innate immune cells such as macrophages or dendritic cells, induce 
STAT1 activation.  This, in turn, leads to the expression of the Th1 master transcription factor T-bet 
(Szabo et al., 2000).  T-bet is highly expressed in Th1 cells and induces IFN- production as well as 
upregulation of IL-12 receptor 2 chain (Szabo et al., 2000).  Upon upregulation of the latter, IL-12 
induces activation of STAT4, which further enhances IFN- expression and thus acts in an autocrine 
loop.  Interestingly, STAT4 or T-bet deficient mice are unable to induce Th1 cells (Kaplan et al., 1996; 
Szabo et al., 2002).  T-bet not only stimulates the expression of IFN- but is also capable of redirecting 
developing Th2 cells into Th1 cells, demonstrating that T-bet is required to initiate commitment towards 
Th1 cells and is also capable of repressing Th2 cell induction (Szabo et al., 2000). 
Th2 cell generation requires IL-4, which signals through STAT6 to induce expression of the 
master transcription factor GATA-3 (Zheng and Flavell, 1997).  GATA-3, similar to T-bet, not only 
induces epigenetic modifications in il4, il5 and il13 loci that lead to their expression, but also represses 
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Th1 cell generation by interfering with STAT4 and IL-12R2 expression (Ouyang et al., 2000; Ouyang 
et al., 1998; Pai et al., 2004; Ranganath et al., 1998). 
 
I.2. Gaps in Th1/Th2 paradigm: Identification of Th17 cells as an independent T cell lineage 
 
The Th1/Th2 paradigm has prevailed in the immunology field for over two decades.  However, 
several reports indicated that CD4+ T helper cells can produce other cytokines, such as IL-17 and IL-
17F, that were not co-expressed by IFN--(Th1) or IL-4-(Th2) producing cells (Aggarwal et al., 2003; 
Infante-Duarte et al., 2000).  Furthermore, even though Th1 cells have been associated with 
autoimmune diseases, mice lacking IFN-R, IFN- or STAT1 (all required for Th1 cell development) 
were still susceptible to the autoimmune disease models collagen-induced arthritis (CIA) or 
experimental autoimmune encephalomyelitis (EAE) (Bettelli et al., 2004; Ferber et al., 1996; Kageyama 
et al., 1998; Willenborg et al., 1996).  On the other hand, Icos-/- or Il23-/- mice were resistant to CIA 
development, which correlated with reduced IL-17 expression (Dong, 2003; Murphy et al., 2003).  
Furthermore, it was shown that IL-23 alone could expand Th cells expressing IL-17 and IL-17F, which 
played a pathogenic role in the induction of EAE (Langrish et al., 2005).  These observations led to the 
identification of Th17 cells as an independent lineage from Th2 or Th1 cells (Fig. 1), since IFN-, IL-12 
or IL-4, which are required for Th1 or Th2 cell development, respectively, were dispensable for the 
generation of IL-17-producing T cells both in vitro and in vivo (Harrington et al., 2005; Park et al., 
2005).  Other Th subsets have also been identified in recent years, including Th9 cells, regulatory T 
cells (Treg cells), and follicular helper T cells (Tfh), among others (Fig. 1).  Although effector T cells 
were originally considered to be terminally differentiated, a growing body of evidence has challenged 
this view and suggested that the phenotype of effector T cells is not completely fixed but is more 
flexible or plastic (discussed in Chapter IV).  
Th17 cells have been characterized to produce mainly IL-17A, IL-17F, IL-22 and IL-21 
cytokines as well as the chemokine C-C motif ligand 20 (CCL20).  IL-17A and IL-17F can bind to two 
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receptors: IL-17RA and IL-17RC.  In mice, IL-17RA was found to be expressed in lungs, kidneys, liver, 
spleen, epithelial cells, fibroblasts (Yao et al., 1995), whereas in humans it has been observed in 
epithelial cells, B and T lymphocytes and eosinophils, among others (Cheung et al., 2008; Moseley et al., 
2003).  IL-17RC, on the other hand, was found on human muscle, cartilage, liver, heart and eosinophils 
(Cheung et al., 2008; Moseley et al., 2003).  IL-21 binds to IL-21 receptor (IL-21R), which is expressed 
on many immune cell types such as B, T and NK cells, dendritic cells, macrophages and epithelial cells 
(reviewed in (Leonard and Spolski, 2005)).  IL-22R is expressed in non-immune cells, predominantly 
epithelial cells (reviewed in (Trivella et al., 2010; Wolk et al., 2010)).  Upon binding to their receptors, 
Th17 cytokines can act on different target cell types to induce the secretion of granulopoietic factors 
(stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF)), CC and CXC chemokines, 
matrix metalloproteases, anti-microbial peptides and pro-inflammatory cytokines (reviewed in (Dong, 
2008)).  This combination of factors leads to an increase in the recruitment of immune cell types, 
including neutrophils, and the induction of a local inflammatory and/or antimicrobial immune response 
(Fig. 2).  Therefore, Th17 cells are crucial regulators of host immune responses, but also show an 
important role in inducing inflammatory responses.  
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Figure 1.  Schematic representation of T helper subsets.  Naïve CD4+ Th cells, upon activation can 
differentiate into different effector Th subsets.  Each effector cell expresses specific transcription 
factors (shown inside the cells).  These effector subsets are characterized by the secretion of different 
soluble mediators (shown in blue circles) and therefore display different effector functions (shown in 
green rectangles).  Th1 cells produce IFN- and regulate antigen presentation and immunity against 
intracellular pathogens.  Th2 cells produce IL-4, IL-5 and IL-13, and mediate humoral responses and 
immunity against parasites and are important mediators of allergic diseases.  Th17 cells express IL-17, 
IL-17F, IL-21 and IL-22 (and IL-26 in humans), regulate mucosal host immune responses and 
participate in inflammation and autoimmunity processes.  Th9 cells produce IL-9 and primarily 
mediate host immune responses against parasites.  Tfh cells produce IL-21, and provide help to B cells, 
participating in germinal center reactions.  iTregs express Foxp3 transcription factor and mediate 
immune suppression by secretion of TGF-, IL-10.  Adapted from Dong, 2008; Yoshimura et al., 
2010.
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Figure 2. Role of Th17 cytokines. On immune cells, Th17-produced IL-21 further induces Th17 cell 
differentiation creating a positive feedback loop in an autocrine/paracrine manner. Moreover, both IL-
17 and IL-17F induce production of cytokines and chemokines by eosinophils, leading to allergic 
inflammation.  In non-immune cells, Th17 cytokines collectively induce the secretion of cytokines, 
chemokines, anti-microbial compounds and matrix metalloproteases from epithelial cells, fibroblasts 
and keratinocytes, leading to an increase in inflammation by recruitment of neutrophils and 
macrophages and tissue remodeling. Reprinted from “Regulation and function of proinflammatory
Th17 cells” Gustavo J. Martinez, Roza Nurieva, Xuexian O. Yang and Chen Dong. Annals of the New 
York Academy of Sciences 2008. 1143:188-211 with permission from John Wiley and Sons.
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I.3. Cytokine requirement for the generation of Th17 cells 
 
Similar to the commitment of Th1 or Th2 cells, Th17 cells also require a specific combination 
of cytokines for their induction.  In this section we will describe the positive as well as negative 
regulators of Th17 cell induction. 
 
I.3.a. Positive regulators in the generation of Th17 cells 
 
Upon determination of Th17 cells as an independent Th cell lineage, several groups determined 
that transforming growth factor- (TGF-) and IL-6 are responsible for initiation of Th17 cell responses 
(Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006a).  Stockinger’s group demonstrated 
that while TGF- and IL-6 support the acquisition of IL-17 expression from naïve T cells, IL-1 and 
TNF- further amplify the expression of this cytokine (Veldhoen et al., 2006a).  The requirement of 
TGF- in the induction of a pro-inflammatory T cell lineage was unexpected in view of the role of TGF-
 as an immunosuppressive cytokine that can directly inhibit T cell activation (Gorelik and Flavell, 
2002) or induce the generation of Foxp3+ regulatory T cells (Bettelli et al., 2006; Chen et al., 2003).  
Furthermore, Betelli et al. demonstrated that IL-6 can inhibit TGF--dependent induction of Foxp3+ 
regulatory T cells and favor the generation of IL-17-producing T cells, suggesting that not only is there 
functional antagonism between these two T cell lineages, but also that they are reciprocally regulated 
(see below, and discussed in Chapter II) (Bettelli et al., 2006).  Even though TGF- has been 
demonstrated to be crucial in the induction of Th17 cells, Zhou and colleagues recently demonstrated 
that increasing concentrations of TGF- in vitro decreases IL-23R expression and induces regulatory T 
cells, thus shifting the balance from Th17 to regulatory T cells (Zhou et al., 2008a).  Combined, these 
reports demonstrate that the balance between pro-inflammatory cytokines and TGF- will determine the 
final outcome towards the induction of T cell lineages with opposing functions.  
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The requirement for TGF- and IL-6 in driving Th17 cell generation was also confirmed in vivo. 
Kuchroo and colleagues showed that TGF- transgenic mice immunized with myelin oligodendrocyte 
glycoprotein (MOG) in Complete Freund’s Adjuvant (CFA) responded with a higher Th17 response and 
presented exacerbated EAE (Bettelli et al., 2006). Further supporting the role of TGF- in Th17 cell 
differentiation, Mangan et al. showed that mice deficient in this cytokine were unable to produce IL-17 
in vivo (Mangan et al., 2006).  Deletion of TGF-1, specifically in T cells, also leads to resistance to 
EAE and inability to mount Th17 responses in vivo, suggesting that secretion of TGF- by T cells is 
essential for the proper regulation of effector T cell generation (Li et al., 2007c). As for the requirement 
of IL-6 in vivo, it has been demonstrated that IL-6-deficient mice are unable to mount Th17 responses 
and are therefore resistant to EAE disease development, and also show a higher frequency of Foxp3+ 
regulatory T cells (Korn et al., 2007a; Yang et al., 2007).  
Recently, it has also been established both in vitro and in vivo that IL-21, which is produced by 
Th17 cells, can act in an autocrine manner to induce further Th17 cell development similar to IL-4 and 
IFN- amplification of Th2 and Th1 responses respectively (Korn et al., 2007a; Nurieva et al., 2007; 
Zhou et al., 2007).  IL-21 is induced by IL-6 in a STAT3-dependent manner, supported by the 
observation that T cells from IL-6-deficient mice fail to produce IL-21 or IL-17 in vivo (Nurieva et al., 
2007).  Furthermore, IL-21 in the presence of TGF- induces expression of IL-23R and the transcription 
factor RORt (see below), leading to the generation of IL-17-producing T cells (Nurieva et al., 2007; 
Zhou et al., 2007).  Indeed, mice deficient in either IL-21 or IL-21 receptor fail to generate Th17 cells in 
vivo (Korn et al., 2007a; Nurieva et al., 2007).  However, IL-21 can substitute for IL-6 to generate Th17 
cells in an IL-6-independent manner (Korn et al., 2007a). 
IL-1 has also been shown to be a crucial cytokine in the generation of Th17 cells.  IL-1, which 
has two isoforms (IL-1 and IL-1, can bind similarly to two receptors, IL-1RI and IL-1RII. IL-1RI is 
involved in cell activation by binding to IL-1R accessory protein (IL-1RAcP), whereas IL-1RII acts 
only as a decoy receptor.  Initially, it had been shown that mice lacking IL-1RI were resistant to EAE 
induction (Schiffenbauer et al., 2000).  Indeed, Sutton and colleagues demonstrated that generation of 
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antigen-specific Th17 cells is abrogated in IL-1RI deficient mice, whereas Th1 or Th2 responses were 
not affected (Sutton et al., 2006).  Furthermore, Veldhoen et al. demonstrated that IL-1 can promote 
expansion/development of Th17 cells stimulated in the presence of TGF- and IL-6 (Veldhoen et al., 
2006a).  Recently, Chung and colleagues have also demonstrated that the combination of IL-1, IL-6 and 
IL-23 can initiate Th17 genetic programming, although this polarizing condition still required TGF- 
since neutralization of endogenous TGF- inhibited Th17 cell induction (Chung et al., 2009).  
Importantly, IL-1 was shown to regulate the induction of the transcription factors RORt and IRF4 
during generation of Th17 cells (Chung et al., 2009).  Furthermore, IL-1 can also suppress the inhibitory 
effects IL-2 has on IL-17 production, by inducing the expression of IL-23R, IL-1R and RORt (Kryczek 
et al., 2007a). 
As previously described, IL-23 is another important cytokine for Th17 cell 
generation/maintenance.  IL-23, a heterodimer composed of IL-12 p19 and p40 chains (Oppmann et al., 
2000), binds a heterodimeric receptor complex containing IL-12Rβ1 and IL-23R (Parham et al., 2002).  
In vivo, it has been demonstrated that IL-23 is required for sustained inflammation since mice deficient 
in IL-23 are resistant to EAE (Murphy et al., 2003), inflammatory bowel disease (IBD) (Yen et al., 
2006) and CIA (Murphy et al., 2003), all of which correlate with decreased IL-17 production by T cells.  
IL-23 has been shown to expand Th cells expressing IL-17 and IL-17F (Langrish et al., 2005).  However, 
the exact direct role of IL-23 on Th17 cell differentiation has been unclear since IL-23R is not expressed 
on naïve T cells.  Later work has shown that IL-6 and IL-21, cytokines that initiate Th17 cell generation 
(Nurieva et al., 2007; Yang et al., 2007; Zhou et al., 2007), are able to induce IL-23R (Bettelli et al., 
2006; Mangan et al., 2006; Veldhoen et al., 2006a), indicating that IL-23 plays an important role in the 
maintenance of these cells.  Furthermore, IL-23 synergizes with IL-6 in Th17 cell induction (Yang et al., 
2007) and cooperates with IL-1 to enhance IL-17 expression, independent of TCR stimulation (Chung et 
al., 2009; Sutton et al., 2006).  Recently, Cua and colleagues have demonstrated that il23r-/- mice have 
no defect in the early generation of antigen-specific Th17 cells in vivo after immunization protocols.  
However, they demonstrated that IL-23 is required for Th17 cell expansion and migration to peripheral 
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tissues, whereas it is not necessary for Th1 cells (McGeachy et al., 2009).  Thus, these results 
demonstrate a role of IL-23 not in the initiation but in the maintenance and expansion of Th17 cell 
responses. 
 
I.3.b. Negative regulators of Th17 cell development 
 
Two independent groups demonstrated that neutralization of Th1 and Th2 cytokines, IFN- and 
IL-4 respectively, markedly increased the production of IL-17 by CD4+ Th cells (Harrington et al., 
2005; Park et al., 2005).  Indeed, IFN--deficient mice showed enhanced frequency of IL-17-producing 
cells as well as IL-17 protein expression (Harrington et al., 2005; Park et al., 2005), which correlates 
with previous reports showing that IFN-R- and IFN--deficient mice displayed higher susceptibility to 
EAE induction (Hunter, 2005; Iwakura and Ishigame, 2006; McKenzie et al., 2006).  However, in many 
autoimmune and inflammatory conditions, cells co-expressing IL-17 and IFN- have been observed 
(Abromson-Leeman et al., 2009).  The exact role of these cells in the pathogenesis of these diseases has 
not been determined yet, nor is it known whether they are generated from Th1 or Th17 cells.  
The Th1-promoting cytokine IL-27 has also been shown to negatively regulate Th17 cell 
generation (Batten et al., 2006; Stumhofer et al., 2006).  IL-27, which belongs to the IL-12 cytokine 
family, is formed by two subunits: IL-12 p35-related protein p28 and IL-12 p40-related protein EBI-3 
(EBV-induced gene 3).  IL-27 binds to a receptor composed of gp130, shared by the IL-6 receptor 
complex, and a unique subunit named WSX1 (Hunter, 2005).  IL-27 has been recently shown to 
suppress autoimmune disease models.  Mice deficient in WSX1 developed more severe EAE, which 
correlated with enhanced frequency of IL-17-producing cells infiltrating the central nervous system 
(Batten et al., 2006; Stumhofer et al., 2006).  In addition, these mice chronically infected with 
Toxoplasma gondii had no significant differences in IFN--producing cells, whereas higher frequency of 
IL-17-producing cells were detected in the brain compared to control animals (Stumhofer et al., 2006).  
Moreover, exogenous addition of IL-27 reduced the EAE disease severity (Fitzgerald et al., 2007).  In 
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vitro, it has been shown that IL-27 suppressed induction of Th17 cells both directly through a STAT1 
dependent mechanism and indirectly by inducing IL-10 expression, which was associated with a 
reduction in IL-17-producing cells (Batten et al., 2006; Stumhofer et al., 2006).  Also, IL-27 is able to 
induce expression of SOCS3 (Suppressor of Cytokine Signaling 3), which inhibits Stat3, a transcription 
factor required for Th17 cell generation (see below) (Owaki et al., 2006; Villarino et al., 2006). 
Recently, the T cell growth factor IL-2 has also been shown to suppress development of Th17 
cells (Laurence et al., 2007).  Laurence et al. showed that suppression of IL-17-producing cells and 
induction of Foxp3 by IL-2 is mediated through activation of STAT5, which binds directly to the il17a 
promoter competing with Smad3 binding (Laurence et al., 2007).  Furthermore, addition of IL-2 resulted 
in reduction of RORt levels and enhanced TGF--induced expression of Foxp3, suggesting that IL-
2/STAT5 pathway might shift the balance between Th17 and regulatory T cells. 
 
I.4. Transcriptional regulation of Th17 cells 
  
 As mentioned for Th1 and Th2 cell generation, the Th lineage commitment is determined by 
signaling through cytokine receptors and subsequent induction or activation of specific transcription 
factors, which ultimately initiate and maintain the expression of Th lineage-specific genes.  Similar 
regulatory mechanisms also occur during Th17 cell commitment.  In the present section, we will discuss 
the role of several transcription factors that have been shown to play either positive or negative 
regulatory functions for Th17 cell generation (summarized in Figure 3).  However, it is noteworthy 
mentioning that many of these transcription factors have also been shown to regulate the generation of 
other Th cell subsets or T cell development.   
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Figure 3.  Transcriptional regulation of Th17 cell differentiation. Naïve CD4+ T cells stimulated 
under the presence of IL-6 and/or IL-21 induce activation of the signal transducer and activator of 
transcription 3 (STAT3). Activation of STAT3 induces the expression of retinoic-acid-receptor-related 
orphan receptor- (ROR) and RORt, which establish the expression of Th17-specific gene program.  
The role of STAT3 in directly inducing IRF4 remains unclear. And whether IRF4 also directly 
regulates RORs expression is currently unknown.  STAT1, downstream of IFN- and IL-27 signaling, 
or STAT5, downstream of IL-2 signalling, as well as ETS1, negatively regulate Th17 cell generation. 
Moreover, the transcription factor forkhead box P3 (Foxp3), induced by transforming growth factor-
(TGF-) signalling, antagonizes the Th17 developmental program by directly binding to ROR or 
RORt. Several transcription factors regulate the expression of Th17-associated cytokines in synergism 
with ROR/RORt including BATF, which binds to JunB, IB and AHR, which mainly control IL-22 
production.  How or whether TGF- signaling regulates the expression of Th17-associated transcription 
factors (IB, BATF, AHR, ROR and RORt) or Th17-specific cytokines and chemokines needs 
further clarification.
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I.4.a. STATs 
 
Most of the cytokines required for differentiation of Th lineages bind to Type I/II cytokine 
receptors.  Unlike receptors with intrinsic enzymatic activity, these receptors associate with Janus 
kinases (Jaks), which become activated upon binding of cytokines to their cognate receptors.  After 
becoming activated, Jaks phosphorylate tyrosine residues in the cytokine receptor cytoplasmic domain 
providing a docking site for SH2 (Src homology 2)-containing proteins such as STATs.  Once they 
interact with the receptor, STATs also become phosphorylated, then dimerize and translocate to the 
nucleus to bind DNA target sequences (reviewed in (O'Shea and Murray, 2008)) 
It has been recently shown that STAT1, activated by IL-27 and type I/II IFNs, and IL-2-induced 
STAT5 activation negatively regulate Th17 cell differentiation (Amadi-Obi et al., 2007; Batten et al., 
2006; Harrington et al., 2005; Laurence et al., 2007; Stumhofer et al., 2006), whereas no role has been 
shown for STAT4 or STAT6 (Harrington et al., 2005; Park, 2005).  However, it has been recently 
suggested that STAT4 is required for the synergistic effect of IL-18 and IL-23 in IL-17 production 
(Mathur et al., 2007).  
The requirement of STAT3 in Th17 cell differentiation was originally suggested by studies 
performed using mice deficient in SOCS3, where increased IL-17 production was observed.  This 
phenotype was associated with enhanced STAT3 activity and binding to il17a and il17f promoters in 
response to IL-23 (Chen et al., 2006b).  Furthermore, over-expression of a constitutively active STAT3 
was shown to increase Th17 cell generation whereas deficiency in STAT3 results in impaired Th17 cell 
differentiation in vitro (Laurence et al., 2007; Yang et al., 2007) and in vivo (Zhou et al., 2007).  
Consistent with these findings, patients with STAT3 mutations (in Hyper IgE syndrome) fail to induce 
Th17 responses (Milner et al., 2008).  Moreover, STAT3 is also required for IL-21 expression induced 
by IL-6, and similarly for IL-21-induced Th17 differentiation (Nurieva et al., 2007).  Even though 
STAT3 can bind to il-17a gene promoter (Chen et al., 2006b), STAT3 seems to regulate more than IL-
17 expression in Th17 cells.  It is plausible that STAT3, similar to what occurs with STAT1 and STAT6 
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in Th1 and Th2 differentiation respectively, can regulate the expression of the two Th17 master 
transcription factors retinoic acid receptor (RAR)-related orphan receptor gamma-t (RORt) (Ivanov et 
al., 2006; Laurence et al., 2007; Yang et al., 2007) and ROR (Yang et al., 2008c).   
 
I.4.b. RORt and ROR 
 
RORt was the first master transcription factor identified for Th17 cells (Ivanov et al., 2006).  
Both ROR and T-cell expressed ROR (RORt) are encoded by the same gene Rorc but are expressed 
using alternative promoters. Together with ROR and ROR, ROR and RORt belong to the RAR 
(retinoic acid receptor) orphan nuclear hormone receptor family (reviewed in (Jetten, 2009)  and 
summarized in Figure 4).   
Over-expression of RORt in Th cells leads to the generation of Th17 cells when development 
of Th1 and Th2 cells is inhibited.  RORt, which is regulated by transcription factor STAT3 (Laurence 
et al., 2007; Yang et al., 2007), is required for induction of Th17-specific cytokines IL-17 and IL-17F 
(Ivanov et al., 2006). Conversely, mice deficient in RORt have reduced induction of Th17 cells in vivo 
and therefore displayed reduced susceptibility to EAE disease (Ivanov et al., 2006).  Moreover, reduced 
Th17 cells have also been observed in intestinal lamina propria from RORt-deficient mice compared to 
wild type controls.   
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Figure 4. Schematic illustration of ROR family members. ROR family members include ROR, 
ROR and ROR.  Several isoforms of each member have been described, due to either alternative 
promoter usage or alternative splicing (sequences shown with patterns in the N-terminal region of 
each ROR family member).  Also indicated are the ligand binding domain (LBD), the DNA binding 
domain (DBD) and the activation function 2 (AF2) domain, with the amino acid sequence PLKELF.  
In the right, the expression of these members in human or mouse is indicated by a +.  Adapted from 
Jetten, 2009.
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Besides RORt, Th17 cells show high expression of the orphan nuclear receptor ROR.  Over-
expression of ROR also promotes Th cells to become Th17 cells (Yang et al., 2008c).  Deficiency in 
ROR leads to reduced IL-17 expression both in vivo and in vitro.  Whereas either RORt- or ROR-
deficient mice exhibit reduced EAE disease severity and Th17 cell generation, deficiency in both ROR 
and RORt leads to complete resistance to EAE and impaired induction of Th17 cells in vitro and in 
vivo (Yang et al., 2008c).  Indeed, over-expression of both ROR and RORt resulted in a synergistic 
induction of Th17 cells, even under unfavorable settings in which cells were stimulated under Th1-, 
Th2- or iTreg-skewing conditions (Yang et al., 2008c).  Thus, these results confirm the requirement of 
these two transcription factors in the induction of Th17 cells.  How the two transcription factors 
coordinately regulate Th17 cell responses though remains unclear.    
 
I.4.c. BATF 
 
The AP-1 transcription factor BATF (basic leucine zipper transcription factor, ATF-like) is also 
an important factor for the generation of Th17 cells (Schraml et al., 2009).  BATF was found to 
associate with JunB and directly bind to Il21, Il22 and Il17a promoters in addition to two intergenic 
regions between Il17a-Il17f genes (Schraml et al., 2009).  By using BATF-deficient T cells, Schraml et 
al. showed that BATF is dispensable for Th1 or Th2 cell induction in vitro despite BATF expression in 
these two T cell lineages.  However, T cells lacking BATF were unable to become Th17 cells in vivo or 
upon stimulation with TGF- and IL-6 in vitro (Schraml et al., 2009).   Consistent with these 
observations, BATF-deficient mice were resistant to EAE disease.  At the molecular level, Th cells 
lacking BATF were able to induce ROR and RORt expression at early time points during Th17 cell 
generation (Schraml et al., 2009).  However, these cells were unable to maintain the expression of these 
transcription factors, suggesting that BATF participates directly or indirectly in the maintenance of 
RORs expression in Th17 cells.  Furthermore, Schraml et al also established by over-expression studies 
that BATF and RORt synergize in the induction of Th17 cells, and that these two transcription factors 
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bind to overlapped conserved sequence in the il17a gene (Schraml et al., 2009).  However, over-
expression of RORt in cells lacking BATF failed to induce Th17 cells, suggesting that the synergism 
between these two transcription factors is indispensable for proper generation of Th17 cells.  BATF has 
been previously considered as an AP-1 repressor (Dorsey et al., 1995; Echlin et al., 2000).  Thus, even 
though Schraml et al. demonstrated that binding of BATF with JunB directly regulates Th17-associated 
genes, it still remains unclear whether AP-1 might have an inhibitory role in the induction of Th17 
genes.   
 
I.4.d. IRF4 
 
Interferon Regulatory Factor 4 (IRF4) has been previously shown to regulate development of 
Th2 cells by activation of GATA-3 (Hu et al., 2002; Lohoff et al., 2002; Rengarajan et al., 2002).  
Recently, Brustle et al. also demonstrated that IRF4 is crucial in directing Th17 cell differentiation 
(Brustle et al., 2007).  Th cells deficient in IRF4, or treated with IRF4 siRNA, failed to commit towards 
the Th17 cell lineage.  Indeed, IRF4-deficient Th cells showed impaired RORt expression while 
induction of Foxp3 was enhanced (Brustle et al., 2007).  Also, Irf4-/- mice were resistant to EAE 
induction. However, transfer of wild type Th cells into IRF4 KO mice rescued Th17 cell generation and 
rendered these mice susceptible to EAE disease, demonstrating a T cell-intrinisc role of IRF4 in this 
process (Brustle et al., 2007).     
 
I.4.e. AHR 
 
Another transcription factor shown to regulate Th17 cell generation is the Aryl Hydrocarbon 
Receptor (AHR), a type I nuclear receptor which interacts with Hsp90 upon binding to its ligand 
(Schmidt and Bradfield, 1996).  Even though AHR is expressed both in regulatory T cells as well as 
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Th17 cells, in comparison its expression is significantly enhanced in Th17 cells (Quintana et al., 2008; 
Veldhoen et al., 2008a).  Veldhoen et al demonstrated that AHR-deficient Th cells have defective IL-22 
production, although other Th17 cytokines were not dramatically affected (Veldhoen et al., 2008a).  IL-
22 has been shown to protect against hepatic damage in an acute inflammation model (Zenewicz et al., 
2007).  Consistently, mice lacking AHR develop hepatic defects (Schmidt et al., 1996). 
 Whereas Th17 and Treg levels were not affected in AHR-deficient mice, an increase in either 
Tregs or Th17 cells was observed upon ligation of this receptor with different ligands.  Binding of AHR 
to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) led to an increase in Foxp3 levels, due to a direct 
binding of AHR transcription factor to Foxp3 promoter (Quintana et al., 2008).  Consistently, 
administration of one dose of TCDD in vivo before MOG immunization significantly inhibited EAE 
induction and reduced disease severity (Quintana et al., 2008).  On the other hand, ligation of AHR with 
6-formylindolo[3,2-b]carbazole (FICZ) in vitro during generation of Th17 cells significantly increased 
expression of Th17 cytokines IL-17, IL-17F and most dramatically IL-22 (Quintana et al., 2008; 
Veldhoen et al., 2008a).   Moreover, mice treated with FICZ at the time of MOG immunization showed 
enhanced Th17 cell generation and more severe EAE disease development (Quintana et al., 2008; 
Veldhoen et al., 2008a).  Thus, AHR is an important transcription factor that can regulate Th17/Treg 
balance depending on environmental factors/ligands that bind to it.  
 
I.4.f. T-bet and GATA3 
 
As previously mentioned, terminal differentiation of Th subsets is distinguished by the selective 
expression of lineage-specific transcription factors.  Th1 cells express the master transcription factor T-
bet, whereas Th2 cells express GATA3 (Dong and Flavell, 2000).  Mice lacking T-bet showed enhanced 
IL-17-producing Th cells upon immunization with MOG peptide (Park et al., 2005).   Moreover, T-bet-
deficient mice developed enhanced experimental autoimmune myocarditis compared to wild type 
counterparts, which correlated with increased IL-17-producing T cells infiltrating the heart (Rangachari 
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et al., 2006).  Furthermore, using an allergic airway inflammation model, Fujiwara et al. recently 
demonstrated that T-bet not only inhibits eosinophil recruitment by Th2 cells but also Th17-mediated 
neutrophilic inflammation (Fujiwara et al., 2007).  The same group later demonstrated that whereas T–
bet deficient mice had enhanced Th17 cell generation, mice lacking STAT4 or both STAT4 and T-bet 
had diminished antigen-specific IL-17-producing cells (Furuta et al., 2008).  It has also been 
demonstrated using Trypanozoma cruzi infection model that T-bet is able to regulate in a T cell-intrinsic 
fashion the generation of antigen-specific Th17 cells (Guo et al., 2009).  However, recently it has been 
shown that Th17 cells infiltrating the central nervous system during EAE are able to express T-bet and 
that indeed T-bet expression is crucial for encephalitogenicity of Th1 and Th17 cells (Yang et al., 2009).  
Consistent with this report, Dorf and colleagues have recently shown that CNS infiltrating T cells that 
express both T-bet and RORt produce IFN- but vary in their IL-17 expression (Abromson-Leeman et 
al., 2009).  However, Lovett-Racke and colleagues recently reported that suppression of T-bet reduced 
EAE disease severity by decreasing Th1 autorreactive T cells as well as restraining generation of Th17 
cells through the regulation of IL-23R (Gocke et al., 2007).  More recently, Glimcher and colleagues 
have demonstrated that T-bet inhibits the expression of the master transcription factor RORt by 
preventing Runx1-induced transcription of Rorc gene.  However, even though T-bet inhibits the 
expression of RORt, and thus the development of Th17 cells, over-expression of both T-bet and RORt 
still led to inhibition of IL-17-producing cells, clearly indicating that there is still an unidentified 
mechanism by which T-bet inhibits commitment to Th17 cells (Lazarevic et al., 2011).  Thus, the 
precise role of T-bet, particularly in cells expressing both IFN- and IL-17 found in autoimmune 
diseases still remains controversial.  
The role of GATA3 in Th17 cells has also been addressed.  By utilizing arthritis model in 
transgenic mice overexpressing GATA3 on T cells (CD2-promoter driven), van Hamburg et al. recently 
showed that GATA3 inhibits the generation of IL-17-producing T cells systemically and in the local 
inflammation site (van Hamburg et al., 2009).  Moreover, GATA3 over-expression led to reduced 
expression of the Th17 master transcription factor RORt (van Hamburg et al., 2009).  However, since 
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enhanced Th2 cytokines were also observed, it still remains unclear whether the GATA3 effect on Th17 
cells is direct.  
 
I.5. Th cells with suppressive function: natural and inducible regulatory T cells  
 
The immune system in higher organisms has evolved to be able to recognize and fight against 
pathogens.  However, side effects such as immune responses against self-tissues (autoimmunity), 
commensal microorganisms or even environmental antigens often develop.  Thus, mechanisms to 
prevent such unwanted responses are needed.  Several cell types have been shown to control 
inflammatory responses due to their suppressive nature, including tolerogenic dendritic cells, NKT cells, 
myeloid suppressor cells as well as certain subtypes of B and T cells.  Based on their origin, CD4+ T 
cells with suppressive function can be divided into two groups: i) cells with a thymic origin which have 
never been exposed to their cognate antigen prior to their generation, constituted only by thymus-
derived natural regulatory T cells (nTregs), or ii) cells generated after exposure to their cognate antigen, 
constituted by inducible regulatory T cells (iTregs), IL-10-producing Th cells (Tr1 cells) and TGF--
producing Th cells (Th3 cells).  One hallmark of both natural and inducible regulatory T cells is the 
expression of the master transcription factor Foxp3 (Fig. 5).     
 The identification of thymus-derived natural regulatory T cells became evident in experiments 
using neonatal thymectomized mice, which develop severe inflammatory responses.  However, transfer 
of T cells from euthymic mice (expressing the IL-2R chain, CD25) prevented disease development 
(Sakaguchi et al., 1995; Suri-Payer et al., 1998).  Furthermore, Powrie and Mason showed that adoptive 
transfer of naïve T cells (CD4+CD45RBhigh) into lymphopenic mice caused development of 
inflammatory bowel disease, while co-transfer of CD4+CD45RBlow cells prevented disease induction 
(Powrie and Mason, 1990).  These results clearly demonstrate the existence of a CD4+ T cell population 
with suppressive phenotype. 
 
Figure 5.  Development of natural and inducible regulatory T cells. The expression of the master 
transcription factor forkhead box P3 (Foxp3) defines the regulatory Th subset. Foxp3 expression can be 
acquired in the thymus, and these cells are termed natural Treg cells (nTreg).  The exact mechanism by 
which Foxp3 is induced in thymic CD4 single positive T cells is not entirely understood, but cytokines 
that utilize the common -chain subunit receptor, such as IL-2, are required for nTreg development.  
The role of TGF- in this process is still contradictory.  However, both TGF- and IL-2 are required in 
peripheral tissues for nTreg cell maintenance.  Foxp3 expression can also be induced in the periphery 
from naïve Th cells, in a TGF--dependent manner upon antigen-induced activation of naïve T cells.  
Also, retinoic acid, a vitamin A metabolite, can induce Foxp3 expression in peripheral tissue, primarily 
the gut.  Adapted from Huehn et al., 2009.
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In an attempt to further characterize these regulatory T cells, Foxp3 was then identified as the 
transcription factor required for their generation and suppressive function (Fontenot et al., 2003; Hori et 
al., 2003; Khattri et al., 2003).  Indeed, mice deficient in Foxp3 (scurfy mice) or patients with IPEX 
(Immune-dysregulation Polyendocrinopathy Enteropathy X-linked) syndrome, who show several 
mutations in Foxp3 gene, display a similar autoimmune phenotype as the one observed in neonatal 
thymectomized mice (Brunkow et al., 2001; Chatila et al., 2000; Wildin et al., 2001).  Both mice and 
human diseases are characterized by lymphoproliferation, and infiltration of lymphocytes to several 
tissues.  The role of Foxp3 as the master transcription factor involved in regulatory T cells function has 
been widely confirmed by independent laboratories throughout the world.    
Besides the thymic origin of Foxp3-expressing natural regulatory T cells, cumulative evidence 
has shown that Foxp3 can be acquired in the periphery in a TGF--dependent manner from naïve CD4+ 
Th cells (reviewed in (Curotto de Lafaille and Lafaille, 2009), Fig. 1 and Fig. 5).  TGF- plays an 
important role in the development, maintenance, and induction of regulatory T cells (Chen et al., 2003; 
Curotto de Lafaille et al., 2008; Fantini et al., 2004).  TGF--induced activation of Smad3 leads to its 
recruitment to a cis-regulatory region in Foxp3 gene, and the induction of Foxp3 expression in 
synergism with NFAT (Nuclear Factor of Activated T cells) (Tone et al., 2008).  Furthermore, this 
conserved non-coding sequence (CNS) region has been shown to be crucial for the development of 
iTreg cells, whereas it is completely dispensable for induction of nTreg cells in mice (Zheng et al., 
2010).  
 Foxp3 expression is crucial and required for regulatory T cell function.  Indeed, forced over-
expression of Foxp3 in CD4+ Th cells leads to enhanced expression of Treg-associated markers such as 
CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4), GITR (Glucocorticoid-Induced TNFR-Related protein), 
and acquisition of a suppressive phenotype (Fontenot et al., 2003; Hori et al., 2003).  Furthermore, as a 
master regulator of this lineage commitment, Foxp3 controls its own expression by binding to the 
regulatory element CNS2 in Foxp3 gene in a Cbf--Runx1 dependent manner (Zheng et al., 2010). 
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The relative abundance of effector and suppressor cells will then determine the outcome of an 
immune response.  Excessive control of inflammatory responses by regulatory T cells may promote 
enhanced pathogen survival and/or growth whereas defective suppressive function might lead to 
“collateral” injury to the host tissues due to an increased inflammatory response.  Furthermore, this 
sustained inflammatory response might provoke the induction of autoimmunity.  Indeed, defective 
regulatory T cell activity or numbers has been documented in several autoimmune disorders (reviewed 
in (Jager and Kuchroo, 2010; Littman and Rudensky, 2010; Vila et al., 2009)).  In the following section 
we will focus our attention to the role of inflammatory and regulatory cells in inflammation, 
autoimmunity and cancer. 
 
I.6. Role of Th17 and regulatory T cells in inflammation, autoimmunity and cancer 
 
Over the past few years, Th17 and regulatory T cells, with opposing functions in the immune 
system, have been a major focus of research in several types of diseases, ranging from infectious 
diseases to cancer, inflammation and autoimmunity (reviewed in (Jager and Kuchroo, 2010; Littman 
and Rudensky, 2010; Martinez et al., 2008)).  In this section, we will center our attention to the latest 
findings and controversies on the role of Th17 and regulatory T cells in cancer and autoimmune diseases. 
 
I.6.a. Role of Th17 and Treg cells in cancer 
 
Regulatory T cells inhibit T cell proliferation (Wing et al., 2006) and play important roles in 
hindering anti-tumor immune responses in mouse models (Danese and Rutella, 2007).  Indeed, depletion 
of CD4+CD25+ nTreg cells allows the rejection of a colon tumor (Golgher et al., 2002).  Furthermore, 
high frequency of regulatory T cells have been detected in peripheral blood, draining lymph nodes and 
in tumor sites from patients with cancer (Danese and Rutella, 2007).   
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Several tumors directly secrete IL-10 and TGF-two cytokines that can either induce or 
maintain the generation of regulatory T cells.  TGF- is an important cytokine driving the generation of 
both regulatory and Th17 cells, by inducing the expression of Foxp3 and RORt master transcription 
factors respectively (Ivanov et al., 2006; Marie et al., 2005).  Therefore, TGF- secretion by tumor cells 
or the tumor microenvironment might lead to the development of regulatory T cells or Th17 cells, 
depending on the presence and relative abundance of pro-inflammatory cytokines.  In fact, the tumor 
microenvironment has been found to directly induce the de novo generation of Treg cells (Danese and 
Rutella, 2007), and similar kinetics in recruitment of both Th17 and Treg cells have been observed in 
several tumor microenvironments (Kryczek et al., 2007b).   
The role of Th17 cells in tumor progression/destruction is controversial.  IL-17, produced 
among others by Th17 cells, can stimulate the production of chemokines or cytokines associated with an 
inflammatory process ((Kawaguchi et al., 2004) and reviewed in (Martinez et al., 2008)), and certain 
cancers take advantage of inflammatory mediators for their own benefit to induce angiogenesis and 
tissue destruction/remodeling (Coussens and Werb, 2002; Numasaki et al., 2005).  Also, IL-23, which is 
required to promote Th17 cell expansion and survival, has been shown to be an important factor in 
tumor cell growth and development (Langowski et al., 2006).  On the contrary, recruitment of CD8+ T 
lymphocytes with cytotoxic activity against the tumor can also be enhanced by IL-17 (Benchetrit et al., 
2002).  Moreover, transfer of melanoma-specific Th17 cells into mice confers resistance to tumor 
growth, indicating Th17 cells have an important role in the induction of anti-tumor immune responses 
(Martin-Orozco et al., 2009b; Muranski et al., 2008).  Thus, it still remains controversial whether 
inflammatory responses induced by Th17 cells have pro- or anti-tumor capacities.   
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I.6.b. Role of Th17 and Treg cells in autoimmune/inflammatory diseases 
 
Th17 cells have been shown to have major pathogenic roles in several autoimmune and 
inflammatory diseases.  While in this section we will focus only on multiple sclerosis, Th17 cells play 
important roles in the induction of other diseases including psoriasis (Lowes et al., 2008), rheumatoid 
arthritis (Agarwal et al., 2008; Hirota et al., 2007a; Hirota et al., 2007b; Joosten et al., 2008; Kohno et 
al., 2008; Nistala et al., 2008), Sjörgren’s syndrome (Nguyen et al., 2008), systemic lupus erithematosus 
(Herber et al., 2007; Sawalha et al., 2008; Wong et al., 2008) and systemic sclerosis (Deleuran and 
Abraham, 2007; Murata et al., 2008), among others (reviewed in (Martinez et al., 2008)).  Also, recently 
it was demonstrated that in BDX2 mice, which spontaneously develop autoimmune disease, Th17 cells 
induce autoreactive germinal centers (Hsu et al., 2008).  Furthermore, Th17-associated cytokines IL-
17A, IL-17F and IL-23 can induce the expression of chemokines such as GRO-alpha/CXCL1, MIP-
1beta/CCL4 and IL-8/CXCL8 by human eosinophils, possibly implicating these cytokines in allergic 
inflammation (Cheung et al., 2008) (Fig. 2).   
Multiple sclerosis is a human disease characterized by an ascending paralysis due to an 
inflammatory demyelinating response.  T cells, primarily Th17 cells, play a crucial role in the disease 
onset and progression.  In rodents, ascending paralysis can be induced upon immunization with peptides 
derived from myelin protein, or by adoptive transfer of myelin-specific T cells.  This model in rodents is 
termed experimental autoimmune encephalomyelitis (EAE), and is the mouse homologue to human 
multiple sclerosis.  Before the description of Th17 cells as an independent Th lineage, Th1 cells were 
believed to play an important role in the pathogenesis of this disease.  However, mice deficient in 
STAT1, IL-12 p35 or IFN-showed enhanced susceptibility to EAE, contradicting the current paradigm 
at the time (Bettelli et al., 2004; Ferber et al., 1996; Segal et al., 1998).  It is now well established that 
Th17 cells, rather than Th1 cells, are the primary reactive cells inducing this disease (Cua et al., 2003; 
Langrish et al., 2005; Park et al., 2005; Yang et al., 2008a) .  
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The role of Th17-associated cytokines has been evaluated in the induction and/or maintenance 
of EAE disease.  Even though Th17 cells express IL-22, IL-17 and IL-17F in the central nervous system 
(CNS), IL-17 but not IL-22 or IL-17F is directly required for disease induction (Kreymborg et al., 2007; 
Yang et al., 2008a).  Another cytokine expressed by cells infiltrating the CNS is IL-21, which is 
primarily produced by Th17 cells.  Mice lacking IL-21 or its receptor have delay in EAE disease onset 
and have an overall decrease in disease severity (Korn et al., 2007a; Nurieva et al., 2007).  
 Even though IL-22 seems to be dispensable for induction of EAE, IL-17R and IL-22R are 
highly expressed on CNS vessels within highly infiltrated lesions in brain samples from multiple 
sclerosis patients (Kebir et al., 2007).  IL-17 and IL-22 can increase the permeability of endothelial cells.  
Consistent with this observation, human Th17 cells were able to migrate more avidly across human 
brain-derived microvascular endothelial cells when compared to Th1 cells, indicating that by producing 
IL-17 and IL-22, Th17 cells can access the CNS parenchyma (Kebir et al., 2007).  Also, CD4+CD45RO+ 
cells expressing both IL-22 and IL-17 have been found in highly infiltrated multiple sclerosis lesions 
compared to non-inflamed brain samples (Kebir et al., 2007; Tzartos et al., 2008). 
Due to the controveries on whether Th1 or Th17 cells are required in the induction or 
maintenance of disease, Goverman’s group evaluated the role of these cells in EAE and found that 
inflammation in brain or spinal cord depends on the Th1:Th17 ratio of antigen-specific cells (Stromnes 
et al., 2008).  Low and high ratios of Th17:Th1 cells infiltrate the spinal cord and brain meninges at 
early stages during disease development.  However, at later stages infiltration of cells into brain 
parenchyma occurs only at high Th17:Th1 ratios, while infiltration into spinal cord parenchyma occurs 
at high Th1:Th17 ratios (Stromnes et al., 2008). 
Regulatory T cells restrict over-reactive responses by inhibiting T cell proliferation, and thus 
have crucial roles in preventing the induction or maintenance of autoimmune diseases (reviewed in 
(Littman and Rudensky, 2010)).  In EAE settings, Kuchroo and colleagues have demonstrated that while 
antigen-specific regulatory T cells are generated in peripheral tissues and accumulate in the CNS, they 
do not prevent EAE disease onset (Korn et al., 2007b).  However, these regulatory T cells infiltrating 
the CNS are capable of suppressing in vitro naïve T cell proliferation, but are unable to suppress 
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encephalitogenic effector T cells (Korn et al., 2007b).  In human multiple sclerosis, however, no Foxp3+ 
Treg cells were observed in either active or inactive areas of brain tissues (Tzartos et al., 2008), 
indicating a possible difference between human and mouse systems.  On the other hand, in an arthritis 
model, enhanced Th17 cell levels were detected as disease progressed from the mild form of persistent 
oligoarthritis to the more severe form of disease (extended oligoarthritis), whereas an inverse correlation 
was found with regulatory T cells (Nistala et al., 2008).  Thus, even though Treg cells have been clearly 
shown to mediate immune suppression, their exact role in autoimmune diseases in human versus mouse 
systems needs further investigation. 
 
I.7. Objective, hypothesis and specific aims of the present work 
 
The main goal of the present dissertation is to understand the events involved in the induction of 
inflammatory versus suppressive responses by investigating the developmental pathways and factors 
required for the commitment towards Th17 or regulatory T cells, two Th cell lineages with opposing 
functions in the immune system.    In particular, the objective of this dissertation is to further understand 
the reciprocal regulation of Th17 and regulatory T cells so that we can identify key target molecules that 
drive or repress differentiation of each cell lineage at the transcriptional level.  The identification of 
these molecules will aid the development of tools for possible therapies to enhance the commitment to 
one cell lineage while inhibiting the commitment towards the other.  This approach could be used for 
targeting diseases where the balance of these T cells is dysregulated, such as in autoimmunity, chronic 
infectious diseases and cancer. 
We thus hypothesized that there is cross-regulation between Th17 and Treg genetic programs 
and that TGF- induces Th17 or Treg cells through differential signaling pathways.  For this purpose, in 
Chapter II, we have evaluated the role of the Treg-specific transcription factor, Foxp3, in development 
of Th17 cells.  Then, in Chapter III, we determined the requirement of the Smad-dependent TGF- 
signaling pathway in the generation of Th17 and Treg cells.   
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CHAPTER II – RECIPROCAL GENERATION OF TH17 AND                                
REGULATORY T CELLS1 
 
BACKGROUND 
 
In the presence of TGF-, naïve CD4+ T helper (Th) cells can differentiate into either 
suppressor or effector cells (Fig. 1).  TGF- plays an important role in the development of both iTreg 
and Th17 lineages by inducing the expression of the master transcription factors Foxp3 and RORt, 
respectively (Ivanov et al., 2006; Marie et al., 2005).  The requirement of TGF- in the induction of 
iTreg and Th17 cells suggested that these two Th cell lineages, with opposing functions in the immune 
system, may be reciprocally regulated (Fig. 6 and (Bettelli et al., 2006)).  The commitment towards 
either cell lineage therefore depends on additional cytokines present in the microenvironment during T 
cell priming.  Whereas IL-2 regulates the generation of inducible regulatory T (iTreg) cells, IL-6 and/or 
IL-21 induces the generation of Th17 cells (Bettelli et al., 2006; Korn et al., 2007a; Mangan et al., 2006; 
Nurieva et al., 2007; Setoguchi et al., 2005; Veldhoen et al., 2006a).   
In a TGF--rich environment like the gut, presence of a pathogen would induce the activation of 
antigen-presenting cells such as dendritic cells, through the recognition of PAMPs by PRRs.  
Consequently, these activated antigen preseting cells would secrete pro-inflammatory cytokines such as 
IL-6 and IL-23 (Fig. 6).  Thus TGF- and IL-6 would induce the generation of IL-17-producing T cells, 
and IL-23 would further expand these cells.  Moreover, Th17 cells produce IL-21, which would act in 
an autocrine manner to further amplify the induction of Th17 cells in the local microenvironment.  Th17 
cells also secrete IL-17 and IL-17F, which induce the production of G-CSF and IL-8 by epithelial cells 
and fibroblast, leading to the recruitmennt of neutrophils and therefore enhancing the inflammatory 
                                                 
1 The results presented in this Chapter have been published in Yang et al., 2008b. 
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process (Fig. 6).  Also, Th17-associated cytokines can induce the secretion of anti-microbial peptides 
from epithelial cells to help fight the ongoing infection (Fig. 6).   
On the contrary, if the naïve T cell priming occurs in the absence of “danger signals” 
(homeostatic conditions), then the mucosal dendritic cells presenting antigens would produce retinoic 
acid.  This vitamin A derivative inhibits TGF-–dependent Th17 cell generation through inhibition of 
RORt expression while promoting Foxp3+ Treg cell differentiation (Elias et al., 2008; Kang et al., 
2007; Mucida et al., 2007; Schambach et al., 2007; Sun et al., 2007).  Retinoic acid was found to 
enhance Smad3 protein and phosphorylation levels, resulting in increased TGF- signaling, which 
would then lead to increased Foxp3 expression and reduced expression of Th17-associated genes IL-6R, 
IL-23R and IRF4 in a Stat3- and Stat5-independent manner (Elias et al., 2008; Xiao et al., 2008).  Thus, 
retinoic acid, together with TGF- would favor the commitment towards a regulatory T cell, which 
produces IL-10, IL-35 and TGF-, playing important roles in immune-suppression (Fig. 6).  
Foxp3 is a member of the forkhead/winged-helix family of transcription factors (reviewed in 
(Zhou et al., 2008b)).  It has been demonstrated that Foxp3 can interact with other transcription factors, 
including AP-1 (Activator Protein 1) (Lee et al., 2008), NF-B (Nuclear Factor of kappa light 
polypeptide gene enhancer in B cells) (Bettelli et al., 2005), NFAT (Bettelli et al., 2005; Wu et al., 
2006), Forkhead box Protein P1 (Foxp1) (Li et al., 2007b) and Runx1/AML1 (Runt-related transcription 
factor 1/acute myeloid leukemia 1) (Ono et al., 2007).  Furthermore, Foxp3 can also bind to proteins 
with enzymatic activity such as histone deacetylases HDAC1, HDAC9 and HDAC7 as well as HIV-1 
Tat interacting protein 60 KDa (TIP60) (Li et al., 2007a).  Interestingly though, it has been suggested 
that HDAC7 and TIP60, with opposing enzymatic activity, might compete for Foxp3 binding, implying 
a dynamic process (Zhou et al., 2008b).  Consistent with this idea, it has been shown that over-
expression of Foxp3 in T cells can lead to induction of transcription of some genes while inhibition of 
another group of genes.  The enhanced transcription was directly associated with acetylation of histone 
H3 whereas downregulation of transcription correlated with reduced acetylation of histon H3 (Chen et 
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al., 2006a).  Accordingly, Foxp3 can be found in two distinct molecular complexes upon over-
expression which might explain these opposite functions (Liang et al., 2006).  
Foxp3 has been shown to require Runx1 for its transcriptional activity (Ono et al., 2007).  
Interestingly, RORt, the Th17-specific transcription factor, also relies on Runx1 to induce transcription 
of il17a gene, suggesting that both Foxp3 and RORt might compete for Runx1 binding, which in turn 
would define the outcome of a cell becoming a regulatory T cell or a Th17 cell (Zhang et al., 2008).  
Furthermore, while TGF- stimulation leads to enhanced binding of Foxp3 to chromatin, stimulation of 
T cells with TGF- together with IL-6 results in reduced binding of Foxp3 to DNA (Samanta et al., 
2008), suggesting that the reciprocal regulation of these Th lineages might occur at the transcriptional 
level. 
Even though it is clear that Th17 and regulatory T cells are reciprocally regulated during their 
development, the exact molecular regulation of Th17 and iTreg cell genetic programs remains unclear.  
We thus analyzed how Foxp3, the Treg-specifc master transcription factor, can regulate the 
developmental process of the opposing Th17 lineage.  Our results have identified a molecular 
antagonism of Th17 and regulatory T cell genetic programs. 
 
Figure 6.  Reciprocal generation of Th17 and regulatory T cells. In a TGF--rich environment, 
naïve CD4+ Th cells can differentiate into either Th17 or regulatory T cells, depending on whether T 
cell priming occurs in the presence of “danger signals” or under homeostatic conditions.  In the 
absence of “danger signals” (top part), homeostatic dendritic cells present in the gut can convert 
vitamin A from the diet into retinoic acid, which would favor Foxp3 induction and therefore 
generation of inducible regulatory T cells (iTreg).  This scenario leads to an environment where 
immune suppression prevails.  In contrast, in the presence of danger signals, activated (mature) 
dendritic cells would produce pro-inflammatory cytokines such as IL-6, which together with TGF-, 
induce Th17 cell generation (bottom part).  Furthermore, these mature dendritic cells produce IL-23 
which further expands this IL-17-producing T cells.  Th17 cells, through the production of Il-22, IL-17 
and IL-17F induce neutrophil recruitment and production as well as the secretion of antimicrobial 
peptides from epithelial cells.  This scenario then leads to an inflammatory condition.  Adapted from 
Weaver and Hatton, 2009.
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RESULTS 
 
II.1. Foxp3 inhibits differentiation of Th17 cells independently of its DNA binding domain 
 
Previous work has shown that Th17 and regulatory T cells are reciprocally regulated by TGF-
(Bettelli et al., 2006).  Thus, we determined the kinetics for the induction of Th17 and iTreg cells by 
utilizing an IL-17F-RFP and Foxp3-GFP double reporter mouse model.  Naïve T cells from these mice 
were stimulated under Th17 or iTreg polarizing conditions in vitro and RFP and GFP expression was 
determined by flow cytometry (Fig. 7).  We found that during the first two days of in vitro 
differentiation, Foxp3 expression was induced independently of the polarizing condition utilized.  On 
the other hand, a significant proportion of IL-17F-RFP+ cells were observed the second day of culture 
upon Th17-polarizing stimuli.  However, on days three and four, Foxp3 expression was down-regulated 
under Th17-skewing conditions, corresponding with an enhancement of IL-17F-RFP+ cells (Fig. 7).  
Similar results were also obtained when expression of IL-17 and Foxp3 was determined by intracellular 
staining (data not shown). 
Given that Th17-polarizing conditions induced the expression of Foxp3, which was then down-
regulated as the differentiation proceeded, we next evaluated the role of sustained Foxp3 expression on 
Th17 cell differentiation.  For this purpose, Foxp3 was over-expressed in activated T cells by retroviral 
transduction with bicistronic virus containing IRES-GFP, which allows transduced cells to be identified 
based on GFP expression.  Naïve OT-II TCR transgenic T cells were cultured with irradiated T-cell 
depleted splenocytes as antigen presenting cells (APCs) under Th17-skewing conditions and after one 
day, cells were infected with viral supernatants.  Four days later, cells were analyzed for Foxp3 and IL-
17 expression by intracellular staining in GFP- (non-infected) or GFP+ (infected) cells.  Over-expression 
of Foxp3 greatly reduced the generation of IL-17-producing T cells compared to cells infected with a 
control virus (Fig. 8A).   
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Figure 7. Transient induction of Foxp3 expression in developing Th17 cells.  FACS-sorted naïve 
T cells from IL-17F-RFP x Foxp3-GFP mice were activated under Th17 (TGF-, IL-6, anti-IFN-, 
anti-IL-4) or iTreg (TGF-, IL-2, anti-IFN-, anti-IL-4) conditions.  GFP and RFP expression was 
assessed daily by flow cytometry.  A representative experiment out of three is shown.  Similar 
results were also obtained by performing intracellular cytokine staining.  Reprinted from “Molecular 
antagonism and plasticity of regulatory and inflammatory T cell programs.” Xuexian O. Yang, Roza
Nurieva, Gustavo J. Martinez, Hong Soon Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, 
Seon Hee Chang, Kimberly S. Schluns, Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten
and Chen Dong. Immunity. 2008. 29(1):44-56 with permission from Elsevier.
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Figure 8. Foxp3 over-expression inhibits Th17 cell generation.  FACS-sorted naïve T cells from 
OT-II TCR transgenic mice were activated under Th17 conditions (TGF-, IL-6, anti-IFN-, anti-IL-
4) and infected with an IRES-GFP-containing bicistronic retrovirus expressing Foxp3 or a vector 
control virus.  GFP- and GFP+ cells were FACS-sorted, and IL-17- and Foxp3-expressing cells were 
measured by intracellular staining on each population.  The experiments were repeated at least three 
times with similar results.  (B) GFP- or GFP+ cells from (A) were restimulated for 4 hours with anti-
CD3.  mRNA expression of indicated genes was analyzed by real-time RT–PCR.  The data shown 
were normalized to expression of a reference gene -actin.  The lowest expression levels for each gene 
were referred as 1.  Data shows mean ± S.D.  A representative experiment out of four is shown. 
Reprinted from “Molecular antagonism and plasticity of regulatory and inflammatory T cell 
programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. Martinez, Hong Soon Kang, Yeonseok
Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, Kimberly S. Schluns, Stephanie S. 
Watowich, Xin-Hua Feng, Anton M. Jetten and Chen Dong. Immunity. 2008. 29(1):44-56 with 
permission from Elsevier.
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To identify the mechanism by which Foxp3 inhibits the generation of IL-17-producing T cells, 
cells were purified by FACS-sorting based on GFP expression and their gene expression profile was 
determined by real time RT-PCR.  Compared to cells infected with a control virus, cells over-expressing 
Foxp3 exhibited lower IL-17, IL-17F and IL-21 mRNA levels, while the expression of the two major 
Th17 transcription factors ROR and ROR was not affected (Fig. 8B).  These results suggested that 
Foxp3 might affect Th17 cell generation by directly hindering with the function of these Th17-
associated transcription factors. 
To test the hypothesis that Foxp3 interferes with ROR or RORt transcriptional activity, we 
used a luciferase reporter assay.  EL-4 thymoma cells were transfected with a luciferase reporter vector 
where Firefly Luciferase was cloned under the control of an Il17 promoter and conserved non-coding 
sequence 2 (CNS2) region (Yang et al., 2008c) in the presence or absence of vectors coding for ROR 
RORt and/or Foxp3.  Expression of either ROR or RORt alone led to substantial luciferase activity 
while co-expression of Foxp3 inhibited this induction (Fig. 9A and B).  Furthermore, Foxp3 also 
inhibited RORt activation of a RORE (ROR response element) luciferase reporter in a dose-dependent 
manner (Fig. 9C).  Although no putative Foxp3-binding sites were identified in Il17 promoter, CNS2 
region or RORE luciferase vector, we tested whether Foxp3 DNA binding or homo-dimerization 
domains were required for the suppression of RORt or ROR function.  By using site-directed 
mutagenesis, two Foxp3 mutants were cloned into the retrovirus vectors: i) Foxp3 FKH/NLS, a mutant 
containing the SV40 nuclear localization sequence but lacking the forkhead domain (Lee et al., 2008), 
or ii) Foxp3 E250, a mutant that contains a single amino acid deletion in the leucine-zipper domain 
which impairs its ability to homo-dimerize and thus reduces its ability to bind DNA (Chae et al., 2006).  
Co-expression of Foxp3 mutants were still found to inhibit both ROR and RORt-induced luciferase 
activity (Fig. 9A and B).  Also, Foxp3E250 and Foxp3 FKH/NLS were able to inhibit Th17 cell 
generation in primary T cells (Fig. 9D).  Together, these data indicated that sustained Foxp3 expression 
decreased Th17 cell development through inhibition of ROR and RORt transcriptional activity in a 
process that is independent of DNA binding. 
Figure 9. Foxp3 inhibits ROR and RORt transcriptional activity independent of DNA binding 
or homo-dimerization. (A-B) EL-4 cells were transfected with a vector containing the firefly 
luciferase gene under the control of the Il17 promoter-CNS2 region, a vector expressing Renilla
luciferase, and IRES-GFP-containing bicistronic vectors expressing RORt (A) or ROR (B), Foxp3 
wild-type (WT) or various Foxp3 mutants, or vector alone.  Cells were stimulated with PMA and 
ionomycin, and luciferase activity was determined and normalized to Renilla luciferase.  Values were 
also normalized to vector alone.  The data represent at least four independent experiments with 
consistent results.  (C) HEK 293T cells were co-transfected with RORE-Luciferase reporter vector in 
the presence or absence of RORt and Foxp3 WT with increasing concentrations.  Then, luciferase
activity was determined and normalized to -galactosidase activity.  Values were also normalized to 
vector alone.  The data represent at least three independent experiments with consistent results.  (A-C)  
data shows mean ± S.D.  (D) FACS-sorted naïve OT-II TCR transgenic T cells were stimulated under 
Th17 polarizing conditions (TGF-, IL-6, anti-IFN-, anti-IL-4) and infected with an IRES-GFP-
containing bicistronic retrovirus expressing Foxp3 (WT or mutants) or a vector control virus. IL-17-
expressing cells were measured by intracellular staining.  The experiments were repeated at least two 
times with similar results.  Reprinted from “Molecular antagonism and plasticity of regulatory and 
inflammatory T cell programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. Martinez, Hong Soon 
Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, Kimberly S. Schluns, 
Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten and Chen Dong. Immunity. 2008. 29(1):44-56 
with permission from Elsevier.
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II.2. Foxp3 LxxLL and TIP60/HDAC7 domains are required for inhibition of RORs 
transcriptional activity 
 
Nuclear receptors such as ROR and RORt bind to LxxLL motifs (where L means leucine 
residues and x means any other amino acid) in nuclear corepressor (NCOR) or nuclear coactivator 
(NCOA) family members through their AF2 transactivation domain (reviewed in (Xu et al., 2009)).  
Since Foxp3 contains the sequence LQALL in its second exon (LxxLL structure), we hypothesized that 
Foxp3 directly interacts with ROR or RORt, competing with the ability of coactivators to bind to 
these nuclear receptors.  To examine this hypothesis, we first determined the ability of Foxp3 to bind 
ROR by co-immunoprecipitation.  Flag-tagged ROR was over-expressed in HEK 293T cells in the 
presence or absence of full length Foxp3 or several Foxp3 mutants, and immunoprecipitation was 
performed using anti-Flag.  We found that Foxp3 interacted with ROR upon over-expression (Fig. 
10A).  However, a Foxp3 variant with a mutation in the LxxLL sequence (LL-AA mutant where the last 
two consecutive leucine residues where mutated to alanine residues) showed a severe reduction in its 
association with ROR (Fig. 10A).  Furthermore, a Foxp3 mutant that contains only the first two exons 
of Foxp3 (which includes the LxxLL motif) but lacks the dimerization and DNA binding domains was 
capable of inhibiting RORt transcriptional activity (Fig. 10B). 
Given that Foxp3 can be found in a molecular complex containing ROR, and since Foxp3 
contains an LxxLL sequence, we next determined whether Foxp3 could prevent the functional 
association between coactivators and RORs.  We utilized a mammalian two-hybrid system where 
luciferase reporter activity is induced upon binding of ROR to a peptide (termed EBIP96) containing a 
high-affinity LxxLL motif (Kurebayashi et al., 2004) (Fig. 11A).  In this system, ROR was fused to the 
VP16 transactivation domain (VP16 TD-ROR) while the EBIP96 peptide was fused to the Gal4 DNA 
binding domain (Gal4 DBD- EBIP96) (Fig. 11A).  Surprisingly, increasing concentrations of Foxp3 
inhibited luciferase activity induction in a dose-dependent manner (Fig. 11B), suggesting that Foxp3 
might interfere with the association between ROR and nuclear coactivators.  We next evaluated the 
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function of the LxxLL domain in Foxp3 by using the LL-AA mutant and found decreased inhibition of 
luciferase activity compared to WT Foxp3 (Fig. 11B), indicating that LxxLL domain is at least partially, 
but not completely required for the displacement of association of ROR to nuclear coactivators.  To 
further evaluate the functional role of Foxp3 LxxLL sequence, we determined whether mutation in this 
domain renders Foxp3 incapable of inhibiting RORt transcriptional activity.  To this end, we utilized 
the IL-17 promoter-CNS2 luciferase reporter assay, and observed as in our previous experiments down-
regulation of luciferase activity when WT Foxp3 was coexpressed with RORt or ROR (Fig. 12A and 
B).  Even though the Foxp3 LL-AA mutant had severe reduction in the binding ability to ROR (Fig. 
10A), it was still able to inhibit the luciferase activity induced by either ROR or RORt, although to a 
lesser extent to that compared to WT Foxp3 (Fig. 12A and B).  Together, these results suggest that the 
Foxp3 LxxLL domain is required for optimum binding to RORs.  However, the lack of this functional 
domain does not completely abolish the inhibition of RORs activity by Foxp3, indicating that additional 
domains in Foxp3 might still be required for interfering with RORs transcriptional activity.   
Previous reports have shown that Foxp3 can interact with the acetyltransferase TIP60 and the 
histone deacetylase 7 (HDAC7) through amino acids 105-190 (Li et al., 2007a).  Thus, we next 
investigated whether this domain is functionally required for Foxp3 to dampen the transcriptional 
activity of RORs by utilizing a Foxp3 105-190 mutant (Li et al., 2007a).  Even though this mutant was 
capable of binding to ROR upon over-expression in HEK 293T cells (Fig. 10A), it only partially 
repressed RORs transcriptional activity compared to WT Foxp3 (Fig. 12A and B).  Interestingly, 
simultaneous disruption of LxxLL and TIP60/HDAC7 binding domains completely abolished Foxp3-
mediated inhibition of RORt or ROR transcriptional activity (Fig. 12A and B).  To further evaluate 
the role of these two domains in Th17 cell generation, Foxp3 WT or mutants were over-expressed by 
retroviral transduction.  Naïve OT-II cells were stimulated under Th17-polarizing conditions and 
infected with Foxp3-expressing constructs (WT or mutants), after which the amount of IL-17-producing 
cells was determined by intracellular staining.  Over-expression of WT Foxp3, LL-AA or 105-190 
Foxp3 mutants greatly reduced the frequency of IL-17-producing cells in GFP+ infected cells compared 
 40
to mock-infected cells (Fig. 12C).  However, consistent with the luciferase reporter assay, the Foxp3 
mutant lacking both domains was incapable of blocking Th17 cell generation (Fig. 12C).  Thus, these 
results demonstrate that Foxp3 suppresses the generation of IL-17-producing cells by inhibiting ROR 
and RORt transcriptional activity through the LxxLL and TIP60/HDAC7 binding domains. 
 
Figure 10. Foxp3 LxxLL sequence is required for binding to ROR and inhibition of RORt
transcriptional activity.  (A) HEK 293T cells were transiently transfected with pCMV-Flag-tagged 
ROR in the presence or absence of bicistronic vectors expressing wild-type (WT) Foxp3, or Foxp3 
mutants as indicated.  After 48 h, lysates were prepared and immunoprecipitated with an anti-FLAG 
mAb (IP), followed by immunoblotting with mouse anti-Foxp3, or rabbit anti-FLAG (top two 
panels).  Bottom two panels indicate western blot of whole cell lysates. *, non-specific.  (B) HEK 
293T cells were co-transfected with RORE-Luciferase reporter vector in the presence or absence of 
ROR and Foxp3 WT or Foxp3 C (containing only the first two exons).  Then, luciferase activity 
was determined and normalized to -galactosidase activity.  Values were also normalized to vector 
alone.  Data shows mean ± S.D.  The data represent at least three independent experiments with 
consistent results.  Reprinted from “Molecular antagonism and plasticity of regulatory and 
inflammatory T cell programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. Martinez, Hong Soon 
Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, Kimberly S. Schluns, 
Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten and Chen Dong. Immunity. 2008. 29(1):44-
56 with permission from Elsevier.
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Figure 11. Foxp3 prevents ROR functional association with a peptide containing LxxLL
sequence partially through its LQALL sequence.  (A) Schematic representation of the 
mammalian two hybrid system utilized.  (B) CHO cells were transfected with (UAS)5-Luciferase 
construct, and the indicated vectors, and luciferase assay was determined to assess the binding of 
ROR to a peptide containing a high-affinity LxxLL sequence (termed EBIP96).  The luciferase
activity was normalized to -galactosidase activity.  Data shows mean ± S.D.  The data 
represents at least two independent experiments with similar results.  The experiment was 
performed by Dr. Kang at NIEHS-NIH.  Reprinted from “Molecular antagonism and plasticity of 
regulatory and inflammatory T cell programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. 
Martinez, Hong Soon Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, 
Kimberly S. Schluns, Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten and Chen Dong. 
Immunity. 2008. 29(1):44-56 with permission from Elsevier.
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Figure 12. Foxp3 requires both LxxLL and TIP60/HDAC7 binding domains to inhibit ROR and 
RORt transcriptional activity.  (A-B) EL-4 cells were transfected with a vector containing the firefly 
luciferase gene under the control of the Il17 promoter-CNS2 region, a vector expressing Renilla
luciferase, and IRES-GFP-containing bicistronic vectors expressing RORt (A) or ROR (B) and Foxp3 
wild-type (WT) or various Foxp3 mutants, or vector alone.  Then, cells were stimulated with PMA and 
ionomycin for the last 5h of culture, and luciferase activity was determined and normalized to Renilla
luciferase.  Values were also normalized to vector alone.  Data shows mean ± S.D.  The data represent 
at least four independent experiments with consistent results.  (C) FACS-sorted naïve OT-II T cells were 
activated under Th17 conditions and infected with an IRES-GFP-containing bicistronic retrovirus 
expressing Foxp3 WT or Foxp3 mutants or a vector control virus. IL-17-expressing cells were 
measured by intracellular staining on the GFP- and GFP+ population.  The experiments were repeated at 
least three times with similar results.  Reprinted from “Molecular antagonism and plasticity of 
regulatory and inflammatory T cell programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. Martinez, 
Hong Soon Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, Kimberly S. 
Schluns, Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten and Chen Dong. Immunity. 2008. 
29(1):44-56 with permission from Elsevier. 43
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II.3. Lack of Foxp3 does not result in enhanced development of IL-17-producing T cells 
 
 To further understand the role of Foxp3 in Th17 cell generation, we utilized mice with 
deficiency in Foxp3.  These mice (Scurfy mice) possess a frameshift mutation in the Foxp3 gene that 
results in a product that lacks the forkhead domain (DNA binding domain) and thus develop a severe 
autoimmune syndrome (Brunkow et al., 2001).  To minimize the autoimmune phenotype, we crossed 
these mice with OT-II TCR transgenic mice.  These TCR transgenic Scurfy mice still developed an 
autoimmune phenotype although delayed compared to non-TCR transgenic Scurfy mice (data not 
shown).  In our experiments, 5-6 week old mice were utilized, and naïve CD4+ T cells were isolated by 
FACS-sorting.  These cells were then cultured with irradiated T cell-depleted splenocytes as antigen 
presenting cells and OT-II peptide in the presence of various cytokines.  Similar to their WT 
counterparts, T cells lacking functional Foxp3 were not able to produce IL-17 when stimulated with 
TGF- alone (Fig. 13), indicating that IL-6 signaling, in combination with TGF-, is necessary for the 
proper induction of Th17 cells even in the absence of Foxp3.  When Scurfy T cells were activated in the 
presence of TGF- and IL-6, reduced IL-17-producing cells were detected compared to WT controls 
(Fig. 13A).  Moreover, we observed lower expression of Th17-associated cytokines IL-17 and IL-17F, 
while no differences in IL-21 production were detected (Fig. 13B and C).  In contrast, IFN- expression 
was enhanced in cells lacking functional Foxp3 compared to WT controls stimulated under this 
condition (Fig. 13B and C), which may account for the reduced expression of Th17 cytokines.  The fact 
that no differences in IL-21 production were detected could be accounted based on the notion that IL-21 
can also be produced by Th1 cells (Ma et al., 2009).  Given that enhanced Th1 and Th2 cytokines were 
detected (Fig. 13 and data not shown), we then neutralized endogenous IFN- and IL-4 levels by using 
blocking antibodies and found a similar IL-17 production in Scurfy and WT OT-II Th17 cells (Fig. 13).  
Real time RT-PCR analysis of activated Foxp3-deficient T cells also showed decreased expression of 
Th17 cytokines as well as the Th17 transcription factor ROR when cells were stimulated in the 
presence of TGF- and IL-6.  However, the addition of blocking antibodies against IFN- and IL-4 
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restored the expression of Th17-associated genes (Fig. 13B).  These results suggest that deficiency in 
the master transcription factor Foxp3 leads to enhanced Th1/Th2 differentiation, but does not alter Th17 
cell generation upon optimal stimulation conditions.   
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Figure 13.  Lack of Foxp3 does not result in enhanced Th17 cell commitment when induction of 
other Th lineages is inhibited.  FACS-sorted naïve T cells from 5-6 weeks old OT-II TCR transgenic 
Foxp3 WT or Foxp3-deficient (Scurfy) mice were activated with plate-bound anti-CD3 and anti-CD28 
under indicated conditions for 4 days.  (A) Cells were then restimulated with PMA and ionomycin in the 
presence of Golgi inhibitor for 4h and IL-17- and IFN--expressing cells were assessed by intracellular 
staining.  (B) Cells were then restimulated with anti-CD3 for 16h, and cytokine concentration in culture 
supernatants was measured by ELISA.  (C) Cells were restimulated with anti-CD3 for 4h and cDNA
was prepared.  Gene expression profile was analyzed by real-time RT-PCR. Data were normalized to a 
reference gene Actb.  The lower expression level for each gene was referred as 1.  (B-C) Data shows 
mean ± S.D.  A representative experiment out of two is shown.  Reprinted from “Molecular antagonism 
and plasticity of regulatory and inflammatory T cell programs.” Xuexian O. Yang, Roza Nurieva, 
Gustavo J. Martinez, Hong Soon Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee
Chang, Kimberly S. Schluns, Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten and Chen Dong. 
Immunity. 2008. 29(1):44-56 with permission from Elsevier.
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DISCUSSION 
 
TGF- plays an important role in the development of Th17 cells while contributing also to the 
generation and maintenance of regulatory T cells by inducing the master transcription factors RORt 
and Foxp3, respectively (Ivanov et al., 2006; Marie et al., 2005).  Therefore, Kuchroo and colleagues 
have suggested a reciprocal regulation of these two cell lineages (Bettelli et al., 2006).  In the present 
chapter we have evaluated the molecular regulation of regulatory T and Th17 cell genetic programs.  
Using double reporter mice containing IL-17F-RFP and Foxp3-GFP, we found that during in vitro 
generation of Th17 cells, a transient population expresses both RFP and GFP markers.  These data 
suggest that the Treg and Th17 genetic programs can simultaneously arise in cells that are not yet fully 
differentiated.   
We evaluated the role of Foxp3 induction during Th17 cell generation by over-expression 
studies and found that ectopic expression of Foxp3 led to a reduction in the generation of IL-17-
producing cells.  When determining the gene expression profile from these cells over-expressing Foxp3, 
we observed reduced induction of Th17-associated cytokines but not the Th17-specific transcription 
factors ROR and RORt.  These results indicated that Foxp3 might block the induction of the Th17-
transcriptional program by directly interfering with RORs.  In support of this idea, Foxp3 was capable 
of suppressing the transcriptional activity of RORs, as assessed by luciferase reporter assays containing 
ROR binding sites (RORE or Il17p-CNS2 luciferase reporters).  Interestingly, such inhibition was 
independent of Foxp3 DNA binding or homo-dimerization domains.  Using mutagenesis analysis, we 
concluded that Foxp3 can interfere with the transcriptional activity of RORs via two independent, and 
most likely non-exclusive, mechanisms:  first, Foxp3 would bind to RORs through its LQALL sequence 
coded in the second exon, and thus prevent the association of RORs with coactivators such as the 
Steroid Receptor Coactivator molecules; second, through the recruitment of TIP60/HDAC7 complex, 
Foxp3 may impede the direct binding of nuclear co-activators via components in this complex or may 
induce deacetylation of specific molecules including histones, preventing the transcription of ROR-
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target genes (Fig. 14).  Interestingly, deficiency of either the LQALL or TIP60/HDAC7 domains 
partially impaired Foxp3-mediated block of development of IL-17-producing cells.  However, lack of 
both domains completely abrogated the inhibitory function of Foxp3 in the context of Th17 cell 
development.  Thus, our results indicate that the presence of both domains is required to impede the 
generation of IL-17-producing T cells.  Further investigation is needed to thoroughly comprehend how 
these two mechanisms cooperate in the repressive activity of Foxp3, and whether there might be 
redundancy amongst them.  Also, whether Foxp3 utilizes the same machinery to target other Th-specific 
genes still remains unclear.  
Recently, the laboratories of Drs. Yoshimura, Littman and Ziegler have also independently 
demonstrated that Foxp3 can directly interact with RORt and/or ROR, hindering with their 
transcriptional activity (Du et al., 2008; Ichiyama et al., 2008; Zhou et al., 2008a).  Indeed, using 
RORt-GFP reporter mice, Littman’s group showed that cells co-expressing Foxp3 and RORt in the 
lamina propria produced lower levels of IL-17 compared to cells expressing RORt alone (Zhou et al., 
2008a), consistent with our in vitro data demonstrating that ectopic expression of Foxp3 leads to 
reduced generation of IL-17-producing T cells.  Moreover, Foxp3 exon 2 (amino acids 71-105), which 
contains the LxxLL sequence, was shown to associate with the Th17-specific transcription factors 
ROR and RORt (Du et al., 2008; Zhou et al., 2008a).  However, unlike our observations, these 
authors showed that complete deletion of exon 2 resulted in impaired suppressive activity by Foxp3 (Du 
et al., 2008; Ichiyama et al., 2008; Zhou et al., 2008a).  Interestingly, Foxp3 has two different isoforms 
in humans, one isoform containing the full protein while the other isoform has a deletion of exon 2 by 
alternative splicing.  The differential role of these two isoforms in human regulatory T cell functions 
still remains unclear but suggests that a fraction of these regulatory T cells (expressing a Foxp3 exon 2 
isoform) might not fully antagonize the Th17 program efficiently.  Further research needs to be 
performed in mouse studies to try to elucidate the role of regulatory T cells expressing only this short 
isoform.  Also, the exact role of the Tip60/HDAC7-binding domain in Foxp3 still remains unclear.  
Whether Foxp3 is able to recruit complexes containing HDAC7 to ROR/RORt-target loci needs 
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confirmation using genomic-wide studies.  Thus, these combined results suggest a potential role of 
Foxp3 in the suppression of Th17 development in vivo by restraining both ROR and RORt activity.   
We further determined the requirement of Foxp3 in Th17 differentiation by using mice deficient 
in Foxp3 (Scurfy mice).  Cells lacking functional Foxp3 did not spontaneously differentiate into Th17 
cells when stimulated with TGF-alone, suggesting that TGF- signaling itself is not sufficient to force 
the commitment towards Th17 cell differentiation in the absence of a commitment towards the 
regulatory T cell program.  IL-6 and IL-21, through STAT3 activation (Nurieva et al., 2007; Yang et al., 
2007), are thus also required for Th17 commitment indicating that the role of these factors extends 
beyond inducing Foxp3 down-regulation (Bettelli et al., 2006; Yang et al., 2008b), supporting the idea 
of a synergism between IL-6 and TGF- signaling for the induction of Th17 cells.  Interestingly, 
stimulation of Scurfy naïve CD4+ T cells with TGF- resulted in enhanced Th1 and Th2 cytokines, 
suggesting that a functional Foxp3 is required to inhibit Th1 and Th2 cell induction.  Future research 
needs to be performed to clarify how Foxp3 deficiency results in enhanced Th1 and Th2, but not Th17, 
cell development.  It is possible that Foxp3 could inhibit the generation of these cell lineages by directly 
antagonizing T-bet or GATA-3 expression, respectively.  Also, Foxp3 could directly inhibit the 
induction of Th1/Th2 cytokines by directly binding to DNA in these cytokine gene loci.   
When Scurfy naïve CD4+ T cells were stimulated only with TGF- and IL-6, we found reduced 
expression of the Th17-associated cytokines IL-17 and IL-17F, as well as the transcription factor RORt, 
compared to wild-type controls.  This reduced expression of Th17-specific genes correlated with 
enhanced Th1 and Th2 cytokine secretion.  Since blockade of Th1 and Th2 pathways can enhance the 
commitment towards Th17 cells (Harrington et al., 2005; Park et al., 2005), we used neutralizing 
antibodies against IFN- and IL-4.   Surprisingly, we found that the expression of Th17-specific genes 
was restored in functional Foxp3-deficient cells.  Several different explanations could account for the 
observed results:  
i) Our data showing inhibition of ROR/RORt transcriptional activity by Foxp3 is based on 
over-expression studies, which could be artificial since over-expression studies exclude the endogenous 
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regulatory mechanisms by which these transcription factors are subjected.  However, given that Littman 
and colleagues have shown that cells co-expressing Foxp3 and RORt in lamina propria show reduced 
expression of IL-17 compared to cells expressing RORt alone, we believe this is not the most 
appropriate explanation.   
ii) Although Foxp3 is transiently induced in developing Th17 cells in vitro and coexpressed 
with RORt in vivo (Zhou et al., 2008a), Foxp3 expression is inhibited by IL-6 in a STAT3-dependent 
manner (Bettelli et al., 2006; Yang et al., 2008b).  Littman and colleagues have shown that enhanced 
TGF- stimulation would favor the induction of Foxp3+ regulatory T cells while inhibit the commitment 
towards Th17 cells (Zhou et al., 2008a).  In our in vitro stimulation conditions, IL-6 signaling could be 
strong enough to induce complete Foxp3 downregulation, and thus lack of a functional Foxp3 does not 
lead to enhanced Th17 cell development.  Therefore, experiments using titration of both TGF- and IL-
6 concentrations could help address this controversy. 
iii) Naïve CD4+ T cells isolated from Scurfy mice express a Foxp3 mutant that has a deletion of 
the forkhead domain, but still conserve an intact exon 2 (containing LxxLL sequence) and 
Tip60/HDAC7 domains.  These two domains could then prevent the enhanced induction of IL-17-
producing cells by interfering with ROR/RORt transcriptional activity as previously described.   
In conclusion, our results contributed to our understanding of the reciprocal regulation of 
Th17/Treg cell development through the identification of an inhibitory role of Treg-specific 
transcription factor Foxp3 in the generation of Th17 cells.  Thus, we have demonstrated a molecular 
antagonism between regulatory T cell and Th17 cell genetic programs.  
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Figure 14.  Model of inhibitory function of Foxp3 in developing Th17 cells.  TGF- stimulation of 
naïve T cells leads to the expression of both Foxp3 and RORt transcription factors.  Under high TGF-
concentrations, Foxp3 expression is maintained.  In turn, Foxp3 would bind to ROR/RORt through its 
LxxLL sequence, preventing the binding of coactivators to these nuclear receptors.  Also, Foxp3 might 
recruit histone deacetylase 7 (HDAC7), which might also prevent the transcription of ROR-target genes 
through repressive chromatin modifications.  The direct recruitment of Foxp3 to ROR-target genes, as 
well as the role of HDAC7 in Foxp3 repression still needs further elucidation.  
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CHAPTER III – ROLE OF TGF- SIGNALING PATHWAY IN TH17/TREG 
DIFFERENTIATION2 
 
BACKGROUND 
 
 The transforming growth factor beta (TGF-) superfamily is a group of secreted proteins that 
regulate cellular processes such as proliferation, differentiation, apoptosis and migration, among others.  
This family of proteins is composed of over 50 members including TGF-s, Activins, Nodals and Bone 
Morphogenic Proteins (BMPs).  Within the TGF- family, there are three different isoforms: TGF-1, 
TGF-2 and TGF-3 (reviewed in (Feng and Derynck, 2005; Schmierer and Hill, 2007)).  TGF-1 
(referred to as TGF- throughout this work) but not TGF-2 or TGF-3, is mainly expressed in the 
immune system (Chang et al., 2002; Govinden and Bhoola, 2003).  TGF- has either positive or 
negative regulatory properties in several immune cell types, and is thus a crucial cytokine with many 
immunological functions (reviewed in (Wan and Flavell, 2007)).   
 TGF- superfamily cytokines signal through tetrameric serine/threonine kinase transmembrane 
receptors.  There are two functional classes of TGF- superfamily receptors, TGFRI and TGFRII, 
with seven type I receptors, termed activin receptor-like kinases (ALK) 1-7, and five type II receptors: 
TGFRII, AMHR-II, BMPR-II, ActR-II and ActR-IIB (reviewed in (Feng and Derynck, 2005; 
Schmierer and Hill, 2007)).  Even though there are considerably fewer receptors compared to ligands, 
signaling mechanisms are more flexible than expected.  This versatility is the result of the combinatorial 
interactions between the two classes of receptors, a variety of different signaling pathways that can be 
activated, and the interaction of these signaling pathways (such as Smad molecules) with different types 
of transcription factors or coactivators (see below).       
                                                 
2 The results presented in this Chapter have been published in Yang et al., 2008b; Martinez et al., 2009; Martinez 
et al., 2010.  
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Binding of a TGF- homodimer to the pre-formed TGFRII dimer leads to the association of 
these molecules with the pre-formed homodimer of TGFRI.  The TGFRII is thought to be 
constitutively active and, upon formation of a stable receptor complex, TGFRII kinase activity induces 
the phosphorylation of the glycine-serine rich region (GS sequence) in TGFRI, which is highly 
conserved among all the TGFRI members (reviewed in (Feng and Derynck, 2005; Schmierer and Hill, 
2007)).  Upon phosphorylation of this regulatory domain, TGFRI becomes activated allowing for the 
recruitment and subsequent phosphorylation of receptor-associated Smads (mothers against 
decapentaplegic homologue; R-Smads: Smad1, Smad2, Smad3, Smad5 and Smad8) at two Serine 
residues in the distal C-terminus SXS motif.  Once phosphorylated, R-Smads interact with the 
Common-Smad (C-Smad: Smad4), exposing the nuclear localization signal which allows the complex 
to translocate to the nucleus (reviewed in (Feng and Derynck, 2005; Schmierer and Hill, 2007)) (Fig. 
15). 
Smads are not thought to recruit the basal transcription factor machinery to target genes.  
Rather, they are believed to recruit chromatin remodeling complexes, such as Swi/Snf and Brg1, and 
histone acetyltransferases such as p300 and CBP (Ross et al., 2006).  Furthermore, the binding of Smads 
to Smad Binding Elements (SBE) in DNA is relatively weak.  However, association of Smads with 
other transcription factors, which contain DNA binding sequences adjacent to SBE sequences, leads to 
enhanced binding of the Smad-transcription factor complex to their respective cognate DNA sequences.  
For instance, upon interaction of Smad3 with Sp1 and c-Jun, their DNA binding capacity is 
synergistically increased (Feng et al., 2000; Qing et al., 2000).  
 It is commonly accepted that TGF-, through binding to TGFRI ALK5, induces the 
phosphorylation of Smad2 and Smad3 (reviewed in (Feng and Derynck, 2005)).  However, recent 
reports have suggested that TGF- can induce phosphorylation of Smad1 and Smad5 through ALK1 and 
ALK5 in a cell-type specific manner (Bharathy et al., 2008).  Also noteworthy is the fact that TGF- 
can signal through Smad-independent pathways (Fig. 15).  Studies using Smad4-deficient or a TGFRI 
mutant that lacks the Smad-binding domain L45 loop, have shown that TGF- stimulation leads to the 
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activation of MAPK in different cell types (Goumans et al., 2003; Goumans et al., 2002; Itoh et al., 
2003; Lebrin et al., 2004; Pannu et al., 2007; Wrighton et al., 2009; Yu et al., 2002).  The role of TGF-
-induced phosphorylation of Smad2/3 and/or Smad1/5, as well as the Smad-independent TGF- 
signaling pathway, in the commitment towards Th17/iTreg cells remains unclear. 
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Figure 15.  Schematic representation of TGF- signaling pathway.  Upon binding to its receptor, 
TGF- induces activation of Smad-dependent or Smad-independent signaling pathways.  The Smad-
dependent pathway is constituted by activation (phosphorylation) of Smad2 and Smad3, which then 
bind to Smad4 and translocate to the nucleus and bind to Smad Binding Elements (SBE) in DNA.  The 
Smad-independent pathway includes several pathways, mostly mitogen-activated protein kinases
(MAPKs) and Akt-mTOR (mammalian target of Rapamycin) pathways.  Interestingly, there is cross-
talk between the Smad-dependent and Smad-independent pathways, as indicated with red arrows where 
both Jnk and Erk MAPK can phosphorylate Smad molecules.  Upon binding to target sequences, Smad
molecules recruit histone modifying complexes such as the histone acetyltransferase CBP and synergize 
with other adjacent transcription factors (T.F.) in the transcription of target genes.  Adapted from cell 
signaling technology (http://www.cellsignal.com/pathways/tgf-beta-smad.jsp)
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RESULTS 
 
III.1. TGF- signaling through TGFRI is required for the differentiation of Th17 and 
inducible regulatory T cells 
 
Th17 and regulatory T cells both require TGF- stimulus for their generation (Bettelli et al., 
2006; Veldhoen et al., 2006a).  Development of iTreg cells depends on TGF-and IL-2 signaling, 
whereas Th17 cell differentiation is regulated by TGF- in combination with IL-6 and/or IL-21.  Our 
group and others have demonstrated that IL-6-mediated STAT3 activation is essential for the generation 
of Th17 cells (Chen et al., 2006b; Laurence et al., 2007; Yang et al., 2007; Zhou et al., 2007), whereas 
STAT5 activation by IL-2 is indispensable for the generation of regulatory T cells (Burchill et al., 2007; 
Yao et al., 2007).  However, the signaling pathway induced by TGF- in the differentiation of either cell 
lineage is still unclear.  Additionally, whether Th17 or iTregs require TGF--mediated activation of 
Smads or MAPKs during their development has not been completely established.  Finally, whether the 
TGF- Smad-dependent or -independent signaling pathway crosstalk with STAT3/STAT5 and/or 
regulate the lineage-specific transcription factors needs to be determined.   
To address these aspects of TGF- biology, we investigated the molecular mechanisms induced 
by TGF- that lead to the commitment towards either cell lineage.  We first isolated naïve CD4+ T cells 
(CD4+CD25-CD62LhiCD44lo) from C57BL/6 mice and stimulated these cells with TGF- and/or IL-6 in 
the presence of a TGFRI kinase inhibitor, SB431542 (Inman et al., 2002).  To confirm the inhibition of 
TGFRI kinase activity by this compound, we evaluated the phosphorylation levels of Smad2 and 
Smad3 by Western blot and indeed found reduction in their activation upon SB431542 treatment (Fig. 
16). 
Figure 16. TGFRI signaling induces activation of Smad2 and Smad3. 
FACS-sorted naïve T cells from B6 mice were activated with plate-bound anti-
CD3 and anti-CD28 in the presence of indicated cytokines or TGFRI kinase
inhibitor (SB431542, 5M) for 1 hour.  Then, cell extracts were prepared and 
expression and phosphorylation of Smad molecules was determined by Western 
blot.  
Smad2
beta-actin
pSmad2
Smad1
Smad3
pSmad3
TGF- + + +- -
SB431542 +- - - -
IL-6 + +- - -
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To evaluate the kinetics of TGF- signaling during Th17 differentiation, naïve CD4+ T cells 
were stimulated with Th17-skewing conditions for four days and the TGFRI kinase inhibitor was 
added in the culture at different time points.  When TGF- signaling pathway was inhibited on day zero 
or day one, the generation of IL-17-producing cells was completely abolished (Fig. 17A and B).  
Furthermore, a 50% reduction in Th17 cells was observed when the TGFRI kinase inhibitor was added 
on day two, whereas no differences were observed on day three (Fig. 17A and B).  The decrease in IL-
17-producing cells in the presence of the TGFRI inhibitor was confirmed by analysis of gene 
expression in these cells.  Reduction of IL-17, IL-17F, ROR, RORt and IL-23R mRNA was detected 
following addition of SB431542 on day zero and day one (Fig. 17B).  Similar kinetics requirements for 
TGF- singaling were obtained for the induction of Foxp3 expression and thus the generation of 
inducible regulatory T cells (Fig. 18).  Thus, our data suggests that TGF- signaling is indispensable 
during the first two days of in vitro generated Th17 and iTreg cells.  
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Figure 17. TGFRI signaling is required for the generation of Th17 cells.  FACS-sorted naïve T 
cells from B6 mice were activated with plate-bound anti-CD3 and anti-CD28 under Th17 (TGF- IL-6, 
anti-IFN- anti-IL-4) conditions, and a TGFRI kinase inhibitor (SB431542, 5M) was added at 
different time points as indicated.  (A) 4d after differentiation, cells were stimulated with PMA and 
ionomycin in the presence of Golgi Stop for 4h, and intracellular cytokine staining performed.  A 
representative dot plot graph is shown in the top panel, and the numbers in quadrants represent the 
percentages.  In the bottom panel, the inhibition of IL-17-producing cells for six independent 
experiments are indicated.  *, p<0.05, Wilcoxon signed rank test.  (B) 4d after differentiation, cells were 
stimulated with plate bound anti-CD3 (1 g/ml) for 4h, and then mRNA expression of indicated genes 
was analyzed by real-time RT-PCR.  The data shown was normalized to expression of a reference gene 
-actin.  The lowest expression levels for each gene were referred as 1.  (A-B) Data shows mean ± S.D.  
Reprinted from “Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.”
Xuexian O. Yang, Roza Nurieva, Gustavo J. Martinez, Hong Soon Kang, Yeonseok Chung, Bhanu P. 
Pappu, Bhavin Shah, Seon Hee Chang, Kimberly S. Schluns, Stephanie S. Watowich, Xin-Hua Feng, 
Anton M. Jetten and Chen Dong. Immunity. 2008. 29(1):44-56 with permission from Elsevier.
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Figure 18. TGFRI signaling is required for the generation of inducible Treg cells.
FACS-sorted naïve T cells from B6 mice were activated with plate-bound anti-CD3 and 
anti-CD28 under iTreg conditions (TGF- IL-2, anti-IFN-, anti-IL-4), and a TGFRI
kinase inhibitor (SB431542, 5M) was added at different time points as indicated.  Cells 
were assessed for Foxp3 expression after 4 days of stimulation using intracellular staining.  
A representative dot plot graph is shown in the top panel, and the numbers in quadrants 
represent the percentages.  In the bottom panel, the inhibition of Foxp3+ cells for six 
independent experiments are indicated.  Data shows mean ± S.D. *, p<0.05, Wilcoxon
signed rank test.  Reprinted from “Molecular antagonism and plasticity of regulatory and 
inflammatory T cell programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. Martinez, 
Hong Soon Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, 
Kimberly S. Schluns, Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten and Chen 
Dong. Immunity. 2008. 29(1):44-56 with permission from Elsevier.
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III.2.  Role of the Smad-signaling pathway in the generation of regulatory T cells 
 
III.2.a. Smad4 partially regulates the generation of iTreg cells 
 
Given that TGF- signaling is indispensable for iTreg generation, we next investigated the 
downstream signaling molecules that could participate in such commitment.  Since Smad4 is the 
common Smad factor (Feng and Derynck, 2005), the role of this molecule in Treg biology was initially 
determined.  Mice with T cell-specific Smad4 deficiency were generated by crossing mice with floxed 
Smad4 alleles (Smad4fl/fl) (Chu et al., 2004) with mice bearing the Cre recombinase under the control of 
Cd4 promoter (CD4-Cre mice) (Lee et al., 2001).  Appropriate deletion of the Smad4 gene was 
confirmed by PCR strategy in CD4+ T cells by analyzing thymus of Smad4fl/fl CD4Cre+ (Smad4 tKO) 
and WT control mice (Fig. 19A).  Smad4 tKO mice exhibited normal levels of CD4+ and CD8+ T cells, 
as well as natural regulatory T cells (nTregs; CD4+CD25+Foxp3+) in all the lymphoid organs analyzed 
(spleen, peripheral and mesenteric lymph nodes, and thymus) (Fig. 19 and 20A respectively).  
Furthermore, Smad4-deficient nTregs exhibited the same suppressive activity in vitro as their WT 
counterparts (Fig. 20B).  Together these results indicate that Smad4 is dispensable for the generation or 
function of nTreg cells.  
Then, we determined whether the generation of iTreg cells in vitro required Smad4 expression.  
Naïve T cells from either Smad4fl/fl CD4Cre- (WT) or Smad4fl/fl CD4Cre+ (tKO) mice were stimulated 
with iTreg-polarizing conditions (TGF-, IL-2 and neutralizing antibodies against IFN- and IL-4) for 
four days.  We found that cells lacking Smad4 exhibited a 50% reduction in Foxp3 expression compared 
to their WT counterparts (Fig. 20C).  Thus, these results indicate that the Smad-dependent TGF- 
signaling pathway is at least partially required for the generation of inducible regulatory T cells.  
However, given that Smad2/3 can bind factors other than Smad4, and that Smad4 deficiency does not 
fully impair Smad2/3 transcriptional activity in other cell types (Descargues et al., 2008; Doisne et al., 
2009; He et al., 2006), we evaluated the role of the other Smad molecules in Treg biology. 
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Figure 19. Normal T cell development in mice with a specific deletion of Smad4 in T cells.  (A)  
Genomic DNA from MACS sorted CD4+ thymocytes was analyzed for Smad4 gene deletion by PCR.   
(B) CD4+ and CD8+ T cells levels were determined in peripheral lymph nodes, spleen, mesenteric 
lymph nodes and thymus.  A representative dot plot example is shown for peripheral lymph nodes 
and thymus (left panel), and the combined analysis for seven mice each group is also indicated (right 
panel).  Right panel shows mean ± S.D.  Reprinted from “Molecular antagonism and plasticity of 
regulatory and inflammatory T cell programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. 
Martinez, Hong Soon Kang, Yeonseok Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, 
Kimberly S. Schluns, Stephanie S. Watowich, Xin-Hua Feng, Anton M. Jetten and Chen Dong. 
Immunity. 2008. 29(1):44-56 with permission from Elsevier.
62
CD25
Fo
xp
3
Spleen LN MLN
CD4 SP 
thymocytes
A.
2.51 9.83
1.186.6
2.66 7
1.788.6
2.49 5.31
1.2890.9
1.26 2.51
1.9894.3
3.3 11.5
0.9784.2
2.79 7.58
1.9487.7
2.72 4.82
1.3291.1
1.48 3.4
1.6493.5 Sm
ad
4 
tK
O
Sm
ad
4 
W
T
%
 o
f C
D
25
+ F
ox
p3
+
ce
lls
(g
at
ed
 o
n 
C
D
4+
ce
lls
)
0
4
8
12
16 Smad4 WT
Smad4 tKO
Naive Naïve +
Smad4 WT 
nTregs
Naïve +
Smad4 KO
nTregs
0
4
8
12
H
3-
Th
ym
id
in
e
in
co
rp
or
at
io
n 
 
(c
pm
x1
03
)
B.
Smad4 WT
Smad4 tKO
Foxp3
IL
-1
7
C.
43.3
81.8
Sm
ad
4 
tK
O
Sm
ad
4 
W
T
Figure 20.  Differential role of Smad4 in the generation of natural versus inducible regulatory T 
cells.  (A) Presence of CD25+Foxp3+ cells in a CD4+ T cell gate was analyzed in different tissues.  A 
representative dot plot example is shown for each group in each tissue, and the combined results for 
seven mice each group is indicated (mean ± S.D.).  (B) CD4+CD25-CD62LhiCD44lo naïve T cells from 
Smad4fl/flCD4Cre- (WT) or Smad4fl/flCD4Cre+ (tKO) mice were cultured with or without WT or KO 
CD4+CD25hi natural regulatory T cells in triplicate wells with irradiated APCs and stimulated with 2 
g/ml of anti-CD3.  Proliferation was assayed 72 h after treatment by adding [3H]-thymidine to the 
culture for the last 8 h.  Data shows mean ± S.D.  A representative example of three independent 
experiments is shown.  (C) CD4+CD25-CD62LhiCD44lo naïve T cells from Smad4 WT or Smad4 tKO
mice were activated with anti-CD3/CD28 in the presence of TGF-, IL-2, anti-IFN- and anti-IL-4.  
After 4d, Foxp3 expression was analyzed by intracellular staining.  Numbers in quadrants represent the 
percentages.  The experiments were repeated three times with consistent results.  Reprinted from 
“Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.” Xuexian O. 
Yang, Roza Nurieva, Gustavo J. Martinez, Hong Soon Kang, Yeonseok Chung, Bhanu P. Pappu, 
Bhavin Shah, Seon Hee Chang, Kimberly S. Schluns, Stephanie S. Watowich, Xin-Hua Feng, Anton 
M. Jetten and Chen Dong. Immunity. 2008. 29(1):44-56 with permission from Elsevier.
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III.2.b. Smad3 partially induces the generation of Foxp3-expressing T cells   
 
To further delineate the role of the TGF- signaling pathway in Treg cell generation, Smad3 
KO mice were utilized (Datto et al., 1999).  Similar to the Smad4 tKO mice, these mice presented 
normal levels of CD4+ and CD8+ T cells in vivo as well as nTreg cells in spleen, peripheral and 
mesenteric lymph nodes (Fig. 21A and B).  However, a significantly lower frequency of nTreg cells was 
observed in Smad3-deficient thymi, indicating either reduced Treg generation or homeostasis in this 
organ (Fig. 21A and B).  Nevertheless, the function of peripheral nTreg cells was unaffected as 
evaluated by in vitro suppressive activity (Fig. 21C).  Altogether, these results suggest that the 
maintenance or suppressive activity of nTreg cells in the periphery does not depend on Smad3.  
We next evaluated whether the generation of inducible regulatory T cells in vitro require Smad3.  
Naïve T cells from Smad3 KO or WT littermates were activated with plate bound anti-CD3 and anti-
CD28 together with TGF- and IL-2 for four days, and the expression of Foxp3 was determined by 
intracellular staining.  Deficiency of Smad3 led to a 50-60% reduction in Foxp3-expressing cells 
compared to WT counterparts (Fig. 22A and B), similar to what was observed for Smad4-deficient T 
cells.  Furthermore, the expression of iTreg-associated genes, Gpr83 (G- protein coupled receptor 83) 
and Ecm1 (Extracellular matrix protein 1), was also reduced in Smad3-deficient T cells (Fig. 22B). 
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Figure 21. Smad3 is not required for nTreg generation or suppressive activity, although there is 
slight decrease in nTreg numbers in thymus. (A) Presence of CD25+Foxp3+ cells in a CD4+ T cell 
gate was analyzed in different tissues from Smad3 WT or KO mice. A representative dot plot example is 
shown for each group in each tissue (A), and the combined results for seven-ten mice each group is 
indicated (B). Data shows mean ± S.D.  p values were calculated using Student t test. ***, p < 0.001.  
(C) CD4+CD25-CD62LhiCD44lo naïve T cells from Smad3 WT mice were cultured with or without WT 
or KO CD4+CD25+ natural regulatory T cells in triplicate wells with irradiated APCs and stimulated 
with 1 g/ml of anti-CD3.  Proliferation was assayed 72 h after treatment by adding [3H]-thymidine to 
the culture for the last 8 h.  Data shows mean ± S.D.  A representative example of three independent 
experiments is shown.  This research was originally published in “Smad3 Differentially Regulates the 
Induction of Regulatory and Inflammatory T Cell Differentiation.” Gustavo J. Martinez, Zhengmao
Zhang, Yeonseok Chung, Joseph M. Reynolds, Xia Lin, Anton M. Jetten, Xin-Hua Feng, and Chen 
Dong. J. Biol. Chem. 2009 284: 35283-35286. © the American Society for Biochemistry and Molecular 
Biology.
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Figure 22. Smad3 is partially required for the generation of inducible regulatory T cells in 
vitro.  (A) FACS-sorted naïve CD4+CD25-CD62LhiCD44lo T cells from Smad3 WT or KO mice 
were activated under the indicated inducible regulatory T cell polarizing conditions with plate-
bound anti-CD3 and anti-CD28 for 4 days and Foxp3 expression was analyzed by intracellular 
staining.  A representative experiment from four independent experiments is shown.  (B) Cells 
were differentiated as in (A), then restimulated with anti-CD3 for 4 h and cDNA was prepared.  
Gene expression profile was analyzed by real-time RT-PCR. Data were normalized to a reference 
gene Actb.  The lower expression level for each gene was referred as 1.  Data shows mean ± S.D.  
This research was originally published in “Smad3 Differentially Regulates the Induction of 
Regulatory and Inflammatory T Cell Differentiation.” Gustavo J. Martinez, Zhengmao Zhang, 
Yeonseok Chung, Joseph M. Reynolds, Xia Lin, Anton M. Jetten, Xin-Hua Feng, and Chen 
Dong. J. Biol. Chem. 2009 284: 35283-35286. © the American Society for Biochemistry and 
Molecular Biology.
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III.2.c. Smad2 deficiency results in reduced generation of Foxp3+ iTreg cells  
 
Given that Smad3 and Smad4 have been shown to partially regulate TGF--induced Foxp3 
expression, we next determined the role of Smad2 in the generation of inducible regulatory T cells.  
Mice lacking Smad2 in T cells (Smad2 tKO) were generated by breeding Smad2 floxed mice (Vincent 
et al., 2003) with CD4-Cre transgenic mice (Lee et al., 2001) (Fig 23).  Smad2 tKO mice exhibited 
normal development of CD4+ and CD8+ T cells in thymus compared to wild type littermate controls (Fig. 
24).  Moreover, Smad2 tKO mice showed similar frequencies and absolute cell numbers of CD8+ and 
CD4+ T cells in peripheral tissues compared to WT controls, with only a modest reduction in the 
frequency of CD8+ T cells in spleens (Fig 25 and data not shown).  Furthermore, when we analyzed the 
phenotype of CD4+ T cells in the periphery, we observed an increase of effector memory 
(CD44hiCD62Llow) T cells in Smad2 tKO mice compared to wild type controls (Fig. 26).   
We next determined whether the generation of natural regulatory T cells would be affected in 
the absence of Smad2.  Unlike the phenotype observed for Smad4 tKO or Smad3 KO mice, Smad2 tKO 
mice showed increased frequency of nTreg cells in all the lymphoid tissues studied, including the 
thymus (Fig. 27A).  Because of the enhanced levels of memory/activated CD4+ T cells in spleen, we 
then hypothesized that nTregs deficient in Smad2 may have reduced suppressive activity.  To evaluate 
this, we analyzed peripheral nTreg cell function by using an in vitro suppressive assay, in which naïve 
CD4+ T cells were stimulated in the presence of wild type or Smad2-deficient nTreg cells.  Interestingly, 
Smad2-deficient nTreg cells displayed similar suppressive capacity compared to their wild type 
counterparts (Fig. 27B).  Thus, these results, combined with our data from Smad3- and Smad4-deficient 
nTreg cells, suggest that nTreg suppressive activity might be Smad-independent.  However, whether 
compensatory mechanisms exist for Smad function still remains to be determined.  
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Figure 23. Mice with a Smad2-specific deletion in T cells show deficiency of 
Smad2 but not Smad3 in T cells. Splenocytes and peripheral lymph nodes were 
harvested from Smad2fl/flCD4Cre- (Smad2 WT) or Smad2fl/flCD4Cre+ (Smad2 tKO) 
mice.  Cells were sorted based on expression of the following markers: B220+ (B cells), 
CD4+ (CD4 T cells) or CD8+ (CD8 T cells).  Then, cell extracts were prepared and 
expression of Smad2, Smad3 and -actin was analyzed by western blot.  This research 
was originally published in “Smad2 positively regulates the generation of Th17 cells”
Gustavo J. Martinez, Zhengmao Zhang, Joseph M. Reynolds, Shinya Tanaka, 
Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua Feng, and Chen 
Dong. J. Biol. Chem. 2010 285: 29039-29043. © the American Society for 
Biochemistry and Molecular Biology.
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Figure 24.  Normal development and maturation of CD4+ and CD8+ T cells in mice lacking 
Smad2 in T cells. Thymocytes from 6-8 weeks old Smad2fl/flCD4Cre- (Smad2 WT) or 
Smad2fl/flCD4Cre+ (Smad2 tKO) mice were harvested.  (A) Frequency of CD4+ and CD8+ T cells 
was determined by flow cytometry.  (B) Expression of CD62L and CD69 was determined in 
CD4+CD8-TCRhi and CD8+CD4-TCRhi T cells by flow cytometry.  (A-B) A representative dot 
plot is shown for each group, and the combined results for 10-15 mice each group are indicated.  p 
values were calculated using Student t test.  This research was originally published in “Smad2 
positively regulates the generation of Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, Joseph 
M. Reynolds, Shinya Tanaka, Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua
Feng, and Chen Dong. J. Biol. Chem. 2010 285: 29039-29043. © the American Society for 
Biochemistry and Molecular Biology.
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Figure 25.  Normal levels of CD4+ and CD8+ T cells in mice lacking Smad2 in T cells in 
peripheral tissues. Spleen, peripheral and mesenteric lymph nodes from 6-8 weeks old 
Smad2fl/flCD4Cre- (Smad2 WT) or Smad2fl/flCD4Cre+ (Smad2 tKO) mice harvested.  Expression of 
CD4 and CD8 markers was determined by flow cytometry.  A representative dot plot is shown for 
each group (top panels), and the combined results for 10-15 mice each group are indicated (bottom 
panels).  p values were calculated using Student t test. *, p < 0.05.  This research was originally 
published in “Smad2 positively regulates the generation of Th17 cells” Gustavo J. Martinez, 
Zhengmao Zhang, Joseph M. Reynolds, Shinya Tanaka, Yeonseok Chung, Ting Liu, Elizabeth 
Robertson, Xia Lin, Xin-Hua Feng, and Chen Dong. J. Biol. Chem. 2010 285: 29039-29043. © the 
American Society for Biochemistry and Molecular Biology.
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Figure 26. Decreased naïve and enhanced memory CD4+ T cells in spleens from mice 
lacking Smad2 in T cells.  Spleens from 6-8 weeks old Smad2fl/flCD4Cre- (Smad2 WT) or 
Smad2fl/flCD4Cre+ (Smad2 tKO) mice were harvested.  Expression of CD62L and CD44 was 
determined in CD4+CD8- T cells by flow cytometry.  A representative dot plot is shown for 
each group (top panels), and the combined results for 10-15 mice each group are indicated 
(bottom panels).  p values were calculated using Student t test. * p < 0.05; *** p < 0.001.  This 
research was originally published in “Smad2 positively regulates the generation of Th17 cells”
Gustavo J. Martinez, Zhengmao Zhang, Joseph M. Reynolds, Shinya Tanaka, Yeonseok Chung, 
Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua Feng, and Chen Dong. J. Biol. Chem. 2010 
285: 29039-29043. © the American Society for Biochemistry and Molecular Biology. 
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Figure 27. Smad2 is not required for development or function of natural regulatory T cells. (A) 
CD25+Foxp3+ cells in a CD4+ T cell gate were analyzed in different tissues from Smad2fl/flCD4Cre-
(Smad2 WT) or Smad2fl/flCD4Cre+ (Smad2 tKO) mice.  A representative dot plot is shown for each 
group in each tissue (left panels), and the combined results for 10-15 mice each group are indicated 
(right panel).  p values were calculated using Student t test.  * p < 0.05; ** p < 0.01; *** p < 0.001.  
(B) CD4+CD25-CD62LhiCD44lo naïve T cells from Smad2 WT mice were cultured in the presence or 
absence of different ratios of Smad2 KO or WT CD4+CD25hi natural regulatory T cells in triplicate 
wells with irradiated APCs and stimulated with 1 g/ml of anti-CD3.  Proliferation was assayed 72 h 
after treatment by adding [3H]-thymidine to the culture for the last 8 h.  Data shows mean ± S.D.  A 
representative of three independent experiments is shown.  This research was originally published in 
“Smad2 positively regulates the generation of Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, 
Joseph M. Reynolds, Shinya Tanaka, Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-
Hua Feng, and Chen Dong. J. Biol. Chem. 2010 285: 29039-29043. © the American Society for 
Biochemistry and Molecular Biology.
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Recently, Tone et al. reported that Smad3 directly induces Foxp3 expression by synergizing 
with NFAT (Tone et al., 2008).  Furthermore, the authors showed that Smad3, but not Smad2, was able 
to induce luciferase activity in a reporter construct containing the Foxp3 enhancer region (Tone et al., 
2008).  However, the Smad2 isoform expressed in T cells contains exon 3 (data not shown), which 
shows reduced or complete lack of DNA-binding capacity (Dennler et al., 1998; Zawel et al., 1998).  
Therefore, Smad2 by itself may not be able to induce transactivation of a reporter gene, so it is still 
plausible that Smad2 regulates Foxp3 expression by associating with Smad3 and Smad4 or other factors.  
We then evaluated the role of Smad2 in the induction of Foxp3.  To this end, FACS-sorted naïve CD4+ 
T cells were stimulated with plate-bound anti-CD3 and anti-CD28 under iTreg-skewing conditions.  We 
observed decreased generation of Foxp3-expressing cells in Smad2-deficient T cells compared to WT 
counterparts (Fig. 28A).  Such reduction in Foxp3 expression was observed at the protein level as well 
as the mRNA level (Fig. 28B).  These results suggest that Smad2, Smad3 and Smad4, by either forming 
a molecular complex with each other, or by binding to other transcription factors, regulate TGF--
induced Foxp3 gene transcription.  However, while single deficiency in a Smad molecule results in 
partial defect in iTreg cell generation, they are not essential for nTreg development/homeostasis.  
However, we cannot rule out possible compensatory mechanisms in these single Smad-deficient mice.  
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Figure 28. TGF--induced Foxp3 expression is regulated by Smad2. FACS-sorted naïve 
CD4+CD25-CD62LhiCD44lo T cells from Smad2fl/flCD4Cre- (Smad2 WT) or Smad2fl/flCD4Cre+
(Smad2 tKO) mice were stimulated with plate bound anti-CD3 and anti-CD28 under inducible 
regulatory T cell (iTreg) conditions (TGF-, IL-2, anti-IFN- and anti-IL-4) for 4 days.  (A) Foxp3 
expression was analyzed by intracellular staining.  (B) After differentiation, cells were restimulated
with anti-CD3 for 4 h and cDNA was prepared.  Foxp3 gene expression was analyzed by real-time 
RT-PCR, and normalized to a reference gene Actb.  The lower expression level for Foxp3 gene in 
naïve T cells was referred as 1.  Data shows mean ± S.D.  A representative of three independent 
experiments is shown.  This research was originally published in “Smad2 positively regulates the 
generation of Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, Joseph M. Reynolds, Shinya 
Tanaka, Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua Feng, and Chen Dong. J. 
Biol. Chem. 2010 285: 29039-29043. © the American Society for Biochemistry and Molecular 
Biology.
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III.3.  Role of Smad-signaling pathway in the generation of Th17 cells 
 
III.3.a.  Dispensable role of Smad4 in Th17 cell differentiation  
 
Given that we found impaired generation of Th17 cells in the presence of a TGFRI kinase 
inhibitor, demonstrating Th17 reliance on TGF- signaling pathway, we then investigated the 
downstream signaling molecules important for such commitment.  We first determined the role of 
Smad4 during Th17 differentiation by isolating naïve T cells from either Smad4fl/fl CD4Cre- (WT) or 
Smad4fl/fl CD4Cre+ (tKO) mice.  Cells were stimulated with Th17-polarizing conditions (TGF-, IL-6, 
and neutralizing antibodies against IFN- and IL-4) for four days.  Interestingly, similar amounts of IL-
17-producing cells were found upon Th17 differentiation in Smad4-deficient and -sufficient T cells (Fig. 
29A).  To further demonstrate that Smad4 does not play a role in the generation of IL-17-producing 
cells in vivo, we utilized an immunization protocol.  Mice were immunized with Keyhole Limpet 
Hemocyanin (KLH) protein emulsified in Complete Freund’s Adjuvant (CFA).  This immunization 
protocol elicits the induction of antigen-specific Th17 responses in vivo (Chung et al., 2009; Nurieva et 
al., 2007).  Seven days after immunization, splenocytes were harvested and restimulated ex vivo with 
increasing concentrations of KLH protein for three days and cytokine expression was determined by 
ELISA.  Consistent with our in vitro results, no differences were observed in the production of Th17-
specific cytokines IL-17, IL-17F and IL-22 between WT and Smad4-deficient cells (Fig. 29B).  Overall, 
these results suggest that Smad4 differentially regulates the generation of Th17 and iTreg cells.   
Figure 29. Smad4 is dispensable for Th17 cell generation in vitro and in vivo. (A) CD4+CD25-
CD62LhiCD44lo naïve Smad4-sufficient or -deficient T cells were activated under Th17 conditions 
(TGF-, IL-6, anti-IFN-, anti-IL-4).  After 4d, cells were restimulated with PMA and ionomycin in the 
presence of Golgi Stop for 4h and IL-17/IFN- expression was analyzed by intracellular staining.  
Numbers in quadrants represent the percentages.  The experiments were repeated three times with 
consistent results.  (B) Smad4fl/fl CD4Cre+ (tKO) or Smad4fl/fl CD4Cre- (WT) mice were immunized 
with KLH in CFA.  Seven days later, splenocytes were re-stimulated with increasing concentration of 
KLH ex vivo for 3d and cytokine production was measured by ELISA in the culture supernatant.  Data 
shows mean ± S.D. (n=4).  The results shown are a representative example of two independent 
experiments.  Reprinted from “Molecular antagonism and plasticity of regulatory and inflammatory T 
cell programs.” Xuexian O. Yang, Roza Nurieva, Gustavo J. Martinez, Hong Soon Kang, Yeonseok
Chung, Bhanu P. Pappu, Bhavin Shah, Seon Hee Chang, Kimberly S. Schluns, Stephanie S. Watowich, 
Xin-Hua Feng, Anton M. Jetten and Chen Dong. Immunity. 2008. 29(1):44-56 with permission from 
Elsevier.
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III.3.b. Smad3 deficiency leads to enhanced Th17 cell differentiation 
 
Since Smad4 was found to be dispensable for the generation of Th17 cells in vivo and in vitro, 
we next evaluated whether Smad3 could regulate the differentiation of Th17 cells.  Thus, naïve T cells 
from Smad3 KO or WT littermates were stimulated with Th17-polarizing conditions as previously 
mentioned.  Interestingly, an increase in frequency of Th17 cells was observed when Smad3-deficient 
naïve T cells were stimulated with TGF-, IL-6 and neutralizing antibodies against IFN- and IL-4 
compared to WT counterparts (Fig. 30A).  Gene expression analysis by real time RT-PCR showed not 
only increased IL-17A but also IL-17F, CCR6 and CCL20 mRNA in T cells lacking Smad3 (Fig. 30B).  
However, no differences were observed for IL-22 or IL-21 mRNA, indicating that their expression is 
not regulated by TGF-.  We also measured cytokine secretion levels by ELISA from in vitro-generated 
WT or Smad3-deficient Th17 cells after anti-CD3 restimulation for 16h.  We found increased IL-17 and 
IL-17F cytokine production, however no differences were observed for IL-21 in Smad3-deficient Th17 
cells (Fig. 30C).  We next analyzed the expression of transcription factors by real time RT-PCR and 
detected a slight increase in ROR, but lower AHR and IRF4 mRNA expression in Smad3-deficient 
Th17 cells compared to WT counterparts.  However, no differences were noticed for RORt expression 
(Fig. 30B).  
Our lab has recently shown that the combination of IL-1, IL-6 and IL-23 also initiates the Th17 
genetic programming.  This polarizing condition still requires low TGF- concentration since 
neutralization of endogenous TGF- levels inhibits Th17 cell induction (Chung et al., 2009).  Thus, we 
next determined if Smad3 deficiency would still affect Th17 cell generation under low TGF- 
concentrations.  For this purpose, Smad3-deficient or –sufficient naïve T cells were activated with anti-
CD3 and anti-CD28 in the presence of IL-1, IL-6 and IL-23.  Even though stimulation with exogenous 
TGF- led to enhanced numbers of IL-17-producing cells, activation of naïve T cells with IL-1, IL-6 
and IL-23 resulted in similar levels of Th17 cells in Smad3 KO T cells compared to WT controls (Fig. 
30A and B).  These results suggested that in the presence of high TGF- concentrations, Smad3 is 
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capable of inhibiting Th17 cell generation.  To further assess this hypothesis, Smad3 KO or WT naïve T 
cells were cultured with IL-6 and neutralizing antibodies against IFN- and IL-4 with increasing 
concentrations of TGF-.  At low concentrations of TGF-, low but similar levels of IL-17-producing 
cells were observed in Smad3-deficient or -sufficient T cells.  However, with increasing concentrations 
of TGF-, higher frequency of IL-17-producing cells was observed in cells lacking Smad3 (Fig. 31).  
Interestingly, at TGF- concentrations that were not sufficient to induce Foxp3 expression, enhanced 
Th17 cells were still detected in Smad3-deficient cells (Fig. 31) indicating that the inhibitory role of 
Smad3 on Th17 cells might be independent of the induction of Foxp3.  
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Figure 30. Smad3 deficiency leads to enhanced Th17 cells upon stimulation with exogenous TGF-
.  FACS-sorted naïve T cells from Smad3 WT or KO mice were activated with plate-bound anti-CD3 
and anti-CD28 under indicated Th17 conditions for 4 days.  (A) Cells were then restimulated with PMA 
and ionomycin in the presence of Golgi inhibitor for 4h and IL-17- and Foxp3-expressing cells were 
assessed by intracellular staining.  (B) Cells were restimulated with anti-CD3 for 4h and cDNA was 
prepared.  Gene expression profile was analyzed by real-time RT-PCR.  Data were normalized to a 
reference gene Actb. The lower expression level for each gene was referred as 1.  (C) Cells were then 
restimulated with anti-CD3 for 16h, and cytokine concentration in culture supernatants was measured 
by ELISA.  A representative experiment out of four is shown.  (B-C) Data shows mean ± S.D.  This 
research was originally published in “Smad3 differentially regulates the induction of regulatory and 
inflammatory T cell differentiation” Gustavo J. Martinez, Zhengmao Zhang, Yeonseok Chung, Joseph 
M. Reynolds, Xia Lin, Anton M. Jetten, Xin-Hua Feng, and Chen Dong. J. Biol. Chem. 2009 284: 
35283-35286. © the American Society for Biochemistry and Molecular Biology.
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Figure 31. Smad3 inhibits Th17 differentiation in a TGF--dose dependent manner.  FACS-
sorted naïve CD4+CD25-CD62LhiCD44lo T cells from Smad3 WT or KO mice were activated with 
plate-bound anti-CD3 and anti-CD28 under indicated Th17-skewing conditions for 4 days.  Cells 
were then restimulated with PMA and ionomycin in the presence of Golgi inhibitor for 5 h and IL-
17- and Foxp3-expressing cells were assessed by intracellular staining.  A representative experiment 
out of three is shown.  This research was originally published in “Smad3 differentially regulates the 
induction of regulatory and inflammatory T cell differentiation.” Gustavo J. Martinez, Zhengmao
Zhang, Yeonseok Chung, Joseph M. Reynolds, Xia Lin, Anton M. Jetten, Xin-Hua Feng, and Chen 
Dong. J. Biol. Chem. 2009 284: 35283-35286. © the American Society for Biochemistry and 
Molecular Biology.
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III.3.c. Smad3 associates with RORt to inhibit its transcriptional activity  
 
Given that Smad3 KO T cells showed an enhanced capability to generate Th17 cells even in 
conditions that were not sufficient to induce Foxp3 expression, and that Smad3-deficient Th17 cells had 
similar mRNA levels of the Th17 master transcription factor RORt, we next determined the regulation 
of RORt function by Smad3.  HEK 293T cells were transfected with the RORE luciferase reporter 
system previously mentioned (Yang et al., 2008b) in the presence or absence of vectors expressing 
RORt and/or a constitutively active form of Smad3.  Transfection of RORt alone induced high 
luciferase activity, whereas expression of RORt with increasing concentrations of constitutively active 
Smad3 led to a significant reduction in luciferase activity (Fig. 32A).   
Since Smad3 is capable of partially inhibiting RORt transcriptional activity, we then 
investigated whether Smad3 could directly or indirectly associate with RORt.  Smad3 was found to be 
in a complex bound to RORt when the two molecules were co-expressed in HEK 293T cells (Fig. 32B).  
Interestingly, this binding seemed to be enhanced upon co-expression of a constitutively active form of 
rat TGF- receptor I (TGFRI T202D) (Feng et al., 2000) (Fig. 32B), indicating that phosphorylated-
Smad3 might show a higher affinity either directly for RORt or for other molecules that also bind to 
RORt.   
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Figure 32. Smad3 binds to RORt and inhibits its transcriptional activity.  (A) HEK 293T cells 
were transfected with RORE-Luciferase and the indicated vectors.  Firefly Luciferase activity was 
normalized to Renilla luciferase activity.  Data shows mean ± S.D.  The data represents at least two 
independent experiments with triplicate measurements with similar results. p values were calculated 
using Student t test. **, p < 0.005; **, p < 0.0005.  (B) HEK 293T cells were transiently transfected
with Myc-tagged Smad3, Flag-tagged RORt and/or His-tagged TGFRI T202D.  After 48h, lysates
were prepared and immunoprecipitated with an anti-FLAG mAb (IP), followed by immunoblotting
with anti-FLAG or anti-Myc (bottom two panels).  Top three panels indicate western blot of whole 
cell lysates.  This experiment was performed by Dr. Zhang at Baylor College of Medicine.  This 
research was originally published in “Smad3 differentially regulates the induction of regulatory and 
inflammatory T cell differentiation.” Gustavo J. Martinez, Zhengmao Zhang, Yeonseok Chung, 
Joseph M. Reynolds, Xia Lin, Anton M. Jetten, Xin-Hua Feng, and Chen Dong. J. Biol. Chem. 
2009 284: 35283-35286. © the American Society for Biochemistry and Molecular Biology.
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III.3.d. Lack of Smad3 leads to enhanced Th17 cell generation in vivo   
 
To further demonstrate that Smad3 deficiency leads to enhanced Th17 cell generation, we next 
analyzed the role of Smad3 in vivo.  Since Smad3-deficient mice develop colorectal adenocarcinomas 
starting at four month of age (Zhu et al., 1998), we utilized bone marrow chimeras for our experiments.  
Sublethally irradiated RAG1 (recombination activating gene 1) KO mice were adoptively transferred 
with WT or Smad3-deficient bone marrow cells.  Eight weeks after reconstitution, mice were 
immunized with MOG peptide emulsified in CFA.  Seven days after immunization, splenocytes were 
restimulated ex vivo with increasing concentrations of MOG peptide for three days and then cytokine 
levels were determined in the culture supernatant.  Increased Th17 cytokines (IL-17, IL-17F and IL-22) 
but not Th1 cytokine IFN-, were observed in splenocytes containing Smad3-deficient T cells compared 
to WT controls (Fig. 33 and data not shown).  Thus, these results confirm our in vitro data and suggest 
that Smad3 deficiency leads to enhanced Th17 cell generation.  
Smad3 KO
Smad3 WT
Figure 33. Smad3 deficiency leads to enhanced Th17 cell differentiation in vivo.  Bone 
marrow cells from Smad3 WT or KO mice were intravenously transferred to sub-lethally 
irradiated RAG1 KO mice.  After 8 weeks, the recipient mice were immunized subcutaneously 
with 150 g of MOG35-55 peptide emulsified in CFA.  Seven days later, splenocytes were 
isolated and restimulated with MOG peptide ex vivo for 3 days.  Cytokine production was 
measured from cell-free supernatants by ELISA.  Data shows mean ± S.D.  A representative 
experiment with five mice in each group out of two is shown.  This research was originally 
published in “Smad3 differentially regulates the induction of regulatory and inflammatory T cell 
differentiation.” Gustavo J. Martinez, Zhengmao Zhang, Yeonseok Chung, Joseph M. 
Reynolds, Xia Lin, Anton M. Jetten, Xin-Hua Feng, and Chen Dong. J. Biol. Chem. 2009 284: 
35283-35286. © the American Society for Biochemistry and Molecular Biology.
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III.3.e. Smad2 deficiency results in a reduction of Th17 cells in vitro 
 
Since TGF- has been shown to be an essential cytokine in driving Th17 cell responses 
independently of direct involvement of Smad3 or Smad4, we next determined the requirement of Smad2 
in Th17 cell generation.  Differentiation into IL-17-producing T cells in vitro was partially impaired in 
cells lacking Smad2 compared to their WT counterparts (Fig. 34A and 35A).  When analyzing the 
expression profile of lineage-specific genes by real-time RT-PCR, we found a reduction in IL-17, IL-
17F and CCL20 mRNA expression in Smad2-deficient T cells (Fig. 34B and 35B).  However, 
expression of other Th17-related cytokines, such as IL-22 or IL-21, was not impaired in Smad2-
deficient T cells (Fig. 34B and 35B), suggesting that the regulation of these cytokines is independent of 
Smad proteins.  Moreover, we did not detect any significant differences in the expression of the Th17-
associated transcription factors RORROR IRF4, AHR, IB and BATF (Fig. 34B, 35B and data not 
shown).  Smad2-deficient T cells also showed similar expression of the Th1, Th2 and iTreg 
transcription factors T-bet, GATA3 and Foxp3, respectively, compared to WT cells (Fig. 34B and data 
not shown), indicating that the Th17 deficiency is not a reflection of enhanced commitment to 
alternative Th lineages.  Furthermore, reduced IL-17-producing cells were also observed using a 
combination of IL-1, IL-6 and IL-23 cytokines in the absence of Smad2 (Fig. 35).  Similarly, decreased 
IL-17, IL-17F and CCL20, but not IL-21, IL-22 or Th17-specific transcription factors ROR and 
RORt were observed in Smad2-deficient Th17 cells when stimulated with IL-1, IL-6 and IL-23 (Fig. 
35B and data not shown).  Thus, our data suggest that Smad2 may function as an important factor in 
inducing Th17-speficic cytokines IL-17 and IL-17F as well as Th17-associated chemokine CCL20.    
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Figure 34.  T cells lacking Smad2 show decreased ability to differentiate into Th17 cells in vitro. 
FACS-sorted naïve CD4+CD25-CD62LhiCD44lo T cells from Smad2fl/flCD4Cre- (Smad2 WT) or 
Smad2fl/flCD4Cre+ (Smad2 tKO) mice were stimulated with plate bound anti-CD3 and anti-CD28 under 
indicated Th17-skewing conditions for 4 days. (A) Cells were then re-stimulated with PMA and 
ionomycin in the presence of Golgi inhibitor for 4h and IL-17- and Foxp3-expressing cells were 
assessed by intracellular staining. (B) After differentiation, cells were re-stimulated with anti-CD3 for 
4h and cDNA was prepared. Gene expression profile was analyzed by real-time RT-PCR. Data were 
normalized to a reference gene Actb. The lower expression level for each gene was referred as 1. A 
representative example of four independent experiments is shown. p values were calculated using 
Student t test. *, p < 0.05; **, p < 0.01.
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Figure 35. Reduced Th17 cell induction in cells lacking Smad2 when stimulated in the 
presence of IL-1, IL-6 and IL-23.  FACS-sorted naïve CD4+CD25-CD62LhiCD44lo T cells from 
Smad2fl/flCD4Cre- (Smad2 WT) or Smad2fl/flCD4Cre+ (Smad2 tKO) mice were stimulated with 
plate bound anti-CD3 and anti-CD28 in the presence of TGF-, IL-6 and neutralizing antibodies 
against IFN- and IL-4, or IL-1, IL-6 and IL-23 for 4 days.  (A) Cells were then re-stimulated with 
PMA and ionomycin in the presence of Golgi inhibitor for 4h and IL-17- and Foxp3-expressing 
cells were assessed by intracellular staining.  (B) After differentiation, cells were re-stimulated with 
anti-CD3 for 4h and cDNA was prepared.  Gene expression profile was analyzed by real-time RT-
PCR.  Data were normalized to a reference gene Actb.  The lower expression level for each gene 
was referred as 1 (expression level in naïve T cells).  Data shows mean ± S.D.  A representative 
example of three independent experiments is shown.  p values were calculated using Student t test. 
*, p < 0.05; **, p < 0.005.  This research (partially) was originally published in “Smad2 positively 
regulates the generation of Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, Joseph M. 
Reynolds, Shinya Tanaka, Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua
Feng, and Chen Dong. J. Biol. Chem. 2010 285: 29039-29043. © the American Society for 
Biochemistry and Molecular Biology.
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III.3.f. Smad2 is necessary for the generation of Th17 cells in vivo 
 
 Since Smad2-deficient naïve T cells exhibited reduced capacity to differentiate into Th17 cells 
in vitro, we next analyzed if the same holds true for in vivo models.  Smad2 tKO or WT control mice 
were first immunized with KLH emulsified in CFA.  Seven days later, cytokine production by cells 
residing in the draining lymph nodes and spleen was determined.  A significant reduction in IL-17-
producing cells (frequency and absolute cell numbers) was observed in Smad2 tKO mice compared to 
WT littermates when cells from draining lymph nodes were restimulated with KLH ex vivo (Fig. 36A).  
Furthermore, significantly lower IL-17 and IL-17F cytokines were observed in culture supernatants 
when cells from draining lymph nodes and spleen were restimulated ex vivo with increasing 
concentrations of KLH (Fig. 36B and C).  However, IL-22 and IFN- expression was similar between 
WT and KO cells, suggesting that Smad2 regulates IL-17 and IL-17F expression but not other Th-
specific cytokines.  
Th17 cells play important roles in autoimmune diseases and inflammatory responses (reviewed 
in (Martinez et al., 2008)).  In particular, Th17 cells have been shown to be the main pathogenic 
population in experimental autoimmune encephalomyelitis (EAE), an inflammatory disease that affects 
the central nervous system (CNS) (Langrish et al., 2005; Park et al., 2005).  Thus, to further 
comprehend the role of Smad2 during in vivo autoimmune settings, we used the EAE model.  Smad2 
WT or tKO mice were immunized with MOG peptide emulsified in CFA on days zero and seven, and 
then injected with pertussis toxin on days one and eight.  Disease scores were monitored daily following 
the second immunization as detailed in material and methods.  We found that both groups of mice 
showed signs of disease at a similar time point and disease severity further progressed until day nine 
after the second immunization (Fig. 37A).  While Smad2 tKO mice showed signs of recovery from 
disease on day ten onward after the second immunization, WT littermates showed increased or sustained 
disease severity.  Mice were euthanized fourteen days following the second immunization, and cell 
infiltration in the CNS was determined.  We observed a significant reduction in the frequency of CD4+ 
 89
T cells in Smad2 tKO mice compared to WT littermates (Fig. 37B).  Furthermore, we found decreased 
total CD4+ T cells in the CNS, althought this comparison was not statistically significant (Fig. 37B).  
We then analyzed the cytokines produced by the CNS-infiltrating CD4+ T cells by intracellular staining 
and observed significantly lower IL-17+ and IL-17+IFN-+ cells (frequency and absolute cell number) 
(Fig. 37C).  However, the amount of IFN--producing CD4+ T cells was similar between WT and 
Smad2 tKO mice (Fig. 37C), further confirming that Smad2 specifically regulates Th17, but not Th1, 
generation in vivo.  Moreover, when splenocytes from Smad2 tKO mice were restimulated with 
increasing concentrations of MOG peptide ex vivo, we found reduced Th17 cytokine secretion, albeit 
similar proliferation potential, compared to WT cells (Fig. 37D).  Taken together, our results suggest 
that Smad2 expression is necessary for normal Th17-mediated immune responses in vitro and in vivo.     
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Figure 36.  Mice with Smad2 deficiency in T cells have impaired Th17 cell responses in vivo. 
Smad2fl/flCD4Cre- (Smad2 WT) or Smad2fl/flCD4Cre+ (Smad2 tKO) mice were immunized 
subcutaneously with keyhole limpet haemocyanin (KLH) emulsified in CFA.  Seven days after 
immunization, spleen and draining lymph nodes were harvested. (A) Cells from draining lymph nodes 
were restimulated with 100 g/ml KLH protein, or media alone for 16h.  Golgi Stop was added during 
the last 6h of culture, and cytokine expression in CD4+ T cells was determined by intracellular staining.  
A representative dot plot is shown (right), and the combined results (frequency or total cell number) for 
four mice in each group are indicated (left).  Left panel shows mean ± S.D.  p values were calculated 
using Student t test.  * p <0.05, *** p <0.001.  (B-C) Cells from spleens (B) or draining lymph nodes 
(C) were isolated and restimulated with increasing concentrations of KLH ex vivo for 3 days.  Cytokine 
production was measured from cell-free supernatants by ELISA.  Data shows mean ± S.D.  p values 
were calculated using Student t test.  * p <0.05, ** p <0.01, *** p <0.001. A representative experiment 
out of two is shown.  This research was originally published in “Smad2 positively regulates the 
generation of Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, Joseph M. Reynolds, Shinya Tanaka, 
Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua Feng, and Chen Dong. J. Biol. 
Chem. 2010 285: 29039-29043. © the American Society for Biochemistry and Molecular Biology.
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Figure 37.  Smad2 deficiency in T cells ameliorates EAE disease development.  EAE was induced in 
Smad2fl/flCD4Cre- (Smad2 WT) or Smad2fl/flCD4Cre+ (Smad2 tKO) female mice.  (A) Disease score 
(mean ± SEM) measured after the second MOG immunization (see Materials and methods) combining 
three independent experiments (Smad2 WT, n=10; Smad2 tKO, n=13).  p values were calculated using 
student t test comparing the disease score within each day.  *, p < 0.05; **, p < 0.005.  (B-C) 
Mononuclear cells infiltrating the central nervous system from the EAE mice were isolated on day 14 
after the 2nd immunization and restimulated with PMA, ionomycin and Golgi Stop for 6h.  CD4 and 
CD11b expression was determined (B) and IL-17- or IFN--expressing cells were measured by 
intracellular staining on a CD4+ T cell gate (C).  (B-C) A representative dot plot is shown, and the 
combined results (frequency or total cell number) for each group are indicated.  p values were calculated 
using Student t test.  * p <0.05, ** p <0.005, *** p <0.001.  (D) Splenocytes from the above mice were 
stimulated with MOG peptide ex vivo and cytokine expression levels were measured by ELISA or 
proliferation by H3-thymidine incorporation.  Data shows mean ± S.D.  Data shown is a representative 
example of three independent experiments with consistent results.  p values were calculated using Student 
t test.  * p <0.05.  This research was originally published in “Smad2 positively regulates the generation of 
Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, Joseph M. Reynolds, Shinya Tanaka, Yeonseok
Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua Feng, and Chen Dong. J. Biol. Chem. 2010 
285: 29039-29043. © the American Society for Biochemistry and Molecular Biology.
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III.3.g. Smad2 binding to RORt results in a synergistic induction of Th17 cells 
 
Given that Th17 cells lacking Smad2 display similar levels of ROR and RORt transcription 
factors compared to their WT controls but show reduced cytokine responses, we hypothesized that 
Smad2 is not necessary for the induction of Th17-associated transcription factors but rather required for 
their function.  Since we observed binding of Smad3 to RORt (Fig. 32A), we evaluated whether Smad2 
could also associate with this transcription factor.  Indeed, by using a co-immunoprecipitation approach, 
we found that Smad2 as well as Smad3, but not Smad4, is found in a molecular complex associated with 
RORt upon co-expression of these molecules in HEK 293T cells (Fig. 38A).  Furthermore, we 
observed that this association was enhanced upon co-expression of a constitutively active form of rat 
TGF- type I receptor (TGFRI T202D) (Feng et al., 2000) (Fig. 38A).  Thus, these data indicate that 
Smad2 and/or Smad3 can bind to complexes containing RORt, and further activation of these 
molecules by TGFR signaling can increase such binding.     
Smad2 as well as Smad3 can be present in a molecular complex with RORt.  However, Smad2 
and Smad3 have opposing functions in the generation of Th17 cells.  Thus, we investigated the binding 
affinity of each Smad molecule to RORt by performing a competitive co-immunoprecipitation 
experiment.  We over-expressed constant amounts of Smad2 or Smad3 molecules in the presence of 
increasing concentrations of the other Smad member, in the presence of RORt.  We observed that over-
expression of increasing concentrations of Smad2 did not affect Smad3 binding to RORt (Fig. 38B).  
On the contrary, upon increasing concentrations of Smad3, Smad2 binding to RORt was diminished 
(Fig. 38B).  Thus, these results showed that Smad3 competed with Smad2 for RORt binding, blocking 
Smad2 binding to RORt.  These results then suggest that Smad3 may actually play an indirect 
inhibitory role in Th17 cell generation by restricting RORt function through the prevention of Smad2 
binding.  
Figure 38. Smad3 inhibits Smad2 binding to RORt.  (A) HEK 293T cells were transiently transfected
with 6xMyc-tagged Smad3, 6xMyc-tagged Smad2, 2xMyc-tagged Smad4, Flag-tagged RORt and/or 
His-tagged TGFRI T202D.  After 48h, lysates were prepared and immunoprecipitated with an anti-
FLAG mAb (IP), followed by immunoblotting with anti-FLAG or anti-Myc (bottom two panels).  Top 
three panels indicate western blot of whole cell lysates.  (B) HEK 293T cells were transiently transfected
with Flag-tagged Smad3, Flag-tagged Smad2 and/or cMyc-tagged RORt.  Lanes 4-6, constant Smad2 
and increasing concentrations of Smad3 plasmid (0.25X, 0.5X and 1X) were transfected.  Lanes 8-10, 
constant Smad3 and increasing concentrations of Smad2 plasmid (0.25X, 0.5X and 1X) were transfected.  
After 48h, lysates were prepared and immunoprecipitated with an anti-Myc mAb (IP), followed by 
immunoblotting with anti-FLAG or anti-Myc (bottom two panels).  Top two panels indicate western blot 
of whole cell lysates.  The experiments were performed twice with similar results by Dr. Zhang at Baylor 
College of Medicine.  This research was originally published in “Smad2 positively regulates the 
generation of Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, Joseph M. Reynolds, Shinya Tanaka, 
Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua Feng, and Chen Dong. J. Biol. 
Chem. 2010 285: 29039-29043. © the American Society for Biochemistry and Molecular Biology.
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Given that Smad2 can be found in a molecular complex together with RORt, and that it has 
reduced DNA binding capacity, we next hypothesized that Smad2 could act as a coactivator for RORt 
and therefore synergize with this transcription factor in driving the generation of Th17 cells.  To 
examine this question, we over-expressed RORt and/or constitutively active Smad2 (Smad2-2SD) in T 
cells by retroviral transduction.  The retroviruses also contained IRES-GFP or IRES-hCD2, so that cells 
that have been infected by both viruses can be recognized based on GFP and hCD2 co-expression.  
While over-expression of control vectors alone or Smad2 by itself did not induce Th17 cells (Fig. 39A 
and B), RORt over-expression led to the induction of IL-17-producing cells and increased expression 
of genes related to a Th17 phenotype (Fig. 39A and B).  Interestingly, over-expression of both Smad2-
2SD and RORt greatly enhanced the generation of IL-17-producing cells in comparison to RORt over-
expression alone (Fig. 39A).  To further comprehend the molecular mechanism by which Smad2 could 
synergize with RORt in the induction of IL-17-producing cells, we next determined the gene 
expression profile of these cells.  We found increased RORt-dependent mRNA expression of IL-17, 
IL-17F and CCL20 upon co-expression with Smad2-2SD (Fig. 39B).  Moreover, endogenous ROR 
expression was augmented upon RORt over-expression, and such induction was even higher when 
Smad2-2SD and RORt were co-expressed (Fig. 39B and data not shown).  However, we did not 
observe any differences in other Th17-specific transcription factors such as ROR, BATF and IB 
(Fig. 39B and data not shown).  Thus, our data suggest that Smad2 could function as a coactivator for 
RORt which, in turn, would lead to enhanced Th17 cell generation.  
 
Figure 39. Smad2 synergizes with RORt in the generation of Th17 cells.  FACS-sorted naïve OT-
II CD4+ T cells were activated with OVA peptide-pulsed splenic APCs under neutral (anti-IL-4, anti-
IFN- and anti-TGF-) conditions and co-infected with two bicistronic retroviruses (IRES-GFP or 
IRES-hCD2) expressing RORt-GFP, Smad2-2SD-hCD2 and/or GFP or hCD2 vector controls.  After 
4d, GFP+ hCD2+ infected cells were FACS-sorted.  (A) GFP+ hCD2+ cells were stimulated with PMA, 
ionomycin and Golgi Stop for 4h, and IL-17-producing cells were determined by intracellular staining.  
(B) GFP+ hCD2+ cells were re-stimulated for 4h with anti-CD3, and mRNA expression of the indicated 
genes was analyzed by real time RT-PCR.  The data shown were normalized to expression of a 
reference gene Actb.  The lowest expression of each gene was referred to as 1, and corresponds to 
naïve T cells.  Data shows mean ± S.D.  The data represents at least three independent experiments 
with consistent results. This research was originally published in “Smad2 positively regulates the 
generation of Th17 cells” Gustavo J. Martinez, Zhengmao Zhang, Joseph M. Reynolds, Shinya 
Tanaka, Yeonseok Chung, Ting Liu, Elizabeth Robertson, Xia Lin, Xin-Hua Feng, and Chen Dong. J. 
Biol. Chem. 2010 285: 29039-29043. © the American Society for Biochemistry and Molecular 
Biology.
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DISCUSSION 
 
In the present chapter we have investigated the role of TGF--induced Smad-dependent 
signaling pathway in the generation of two T cell lineages with opposing functions in the immune 
system: Th17 and regulatory T cells.  The role of each Smad molecule in the generation of Th17 or 
regulatory T cells is indicated in Table 1.  In this section, we will first discuss the role of this signaling 
pathway in the regulation of Foxp3 expression and the subsequent generation of regulatory T cells, and 
then we will discuss the Smad-dependent signaling pathway in the commitment towards Th17 cells. 
 
Role in generation of: nTreg cells iTreg cells Th17 cells 
Smad4 
Dispensable (no defect 
in nTreg levels in any 
tissue analyzed) 
Partially required Dispensable 
Smad2 
Inhibitory (enhanced 
nTreg cell levels in 
thymus and peripheral 
tissues)  
Partially required Partially required 
Smad3 
Required in thymus but 
not in peripheral 
tissues, suggesting role 
in generation but not in 
homeostasis 
Partially required Inhibitory 
Table 1.  Role of Smad molecules in the generation of regulatory T and Th17 cells.  The 
requirement of each Smad member studies is indicated based on the phenotype observed in cells or 
animals deficient in each molecule.  The effect observed could be direct or indirect. 
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III.i. Role of the TGF- signaling pathway in the generation and function of natural 
regulatory T cells 
 
We first evaluated the role of Smad molecules in the generation of nTreg cells.  We found that 
whereas Smad4 deficiency in T cells does not affect generation or maintenance of nTreg cells, mice 
with Smad2 deficiency in T cells exhibit enhanced nTreg cells in the thymus and peripheral tissues 
including spleen, lymph nodes and mesenteric lymph nodes (summarized in Table 1).  Takimoto et al. 
and Malhotra et al. have also recently found enhanced CD4+Foxp3+ nTreg cells in thymus, spleen and 
mesenteric lymph nodes of mice lacking Smad2 in T cells as well, confirming our findings (Malhotra 
and Kang, 2010; Takimoto et al., 2010).  These results suggest a mechanism of enhanced generation of 
regulatory T cells and/or homeostatic proliferation in peripheral tissues in the absence of Smad2.  
Indeed, TGFRI conditional KO mice also showed enhanced nTreg levels in the thymus one week after 
birth due to an increased responsiveness to IL-2 (Liu et al., 2008).  Furthermore, Smad2 has been shown 
to be phosphorylated and translocated into the nuclei of CD4+CD8- SP thymocytes, which also co-
expressed the TGFRI (Rosendahl et al., 2003).  Thus, these results indicate that Smad2 activation by 
TGFRI in thymocytes may allow for enhanced IL-2 responsiveness.  Further characterization of mice 
deficient in Smad2 at different ages and biochemical analysis of thymic regulatory T cells isolated from 
those mice could help identify the exact role Smad2 plays in Treg cell development.  Moreover, to fully 
comprehend the role of Smad2 in Treg homeostasis, adoptive transfer experiments could be utilized.  
For this purpose, regulatory T cells from either thymus or peripheral tissues could be isolated and 
transferred into wild type congenic mice to identify whether these cells can expand, leading to enhanced 
numbers, compared to adoptive transfer of wild type Treg cells. 
We also determined the role of Smad3 in nTreg biology and found that Smad3-deficient mice 
exhibited reduced CD4+CD25+Foxp3+ T cells in the thymus compared to WT mice, but no significant 
differences were detected in peripheral tissues.  In contrast to our results, Wang and colleagues have 
found enhanced CD4+CD25+ T cells in peripheral tissues such as spleen, lymph nodes and thymus in 
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mice lacking Smad3 (Wang et al., 2006).  However, in this report, the authors did not evaluate Foxp3 
expression in these animals.  Similarly, Takimoto et al. observed enhanced nTreg cells in peripheral 
tissues including mesenteric lymph nodes and spleens in Smad3 KO mice, while no differences were 
detected in the thymus (Takimoto et al., 2010).  The discrepancies between our data and the other 
reports could be due to the conditions in which these mice were housed, since all these mice are on 
C57BL/6 background.  It would be important to confirm this statement by exchanging the strains 
between the laboratories and confirming each phenotype. 
More recently, Waisman and colleagues have shown that mice lacking the inhibitory Smad, 
Smad7, in T cells do not show enhanced generation of natural regulatory T cells (Kleiter et al., 2010).  
Interestingly, though, mice lacking both Smad2 and Smad3 showed significant reduction in 
CD4+Foxp3+ nTreg cells in peripheral tissues but not in the thymus and display an autoimmune 
phenotype, suggesting that Smad2 and Smad3 have somewhat overlapping roles in the maintenance of 
natural regulatory T cells in vivo (Takimoto et al., 2010).  Overall, these results identify the Smad-
dependent signaling pathway as an important regulator of nTreg cell homeostasis in vivo.  Similar 
results were shown in mice with a T cell-specific deletion of TGF-RII, which show enhanced nTreg 
cell generation in the thymus, but reduced peripheral regulatory T cells, demonstrating an important role 
of TGF- signaling in nTreg cell homeostasis. 
 We also investigated the function of natural regulatory T cells in the absence of Smad 
molecules and found that Smad2, Smad3 or Smad4 are not required for nTreg suppressive function in 
vitro.  Other groups have also demonstrated that Smad2-deficient nTreg cells have similar suppressive 
activity compared to wild type counterparts in vitro and in vivo, supporting our findings (Malhotra and 
Kang, 2010; Takimoto et al., 2010).  In contrast to our results, Maggio-Price et al. have recently shown 
that Smad3-deficient nTreg cells lack suppressive function in vivo.  Recent work has demonstrated that 
Smad3-deficient mice develop colorectal adenocarcinomas spontaneously (Zhu et al., 1998).  However, 
whether this disease is caused by an inflammatory process induced by T cells still remains unclear.  
Maggio-Price et al. evaluated this question by using Smad3-/- RAG-/- mice and showed an increase in the 
incidence of adenocarcinoma in these mice compared to either single KO mice, suggesting that cancer 
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development as a result of Smad3 deficiency is indeed independent of B and T lymphocytes (Maggio-
Price et al., 2009).  These mice also exhibited enhanced pro-inflammatory cytokine production 
following bacterial-induced disease, suggesting a prominent role of Smad3 in innate immune cells.  
Interestingly, adoptive transfer of WT nTregs prevented disease, while transfer of Smad3-deficient 
nTregs into Smad3-/-Rag1-/- mice did not restore bacterial-induced cancer in these mice, suggesting that 
nTregs lacking Smad3 are not functional in vivo in this particular model (Maggio-Price et al., 2009).  
However, the authors have not analyzed the role of Smad3-deficient nTreg cells in vitro.  Thus, the 
discrepancy between our results and the findings from Maggio-Price et al. suggest that further research 
should be performed to fully elucidate the role of Smad3 in Treg cell function in different disease 
settings.  A conditional KO mouse where Smad3 is specifically deleted in regulatory T cells (by 
utilizing Foxp3-Cre transgenic mice) would also be beneficial to address these questions. 
 
III.ii. Induction of de novo Foxp3 expression by naïve T cells 
 
 TGF- plays an important role in the development, maintenance, and induction of regulatory T 
cells (Chen et al., 2003; Curotto de Lafaille et al., 2008; Fantini et al., 2004). Upregulation of Foxp3 
expression in naïve T cells, induced by TGF-, correlates with the acquisition of a suppressive 
phenotype in these cells (Hori et al., 2003).  We first investigated the role of the TGF- signaling 
pathway in the induction of regulatory T cells by using a TGFRI kinase inhibitor.  We found that in 
vitro induction of Foxp3 required TGF- signaling during the first two days of culture.   
When analyzing the role of Smads during iTreg induction, we observed that naïve CD4+ T cells 
lacking Smad2, Smad3 or Smad4 have a partial impairment in the de novo expression of Foxp3 
transcription factor upon stimulation with TGF-(Fig. 40, and summarized in Table 1).  Similar to our 
results, several groups have also demonstrated a partial requirement for either Smad2 or Smad3 in iTreg 
cell generation (Jana et al., 2009; Malhotra and Kang, 2010; Takimoto et al., 2010).  These results 
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suggest that either there may be redundant functions between Smad molecules, or that the TGF- Smad-
independent signaling pathway is also required for activating Foxp3 gene transcription.   
In support of the notion of a redundancy between Smad molecules, Takimoto et al. have 
recently reported that both Smad2 and Smad3 are partially required for induction of Foxp3+ iTreg cells 
(Takimoto et al., 2010).  However, by using Smad2/Smad3 double-deficient T cells, the authors have 
demonstrated that TGF- induction of Foxp3 is completely abrogated, suggesting a synergistic and 
overlapping role of these two molecules in Foxp3 induction (Takimoto et al., 2010).  Consistent with 
these reports and our results, T cells deficient in Smad7 (an inhibitory Smad molecule) showed 
enhanced commitment towards the generation of iTreg cells, whereas cells overexpressing Smad7 have 
impaired induction of Foxp3 expression (Kleiter et al., 2010).   
Smad3 has been shown to synergize with NFAT in the induction of Foxp3 expression upon 
TGF- and TCR stimulation by binding to an enhancer element in Foxp3 gene (Tone et al., 2008; Zheng 
et al., 2010).  Rudensky and colleagues demonstrated the importance of this enhancer element, termed 
conserved non-coding sequence 1 (CNS1), as deletion of this cis-acting sequence prevented the 
generation of iTreg cells, but was dispensable for the induction of thymus-derived regulatory T cells 
(Zheng et al., 2010).  However, these results are inconsistent with the fact that Smad2/Smad3 double 
deficient mice show defective nTreg peripheral maintenance (Takimoto et al., 2010).  Thus, the exact 
mechanism by which Smads regulate Foxp3 expression in vivo remains to be investigated.  One possible 
explanation would be that other unidentified cis-regulatory elements containing Smad-binding sites are 
required for Smads-dependent Foxp3 maintenance.  It is also plausible that Smad molecules bind to 
other transcription factors, and regulate Foxp3 expression independently of their DNA binding.  Finally, 
we cannot rule out an indirect regulation of Foxp3 expression by Smads, in which Smad complexes 
would directly regulate the expression of other transcription factors which would then bind to regulatory 
elements in Foxp3 gene. 
In support of the idea of a TGF--induced Smad-independent signaling pathway controlling 
Foxp3 expression, Huber et al. have suggested that p38 MAPK signaling is crucial for induction of 
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Foxp3 expression (Huber et al., 2008), whereas Lee and colleagues have proposed that TGF--mediated 
inactivation of Erk is a requirement for Foxp3 induction (Luo et al., 2008).  However, recently Lu et al. 
have suggested that Erk activation is needed for generation of iTreg cells, while p38 and JNK play no 
role (Lu et al., 2010).  Furthermore, this group also proposed that neither Smad2 nor Smad3 play a 
significant role in the induction of Foxp3 expression by naïve T cells (Lu et al., 2010).  However, in this 
report the authors did not show evidence of full deletion of either Smad2 or Smad3 in T cells, possibly 
indicating that the lack of deficiency in Foxp3 expression might be due to residual levels of Smad 
proteins (Lu et al., 2010). 
 Overall, our results together with recent publications suggest that the Smad-dependent signaling 
pathway is indispensable for the induction of de novo transcription of Foxp3 gene and maintenance of 
Foxp3 expression in nTreg cells (Fig. 40).  Smad3 has been shown to directly bind to Foxp3 CNS1 
region (Tone et al., 2008).  Even though Smad2 and Smad4 are also required for de novo induction of 
Foxp3 expression, their direct association to this cis-acting regulatory region needs further investigation 
(Fig. 40).  Furthermore, it is still plausible that the Smad-independent signaling pathways also 
collaborate with the Smad-dependent pathway for optimal Foxp3 expression.  Indeed, several reports 
have suggested a crosstalk between MAPKs and Smads signaling pathways (Burch et al., 2010; Carta et 
al., 2009; Jiang et al., 2010; Li et al., 2009; Li et al., 2010).  Further work using mice deficient in both 
signaling pathways could help address the remaining controversies in the field.  However, since the 
MAPK signaling pathway is also required by costimulatory and TCR signals, understanding their exact 
contribution in Treg cell generation or maintenance will be a major challenge.  One possible way of 
studying the MAPK-dependent versus the Smad-dependent contribution induced by TGF- would be to 
utilize cells with a TGFR that has a mutation either in the domain that is required for MAPK activation 
or in the L45 loop required for Smads activation (Yu et al., 2002).  By utilizing knock-in mice with such 
mutations, one could separately study the contribution of each signaling pathway induced by TGF- in 
the induction or maintenance of Foxp3 expression.     
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Figure 40. Summary of the role of TGF- signaling in induction of Foxp3 expression. TGF-
induces activation of Smad2 and Smad3 (phosphorylation), which then bind to Smad4 and translocate to 
the nucleus.  Smad3 directly binds to Foxp3 CNS1 region and synergizes with NFAT in induction of 
Foxp3 (Tone et al. 2008).  We found that Smad2, Smad3 and Smad4 are partially required for TGF--
induced Foxp3 expression.  Also, deficiency in Smad2 and Smad3 completely abrogates Foxp3 
expression (Takimoto et al. 2010), confirming our results on the role of the Smad-dependent signaling 
pathway in the generation of iTreg cells. 
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III.iii. Role of the Smad-dependent signaling pathway in Th17 cell generation 
 
TGF- has also been shown to be required for the induction of Th17 cells (Veldhoen et al., 
2006a).  In fact, mice with TGFRI-deficient T cells are unable to generate Th17 cells in vivo and thus 
fail to develop EAE, albeit the fact that Th1 cells infiltrating the CNS were still detected (Veldhoen et 
al., 2006b).  We have also confirmed the role of TGFRI requirement in vitro by demonstrating that 
inhibition of TGFRI kinase activity also impairs the induction of Th17 cells.  Thus, these results 
suggest that active TGF- signaling is indeed required for induction of these inflammatory T cells.   
It has been suggested that TGF- primarily inhibits Th1 and Th2 differentiation rather than 
directly inducing the commitment towards Th17 cells (Das et al., 2009; Santarlasci et al., 2009; Yang et 
al., 2008d).  While we agree that the TGF--induced Smad-dependent pathway is not required for Th17 
cells commitment (Smad-deficient cells do not have defect in the expression of Th17-associated 
transcription factors), we still believe that TGF- signaling is required for full commitment towards 
Th17 cells generation since inhibition of TGRI kinase activity also results in complete inhibition of 
RORt expression.  Das and colleagues have shown that cells lacking STAT6 and T-bet, which are 
unable to differentiate into Th1 or Th2 cells, only require IL-6 to become IL-17-producing cells.  
Furthermore, when using the EAE model, they observed that STAT6-/-T-bet-/- mice were highly 
susceptible to EAE disease development (Das et al., 2009).  Moreover, they showed that blocking 
endogenous TGF- in vitro still led to the generation of Th17 cells (Das et al., 2009).  Yang et al. have 
also demonstrated that cells lacking T-bet and STAT6 have a lower TGF- threshold required for Th17 
cell generation, and that IL-6 alone can promote the differentiation into IL-17-producing T cells.  
However, IL-6-induced Th17 cells do not express IL-10 and are more pathogenic than TGF-/IL-6-
generated Th17 cells in a colitis model.  Furthermore, whereas Das and colleagues showed no 
significant differences in the generation of Th17 cells between IL-6 and IL-6/TGF- stimulation 
conditions, Ding and colleagues observed enhanced Th17 commitment upon addition of TGF-(Das et 
al., 2009; Yang et al., 2008d).  Thus, these reports suggest that even though TGF- can play an 
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important role in inhibiting Th1 and Th2 generation, it is still required for optimal Th17 cell induction in 
vitro and in vivo (Veldhoen et al., 2006b).   
We examined the TGF--induced Smad-dependent signaling pathway in the induction of Th17 
cells and found that although Smad4 was dispensable, Smad2 was required for their generation 
(summarized in Table 1).  Recently Takimoto et al. and Malhotra et al. have also shown that Smad2-
deficient T cells have impaired Th17 cell development in vitro.  Furthermore, using two in vivo disease 
models where Th17 cells have been shown to play crucial roles, they found reduced EAE disease 
development and enhanced Citrobacter rodentium-induced weight loss, respectively (Malhotra and 
Kang, 2010; Takimoto et al., 2010).  At the molecular level, there are some discrepancies as to what role 
Smad2 plays.  Takimoto et al. suggest that the reduction in Th17 generation is due to enhanced IL-2 and 
IFN- production in the absence of Smad2 (Takimoto et al., 2010).  On the other hand, Malhotra et al. 
found that Smad2-deficient Th17 cells have reduced IL-6R and thus reduced STAT3 activation 
(Malhotra and Kang, 2010).  We have failed to detect any enhanced T-bet, GATA-3, IFN-IL-4, or 
reduced IL-6R expression (data not shown) in Th17 cells lacking Smad2, which suggests to us that 
Smad2 plays a direct role in the induction of several Th17-specific genes rather than acting to prevent 
Th1 or Th2 cell generation.  Indeed, a constitutively active form of Smad2 cooperated in the RORt-
induced Th17 cell generation.    
On the other hand, we found that cells lacking Smad3 had enhanced induction of Th17 cells, 
suggesting that Smad molecules have differential requirements for Th17 cell generation, contrary to 
their role in Foxp3 induction.  Previous work has demonstrated that Smad3-deficient mice have 
enhanced pro-inflammatory cytokines compared to WT mice in a model of contact hypersensitivity 
induced by oxazolone (Anthoni et al., 2008).  Anthoni et al. also found that Smad3-deficient mice 
showed higher IL-17 mRNA levels compared to WT mice upon oxazolone treatment.  However, given 
that these mice also had higher TGF-, IL-6, IL-1 and TNF- levels in inflamed skin, the authors could 
not rule out the possibility that enhanced IL-17 production was due to an increase in Th17-promoting 
factors.  By contrast, we have shown that Smad3 deficiency in T cells intrinsically led to enhanced Th17 
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cell differentiation.  Consistent with this idea, other groups have reported that retinoic acid, important in 
inducing Foxp3 expression and inhibiting Th17 generation, enhances Smad3 protein expression as well 
as its phosphorylation levels.  This enhanced Smad3 activation in turn leads to increased Foxp3 
expression and reduced IL-6R, IL-23R and IRF4 expression, in a Stat3- and Stat5-independent manner 
(Elias et al., 2008; Xiao et al., 2008), leading to inhibition of Th17 cell development. 
We have observed that both Smad2 and Smad3 can be found in a molecular complex associated 
with RORt.  We then determined the relative affinity of each molecule to RORt and found that Smad3 
inhibits Smad2 binding to RORt, suggesting that it might play an indirect inhibitory role in Th17 cell 
generation (Fig. 41).  Even though it is widely accepted that TGFR induces similar phosphorylation 
levels of Smad2 and Smad3, Heikkinen et al. have recently demonstrated that the Protein Phosphatase 
2A (PP2A) differentially regulates Smad2 and Smad3 phosphorylation by directly dephosphorylating 
Smad3 under hypoxic conditions (Heikkinen et al., 2010).  Furthermore, Tu et al. have also shown that 
Smad2 and Smad3 molecules can be distinctively acetylated which results in an enhanced nuclear 
retention of Smad2 over Smad3 (Tu and Luo, 2007).  Thus, these studies suggest that even though 
TGFR similarly phosphorylates Smad2 and Smad3, their activation status may rely independently on 
other molecules/pathways as well.  It is plausible that developing Th17 cells utilize some mechanism to 
guarantee an enhanced Smad2/Smad3 activation ratio that would then allow for full commitment to this 
T helper lineage.  However, it still remains to be determined whether Th17 cells have differential 
activation of Smad2 over Smad3.  For this purpose, future work evaluating the nuclear translocation, 
protein stability and/or post-translational modifications of Smad molecules in Th17 cells throughout 
their development needs to be performed.   
In contrast to our results, Lu et al. have recently suggested that neither Smad2 nor Smad3 play a 
direct role in the induction of Th17 cells (Lu et al., 2010).  Furthermore, the authors showed normal 
EAE disease development in the absence of Smad3 (Lu et al., 2010).  The authors also investigated the 
MAPK signaling pathway required for generation of Th17 cells, and found that p38 and JNK inhibition 
led to reduced differentiation into IL-17-producing cells (Lu et al., 2010).  Indeed, by using a p38 
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inhibitor in vivo they found reduced EAE disease severity, suggesting that p38 might be important in the 
induction of pathogenic T cells (Lu et al., 2010).  However, given that TCR signaling also induces 
MAPK activation, and the crosstalk between MAPK and Smad pathways, the direct role of TGF- 
induced MAPK activation during Th17 differentiation still remains controversial.         
We have observed that Smad-deficient T cells exhibited no defect in the expression of Th17-
associated transcription factors (Fig. 41).  Consistent with our results, Yoshimura and colleagues have 
recently demonstrated that Smad3, Smad2 or double-deficient T cells showed no significant differences 
in the expression of ROR and RORt compared to WT controls, suggesting a Smad-independent 
induction of these transcription factors (Takimoto et al., 2010) (Fig. 41).  Thus, these results indicate 
that the TGF--induced Smad-dependent signaling pathway is not required for the commitment towards 
Th17 cell generation, but rather is necessary for the induction of cytokines or chemokines produced by 
these cells.  However, by using TGFRI-specific kinase inhibitor, we found that the generation of IL-
17-producing cells and the induction of the RORt transcription factor was impaired, suggesting that 
even though the Smad-dependent signaling pathway might be dispensable for Th17 cell commitment, 
TGF- signaling is still required.  Thus, how TGF- directly regulates the induction of such 
transcription factors, and whether other unidentified signaling pathways are required for the de novo 
expression of Th17-associated transcription factors need further investigation.  For example, agonistic 
ligation of PPAR (Peroxisome Proliferator-Activated Receptor gamma leads to a selective inhibition 
of Th17 cell generation by interfering with RORt expression through the impaired removal of the 
nuclear corepressor SMRT (silencing mediator of retinoid and thyroid receptors) from RORt promoter.  
However, in the absence of PPAR agonists and upon TGF- and IL-6 stimulation, the nuclear 
corepressor SMRT complex is displaced from RORt promoter allowing for the opening of the 
chromatin structure and transcription of this gene (Klotz et al., 2009).  Additionally, the MAP3K NIK 
was shown to be required for induction of Th17 cells and RORt expression (Jin et al., 2009).  NIK is 
responsible for the synergistic activation of STAT3 by TCR and IL-6R signaling (Jin et al., 2009), and 
several investigations have shown that STAT3 is required for induction of ROR and RORt (Chen et 
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al., 2006b; Yang et al., 2007).  Therefore, it still remains plausible that TGF- and IL-6 signaling 
pathways cooperate to induce Th17-associated transcription factors.  In fact, STAT3 has been shown to 
bind to the TGF- promoter, inducing TGF- transcription (Kinjyo et al., 2006).  Furthermore, TGF- 
also cooperates with the STAT3 signaling pathway by inhibiting IL-6- and IL-21-induced SOCS3 
expression (Qin et al., 2009).  Thus, TGF- might prolong STAT3 activation which in turn would favor 
Th17 cell development.  Whether this documented TGF- inhibition of SOCS3 expression is Smad-
dependent still remains unclear, but recent evidence suggests that Smad2 might be important for 
sustaining STAT3 activation (Malhotra and Kang, 2010).  
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Figure 41. Summary of the role of TGF- signaling in the generation of Th17 cells. TGF- induces 
activation of Smad2 and Smad3 (phosphorylation), which then bind to Smad4 and translocate to the 
nucleus.  Smad2, Smad3 or Smad4 are not directly required to induce expression of the Th17-associated 
transcription factors ROR and RORt, while IL-6-induced STAT3 activation is.  How TGF- regulates 
ROR or RORt expression needs further understanding.  Smad2 directly binds to RORt, the master 
transcription factor for Th17 cells, cooperating in RORt-induced IL-17 and IL-17F expression.  On the 
contrary, Smad3 inhibits Th17 cell generation by interfering with Smad2 binding to RORt, among other 
possible mechanisms.
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In summary, we have found that Smad molecules differentially regulate the generation of iTreg 
and Th17 cells.  Our results are important in understanding the reciprocal regulation of these two cell 
lineages with opposing functions in the immune system, and may allow for the development of novel 
immunotherapies to target these cell types in vivo.      
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 CHAPTER IV – GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
Naïve CD4+ T helper cells can differentiate into different effector subsets as previously 
described in Chapter I.  Herein, we have focused on the transcriptional regulation of Th17 and 
regulatory T cells, two T helper lineages with opposing functions in the immune system.  We analyzed 
the reciprocal generation of these cells by investigating the role of the Treg-associated master 
transcription factor Foxp3 in Th17 cell development.  We found that Foxp3 inhibits Th17 cell 
generation by suppressing the transcriptional activity of the two main Th17-associated transcription 
factors, nuclear receptors ROR and RORt.  At the molecular level, we identified two different 
functional domains in Foxp3 required for such inhibition: the LxxLL sequence in exon 2 and the 
TIP60/HDAC7 binding domain.  These domains could be crucial for preventing the association of the 
coactivators to nuclear receptors ROR or RORt (through LxxLL sequence) and/or for the recruitment 
of histone deacetylases to ROR-target genes (through the HDAC7 binding domain) (Chapter II).  
Additionally, we investigated the role of TGF-, a common cytokine required for the generation of the 
Th17 and regulatory T cell lineages.  We identified a differential signaling pathway induced by TGF- 
in the generation of Th17 and regulatory T cells.  We observed that while Smad2, Smad3 and Smad4 are 
required for TGF--induced Foxp3 expression and the subsequent development of inducible regulatory 
T cells, only Smad2 is indispensable for the induction of IL-17-producing T cells.  Interestingly, we 
determined that Smad2 is capable of enhancing RORt-induced Th17 cell generation, while Smad3 
inhibits Th17 cell generation by preventing the binding of Smad2 to RORt (Chapter III).  In this 
chapter, we will relate our results to recent reports on the transcriptional regulation of these two Th 
lineages, as well as the heterogeneity and plasticity of T helper subsets.  
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IV.1. The roles of TGF- and its signaling pathway in inducing Th responses  
 
 TGF- can control the generation of inducible regulatory T cells (Chen et al., 2003).  In the 
present work, we demonstrated that the Smad-dependent signaling pathway is crucial for the induction 
of Foxp3 expression in naïve T cells.  In support of our findings, Takimoto et al. have also demonstrated 
that deficiency in both Smad2 and Smad3 leads to a complete inhibition of Foxp3 expression (Takimoto 
et al., 2010).  TGF--induced Smad-independent signaling pathways may also be involved in the 
generation of inducible regulatory T cells, primarily through activation of MAPK.  However, the role of 
these kinases in the TGF--induced Foxp3 transcription remains controversial (Huber et al., 2008; Lu et 
al., 2010; Luo et al., 2008).  Interestingly, while it is clear that Smads directly control Foxp3 expression 
(Chapter III and (Takimoto et al., 2010; Tone et al., 2008)), it has been recently shown that other Fox-
family proteins, specifically Foxo1 and Foxo3, can directly regulate Foxp3 expression as deficiency of 
both molecules also abrogates the induction of Foxp3 (Kerdiles et al., 2010; Ouyang et al., 2010).  Cells 
deficient in both Foxo proteins showed no defect in phosphorylation of Smads (Kerdiles et al., 2010), 
suggesting that activation of Smads is required but not sufficient for proper induction of Foxp3 
expression.  Foxo1 and Foxo3 have been shown to directly bind the MH1 domains of Smad3 and Smad4, 
but not Smad2 or Smad1, and regulate TGF--dependent induction of p21Cip1 (Seoane et al., 2004).  
Thus, based on this previous report, a similar synergism between Smad and Foxo proteins might be 
required for optimal transcription of Foxp3 gene.  To address this issue, sequential chromatin 
immunoprecipitation experiments assesing the binding of Smads and Foxo proteins in the same Foxp3 
promoter/enhancer regions should be performed.  Moreover, overexpression of Foxo proteins in Smad-
deficient cells should determine whether Foxo proteins require the presence of Smad molecules for 
directly inducing Foxp3 expression.   
 Several conserved non-coding sequences (CNS) containing different epigenetic marks in a cell-
type specific manner have been recently identified in Foxp3 gene (Zheng et al., 2010).  The exact 
combination of different transcription factors and chromatin remodeling complexes that bind to these 
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CNS regions still remains unclear.  For instance, Smad3 has been shown to synergize with NFAT in 
Foxp3 transcription by directly binding to one of such CNS regions (Tone et al., 2008).  Whether Smad3 
and NFAT require an “opened” chromatin structure to bind to their target sequences is currently 
unknown.  Furthermore, the sequential events in the binding of Smad3, NFAT and other transcription 
factors to Foxp3 locus are still poorly understood.  Thus, analysis of epigenetic changes in several 
transcription factor-deficient Treg cells (using either Treg-specific conditional or germline knock-out 
mice) will help in our understanding of which transcription factors might act as pioneer transcription 
factors by recruiting chromatin remodeling complexes, and which transcription factors require an open 
chromatin structure prior to their binding to Foxp3 gene. 
TGF- is also important for the generation of Th17 cells (Bettelli et al., 2006; Veldhoen et al., 
2006a).  However, the contribution of the TGF- signaling pathway in the differentiation of Th17 cells 
is still not completely understood.  We and others have shown that Smad2 is vital for the proper 
induction of IL-17-producing cells in vitro and in vivo (Chapter III and (Malhotra and Kang, 2010; 
Takimoto et al., 2010)).  Interestingly, neither of the Smad molecules analyzed were required for the 
expression of Th17-associated transcription factors ROR, RORt, BATF, IB among others (Chapter 
III and (Malhotra and Kang, 2010; Takimoto et al., 2010)).  While we found that Smad2 synergizes with 
RORt in the generation of IL-17-producing T cells, Malhotra et al. suggest that Smad2 controls IL-6R 
expression through STAT3 activation (Malhotra and Kang, 2010).  By contrast, Yoshimura and 
colleagues argue that the role of Smad2 is simply to downregulate inhibitory cytokines such as IL-2 and 
IFN- (Takimoto et al., 2010).  Furthermore, even though TGF- signaling pathway is crucial for the 
induction of RORt expression, as assessed by inhibition of TGFRI kinase activity (Chapter III and 
(Ivanov et al., 2006)), the precise mechanism by which this occurs remains unknown.  It is plausible that 
the Smad-independent signaling pathway, in synergism with IL-6 signaling, contributes to the up-
regulation of RORt and other Th17-associated transcription factors.  However, most of the molecules 
activated by TGF- from the Smad-independent pathway (Figure 14) can also be activated by 
costimulatory molecules, cytokines and TCR signaling.  Thus, understanding the direct contribution of 
 113
the Smad-independent pathway in a TGF--dependent manner will be arduous since these cells also 
require TCR and costimulatory signals for their commitment.  One possible way of addressing this point, 
as previously mentioned, would be the utilization of cells with different mutations in TGFR so that 
only the Smad-dependent or the MAPK pathways can be induced upon TGF- stimulation.  For instance, 
it has been previously demonstrated that mutation in L45 loop in TGFRI prevents Smads 
phosphorylation without affecting the activation of MAPKs (Yu et al., 2002).  Thus, in order to address 
the contribution of each signaling pathway in the generation of Th17 cells, we can either utilize mice 
with a knock-in mutation in L45 loop, or with mutations in the domain required for activation of MAPK. 
In addition to Th17 and Treg cells, TGF- has been more recently linked to the generation of 
other Th lineages such as Tr1 and Th9 cells.  Tr1 cells, characterized by the production of IL-10, can be 
generated in the presence of TGF- and IL-27 (Awasthi et al., 2007).  These cells, which depend on 
cMaf and AHR expression for their generation, are believed to play important roles in tolerance (Apetoh 
et al., 2010).  By contrast, Th9 or IL-9-producing T helper cells require TGF- and IL-4 (Dardalhon et 
al., 2008; Veldhoen et al., 2008b).  More recently it has also been proposed that TGF- together with 
IL-1-family members can also induce IL-9 expression in an IL-4-independent fashion (Uyttenhove et al., 
2010) or that TGF- in combination with IL-25 can drive IL-9 expression in T cells expressing the IL-
25 receptor, IL-17RB (Angkasekwinai et al., 2010).  Th9 cells depend on PU.1 and IRF4 transcription 
factors for their generation (Chang et al., 2010; Staudt et al., 2010), two transcription factors that have 
been also shown to regulate Th2 cell differentiation (Chang et al., 2005; Lohoff et al., 2002; Rengarajan 
et al., 2002).  IL-10, originally identified as a Th2-specific cytokine, has later been shown to be 
produced by other Th subsets including Th1, Th17, Th9 and regulatory T cells (reviewed in (Saraiva 
and O'Garra, 2010)).  Similarly, IL-9 is produced by Th2, Th17 and Treg cells (Beriou et al., 2010; Eller 
et al., 2011; Nowak et al., 2009) and can further regulate both Th17 and Treg cells (Elyaman et al., 
2009).  Because of the production of these cytokines by other Th subsets, the definition of Tr1 and Th9 
cells as independent Th lineages is debatable.  Regardless of whether these cells are indeed an 
independent lineage, it is clear that TGF- is important for the instruction of these cytokine-producing 
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cells, or as suggested by several groups, for the inhibition of the generation of alternative T cell lineages 
(primarily Th1 and Th2 cell differentiation).  Even though the molecules downstream of TGF- 
required for the generation of these cytokine-producing T cells have not been identified, we believe that 
the TGF--induced Smad-dependent signaling pathway could potentially regulate the induction of these 
cytokine-producing cells.  Thus, this lays the foundations for new exciting investigation on the role of 
the TGF- signaling pathway, in combination with other cytokine-induced signaling pathways, in the 
regulation of several cytokine-producing Th cells.  
When we analyzed the role of the Smad-dependent signaling pathway in the generation of the 
reciprocally regulated Th17/Treg cells, we observed a differential requirement of Smad molecules in the 
commitment towards these opposing cell lineages.  While Smad4 showed a partial requirement in the 
generation of inducible regulatory T cells, it was dispensable for the induction of IL-17-producing T 
cells in vitro and in vivo.  On the other hand, Smad2 was required for both Th17 and iTreg cell 
development while Smad3 was only necessary for iTreg generation  Recent reports have shown that 
Smad2 and Smad3 can form complexes with other molecules besides the common Smad, Smad4.  For 
instance, TIF1 (Transcriptional Intermediary Factor 1 gamma, also termed Trim33) as well as IKK 
(IkappaB kinase alpha) can replace Smad4 and associate in molecular complexes with Smad2 and 
Smad3 (Descargues et al., 2008; He et al., 2006).  Furthermore, it was suggested that TIF1 and Smad4 
may have differential roles during TGF--dependent invariant NKT cell development (Doisne et al., 
2009).  Thus, since Th17 cell generation requires Smad2 but not Smad4, it is plausible that TIF1and/or 
IKK, both of which are expressed in T cells, might regulate their development.  Indeed, recently it has 
been shown that IKK has an important role in the generation of IL-17-producing CD4+ T cells in an 
NF-B-independent manner (Li et al., 2011).  Similar to what we have observed in Smads-deficient T 
cells, IKK deficiency does not impact the induction of the Th17-associated transcription factors ROR 
or RORt, but rather dramatically affects the expression of IL-17 but not IL-17F (Li et al., 2011).  While 
the authors did not evaluate the putative association of IKK with Smad molecules, in particular Smad2, 
it is plausible that it regulates IL-17 production by complexing with this molecule.  Future research 
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evaluating the molecular complexes found bound to il17 and il17F locus will help understand the 
transcriptional regulation of these cytokines.  Also, whether Smad2 or Smad3 differentially bind to other 
signaling molecules particularly in Th17 cells remains poorly understood.  Thus, evaluating the different 
complexes containing Smad2 and/or Smad3 during Th17 cell development might provide insight into 
the exact contribution of each molecule in the generation of this Th lineage.  Genome-wide chromatin 
immunoprecipitation experiments can also be crucial for better understanding the genes that are 
differentially regulated by these two signaling molecules.  
Smad3 is directly required for induction of Foxp3 expression, while it inhibits the generation of 
IL-17-producing cells.  Since enhanced levels of regulatory T cells have been shown to occur in some 
models of cancer, while Th17 cells showed a protective role in melanoma mouse models, from a 
therapeutic point of view, Smad3 could be an interesting target in some cancers.  Thus, one would 
expect that Smad3 inhibition would result in a reduction of regulatory T cells and a reciprocal increase 
in the generation of IL-17-producing Th cells.  One caveat for the targeting of Smad3 is that TGF- is 
required in several biological processes, and thus the development of a therapy where Smad3 is only 
targeted in T cells would be desirable.  Specific Smad3-inhibitors have already been described (Jinnin et 
al., 2006; Liu et al., 2006), so the major challenge would be to develop a strategy to specifically deliver 
these compounds to T cells without affecting other cell types in the body.   
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IV.2. Plasticity and heterogeneity of T helper cells: How can we adequately define Th 
subsets? 
  
 As widely discussed in Chapter I, Th subsets produce different cytokines, which dictate their 
immune regulatory functions.  However, at the single cell level, a particular Th subset rarely produces 
all of its associated cytokines at the same time.  For instance, only a limited amount of Th1 cells can 
produce IFN-, IL-2, TNF- and LT at the same time (Darrah et al., 2007).  Additionally, Th1 cells 
can produce IL-10 under certain conditions, but again not every Th1 cell produces IL-10.  The same is 
true for Th2 cells where IL-4, IL-5 and IL-13 are differentially regulated and not always produced in the 
same cell, even though their genes are present in the same locus in mouse chromosome 11 (Tanaka et al., 
2011).  Th17 cells are not the exception either since the genes for the cytokines IL-17 and IL-17F, 
which are also adjacent to one another in a tail-to-tail configuration, are differentially regulated (data not 
shown and (Gomez-Rodriguez et al., 2009)) and IL-17- or IL-17F-single producing cells are readily 
detected (Chung et al., 2009; Gomez-Rodriguez et al., 2009; Yang et al., 2008a).  Also, expression of 
the Th17-associated cytokine IL-22 seems to be independent of IL-17 or IL-17F and indeed it has been 
suggested that IL-22-producing Th cells or Th22 cells might represent an independent Th lineage in the 
human system (Eyerich et al., 2009; Fujita et al., 2009).  Thus, these reports indicate that the Th cell 
lineages can be more heterogenous than previously thought, and a more careful and accurate description 
of the cells under study should be considered. 
The expression of Th-associated transcription factors at the population level as a distinguishing 
cell-intrinsic characteristic is also unclear.  For instance, PU.1 expression is augmented in Th2 cells with 
low expression of IL-4 (Chang et al., 2005), but PU.1 is also indispensable for the generation of IL-9-
producing T cells (Th9 cells) (Chang et al., 2010; Staudt et al., 2010).  Moreover, in Th17 cells, the 
expression of ROR and RORt leads to the induction of Th17-associated cytokines.  However, not all 
RORt+ or ROR+ cells express IL-17 (Ivanov et al., 2006; Yang et al., 2008c).  Furthermore, while 
Th17 cells express RORt and AHR, the relationship between these cells and IL-17 or IL-22 production 
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remains unclear.  Also, IRF4, which is required for the development of Th2 and Th9 cells, can also 
regulate the generation of Th17 cells.  These reports indicate that the same transcription factors are 
required for the development of different Th cell subsets, which suggests that these cells might share the 
same developmental commitment process.  Furthermore, how the combination of expression of 
transcription factors at a single-cell level leads to the acquisition of a particular phenotype is also not 
completely understood. 
 Recent work has demonstrated that Th cell subsets can be more plastic than previously thought.  
For instance, IL-17-producing T cells, when transferred into lymphopenic hosts, can convert into IFN--
producing T cells (Bending et al., 2009; Lee et al., 2009; Martin-Orozco et al., 2009a; Nurieva et al., 
2009).  Moreover, the conversion of Th17 cells into Th1 cells upon IL-12 treatment has also been 
reported in studies in vitro (Lee et al., 2009).  However, whether the reverse conversion of Th1 into 
Th17 cells can also occur, in vitro or in vivo, remains elusive.  Interestingly, Th cells expressing both 
IL-17 and IFN- have been documented in several autoimmune and inflammatory manifestations.  
Whether these cells indeed represent the in vivo conversion of Th17 into Th1 cells, or vice-versa or 
whether they are generated directly into double-producer cells needs further demonstration.  Transfer 
experiments in several disease settings using cells obtained from IL-17 and IFN- double reporter mice, 
or using fate-mapping systems such as IL-17-Cre or IFN--Cre mice crossed with Rosa26-YFP locus 
could help solve this uncertainty.  Indeed, recently Stockinger and colleagues have shown that cells 
expressing IFN- in the central nervous system of mice with experimental autoimmune 
encephalomyelitis disease had expressed IL-17 before converting into IFN--producing cells (Hirota et 
al., 2011).  
Regulatory T cells have also been shown to convert to other Th lineages.  We and others have 
shown that stimulation of regulatory T cells with IL-6 leads to the conversion of these cells into IL-17-
producing T cells, although some remaining cells coexpressed both IL-17 and Foxp3 (Lochner et al., 
2008; Voo et al., 2009; Xu et al., 2007; Yang et al., 2008b).  Foxp3+ Treg cells can also convert into 
IFN--producing T cells when cultured under Th1-skewing conditions or in a Toxoplasma infection 
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model (Oldenhove et al., 2009; Wei et al., 2009).  Furthermore, recently Foxp3+ T cells have been 
shown to become follicular helper T cells in Peyer’s patches in vivo (Tsuji et al., 2009).   
Th2 cells have not been the exception to the conversion to other Th lineages.  For instance, 
human Th2 memory/effector cells have been shown to also express IL-17, which leads to an enhanced 
allergic asthma phenotype (Wang et al., 2010).  Furthermore, memory Th2 cells can become regulatory 
T cells expressing Foxp3, and these converted cells are crucial in inhibiting airway hyperreactivity 
caused by Th2 memory cells (Kim et al., 2010).  Finally, while Th1 and Th2 cells have been always 
considered fixed and stable populations, recently Löhning and colleagues challenged this view and 
demonstrated that in vivo LCMV infection can induce a Th2 cell to stably coexpress GATA3 and T-bet 
with combined characteristics of Th1 and Th2 cells (Hegazy et al., 2010).  
Although effector T cells were originally considered to be terminally differentiated, a growing 
body of evidence discussed in the present section has challenged this view and suggested that the 
phenotype of effector T cells is not completely fixed but is more flexible or plastic. Th cells can have 
‘mixed’ phenotypes (that is, have characteristics usually associated with more than one Th cell subset) 
and can interconvert from one subset phenotype to another.  Th cell plasticity can be important for 
adaptation of immune responses in different microenvironments and might be particularly relevant for 
host defence against pathogens that colonize different tissues.  Thus, the immune system has developed 
different strategies to adapt to the demands of the body.  While we understand from a biology 
perspective that this adaptation of the immune system is extremely important to generate an appropriate 
host defense response in a tissue-specific manner, we (immunologists) should be cautious with the way 
we denominate Th subsets according to the expression of “master” transcription factors or specific 
cytokines.  For instance, we have demonstrated that in Smad- as well as in Steroid Receptor Coactivator 
(SRC)-deficient cells, expression of the Th17 master transcription factors ROR and RORt was not 
significantly affected, albeit an altered pattern of cytokine production was observed (Chapter III and 
data not shown).  Thus, according to a definition in terms of the expression of “master” transcription 
factors, we would have concluded that both Smad and SRC molecules play no role in Th17 cell 
development.  Moreover, Th17 cells were termed on the basis of IL-17 production.  However, in SRC1- 
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and IKK-deficient Th17 cells, only IL-17A production is defective, while the expression of other 
Th17-associated cytokines remains unchanged ((data not shown and (Li et al., 2011)).  In this scenario, 
would it be appropriate to say there is a defect in Th17 cell generation or commitment?  A more 
accurate statement would be to just describe the role of SRC1 or Smad2 in IL-17 production rather than 
discussing their role in Th17 cell development/commitment.   
Thus, our work, together with recent reports on the plasticity and heterogeneity of Th subsets, 
urge for a more stringent interpretation of results, and therefore a more rigorous definition of these 
subsets.  It is understandable that as scientists we need a framework to study our fields, so that we can 
advance our discoveries and refer to the same universal definitions.  However, a re-consideration in our 
nomenclature of CD4+ T helper subsets seems inevitable based on the recent discoveries.  Probably, we 
should refer to our populations on the basis of cytokine production or on their role or characteristics in 
immune responses.  To this effect, Dong and colleagues, in their identification of the currently-termed 
Th17 cells, initially named these cells Thi or inflammatory T helper cells (Park et al., 2005).  This name 
better reflected the role of these cells in immune responses.  With the development of new flow 
cytometry antibodies, the expansion of markers that can be used to analyze CD4+ T helper populations 
at the single cell level and the generation of cytokine or transcription factor reporter mice, we would be 
able to better characterize these populations.  This phenotypification will help develop a better and more 
accurate nomenclature system.     
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IV.3. Reciprocal generation of Th17 and regulatory T cells 
 
In 2006, it was suggested that Th17 and regulatory T cells are reciprocally regulated since both 
lineages depend on TGF- for their generation (Bettelli et al., 2006; Veldhoen et al., 2006a).  The 
requirement of TGF- in Th17 cell generation in vivo was demonstrated in mice deficient in TGF-1 
that were unable to produce IL-17 cytokine in T cells (Mangan et al., 2006).  Recently, Zhou and 
colleagues showed that TGF- levels are crucial for determining the balance between Th17 and 
regulatory T cells.  The authors demonstrated that increasing concentrations of TGF- shifts the balance 
towards the induction of regulatory T cells (Zhou et al., 2008a).  Furthermore, we have demonstrated 
that Foxp3, the master transcription factor for Treg cells that requires TGF- for its expression, is 
transiently induced in developing Th17 cells in vitro.  Also, we found that forced expression of Foxp3, 
which mimics environments with high TGF- levels, leads to the suppression of Th17 cell generation 
through the repression of ROR and RORt transcriptional activity.  Littman and colleagues have also 
identified a cell population in the gut that co-expresses RORt and Foxp3 and has lower IL-17 
production compared to RORt single positive cells (Zhou et al., 2008a).     
The identification of regulatory T cells that express RORt in the gut suggests that either these 
cells could be progenitors of Th17/Treg cells or that Foxp3+ regulatory T cells consist of a heterogenous 
population (Zhou et al., 2008a).  Our in vitro data showing co-expression of Foxp3 and IL-17F in 
developing Th17 cells (Chapter II) would argue in favor of the former.  However, recent reports have 
identified other distinct subpopulations within regulatory T cells that coexpress Foxp3 and other Th-
associated markers, supporting the idea that regulatory T cells consist of a heterogenous population, thus 
challenging the idea of a fixed and completely stable population.  Foxp3+ regulatory T cells can express 
T-bet, IRF4 or Stat3 and control Th1, Th2 or Th17-dependent responses respectively (Chaudhry et al., 
2009; Koch et al., 2009; Zheng et al., 2009).  Cells co-expressing Foxp3 and T-bet show high 
expression of the Th1-associated chemokine receptor CXCR3.  Acquisition of CXCR3 expression in a 
T-bet-dependent manner by regulatory T cells allows them to migrate to inflammatory regions and 
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enables them to control Th1-mediated inflammatory and autoimmune responses (Koch et al., 2009).  
Similarly, cells coexpressing IRF4 and Foxp3 were required to control Th2 responses since mice with a 
specific deletion of Irf4 gene in regulatory T cells showed enhanced plasma cell levels and antibody 
production (Zheng et al., 2009).  Furthermore, unpublished data from our laboratory shows that Foxp3+ 
T cells can express the follicular helper T cell (Tfh)-specific transcription factor Bcl6 and acquire 
CXCR5 expression.  The expression of Bcl6 and CXCR5 by regulatory T cells allows them to migrate 
to the B cell area in germinal center reactions, and seems to be crucial for controlling germinal center 
responses (Chung Y et al. unpublished data).  Also, recently Foxp3+ T cells have been shown to convert 
into Tfh cells in Peyer’s patches (Tsuji et al., 2009).  Thus, these combined studies would suggest that 
the population of regulatory T cells present in the gut that co-express RORt would behave in a similar 
way as cells expressing other Th-associated transcription factors.  Indeed, it has been recently shown 
that these cells coexpressing Foxp3 and RORt can show an inhibitory function in the development of 
autoimmune diabetes (Tartar et al., 2010).  These publications indicate that regulatory T cells might 
acquire the expression of Th-associated transcription factors so that they can migrate to sites where an 
ongoing immune response is occurring, and thus control such response.  It still remains unclear whether 
other subsets of regulatory T cells expressing other Th-associated transcription factors exist.  These 
recent findings in the regulatory T cell field opens up an exciting area of research to further understand 
the exact role regulatory T cells play in health and diseases.  Furthermore, the molecular mechanisms 
behind the acquisition of these transcription factors in regulatory T cells still remain to be determined.     
 
Overall, the findings presented in this work provide novel mechanisms that regulate the 
generation of two T helper lineages with opposing functions in the immune system, and thus could 
result in possible therapeutic targets to treat diseases where the balance of these T cells is dysregulated, 
such as in autoimmunity, chronic infectious diseases and cancer. 
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CHAPTER V - EXPERIMENTAL PROCEDURE 
 
Mice.   C57BL/6, B6.SJL (CD45.1), RAG1-deficient, Scurfy (Foxp3 deficient), OT-II and 2D2 TCR 
transgenic mice were purchased from Jackson Laboratories.  Foxp3-GFP mice were kindly provided by 
Dr. Ruslan Medzhitov with permission of Dr. Alexander Rudensky (Fontenot et al., 2005), and crossed 
with IL-17F-RFP knockin mice, generated by Dr. Xuexian Yang (Yang et al., 2008a; Yang et al., 
2008b). Smad3 KO mice were kindly provided by Dr. Xin-Hua Feng with permission from Dr. Xiao-
Fan Wang (Datto et al., 1999), Smad4fl/fl and Smad2fl/fl mice by Dr. Xin-Hua Feng and Dr. Martin 
Matzuk with permission of Dr. Elizabeth Robertson (Chu et al., 2004; Vincent et al., 2003).  Floxed 
mice were bred with CD4-Cre mice provided by Dr. Christopher Wilson (Lee et al., 2001).  Mice were 
housed in the SPF animal facility at M. D. Anderson Cancer Center and the animal experiments were 
performed at the age of 6-10 weeks using protocols approved by Institutional Animal Care and Use 
Committee.  
 
T cell differentiation. Naïve CD4+ T cells (CD4+CD25-CD62LhiCD44lo) were sorted by FACS 
(Fluorescent Activated Cell Sorting) and stimulated with plate-bound anti-CD3 (0.5 g/ml, clone 2C11) 
and anti-CD28 (0.5 g/ml, clone 37.51) in the presence or absence of the following cytokines, 
antibodies or compounds: IL-2 (50 units/ml), TGF- (1-20 ng/ml, R&D system), IL-6 (1-30 ng/ml, 
R&D system), IL-23 (40 ng/ml, R&D system), IL-1 and IL-1 (10 ng/ml, Peprotech), TNF-10 
ng/ml, R&D system), anti-IL-4 (10 g/ml, clone 11B11), anti-IFN- (10 g/ml, clone XMG 1.2), anti-
TGF- (20 g/ml, clone 1D11) and TGFRI kinase inhibitor SB431542 (5M, Sigma Aldrich).  Four 
days after stimulation, cells were washed and restimulated with 50 ng/ml of PMA and 500 ng/ml of 
ionomycin in the presence of Golgi Stop (BD Pharmingen) for 5 hours.  Then, cells were permeabilized 
with Cytofix/Cytoperm Plus Kit (BD Pharmingen) or Foxp3-staining kit (eBioscience) according to the 
manufacturer's protocols and Foxp3-, IL-17-, IL-17F- and IFN--producing cells were analyzed using 
intracellular staining.  Samples were analyzed using a FACSCalibur or LSRII (BD Biosciences) and 
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analyzed with FlowJo (Tristar).  Also, after differentiation cells were restimulated with anti-CD3 (1 
g/ml, clone 2C11) for 16h after which cytokines were measured in the cell-free culture supernatants by 
enzyme-linked immunosorbent assay (ELISA), or with anti-CD3 for 4h and cDNA was prepared as 
described below. 
 
In vitro regulatory T cells suppression assay.  FACS-sorted naïve CD4+CD25-CD62LhiCD44lo T cells 
were stimulated in the presence or absence of FACS-sorted CD4+CD25hi natural regulatory T cells 
(nTregs) at different ratios with 3000 Rads irradiated T-cell depleted splenocytes as antigen presenting 
cells and soluble anti-CD3 (0.5 g/ml, clone 2C11) for three days. Proliferation was determined by 
addition of [3H]-thymidine to the culture for the last 8h.  
 
Cloning into retrovirus.  Bicistronic retroviral vectors pGFP-RV (provided by Dr. Murphy at 
Washington University (Ouyang et al., 1998)) or pMIG-hCD2 (provided by Dr. Bevan at Washington 
University (Deftos et al., 1998)) containing IRES-regulated GFP and human CD2, respectively were 
utilized.  The coding sequences for the following proteins were cloned in those vectors: 
RORandRORt (Yang et al., 2008c), constitutively active Smad2 (Smad2 2SD) (Dai et al., 2009), 
Smad3 2SD and TGFRI T202D (Feng et al., 2000).  Also, full length Foxp3 was amplified with BglII 
and XhoI sites and cloned into pGFP-RV.  Site directed mutagenesis using specific primers carrying 
deletions or mutations were utilized to generate Foxp3 mutants (Foxp3FKH/NLS, Foxp3E250, 
Foxp3LL-AA, Foxp3105-190 or Foxp3 LL-AA 105-190), and cloned into pGFP-RV vector.  
 
Transduction of T cells by retrovirus. For the generation of retroviral supernatants, HEK 293T cells 
were transfected with the retrovirus constructs together with packaging vector pCL-Eco using calcium 
phosphate precipitation.  Supernatant containing retroviral particles were collected 48h after 
transfection.  For transduction, CD4+CD25-CD62LhiCD44lo T cells from either C57BL/6 or OT-II TCR 
transgenic mice were stimulated with anti-CD3 and anti-CD28 or irradiated T-cell depleted splenocytes 
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and OT-II peptide (10 g/ml), respectively in the presence of various cytokine/antibodies as previously 
indicated for 1d.  Then, supernatants containing retroviral particles and polybrene (8 g/ml) were added 
to activated-T cells and centrifuged at 1800 rpm for 50 min.  Cells were then washed and incubated with 
various cytokine/antibodies.  Four days after infection, cells were sorted based on GFP and/or hCD2 
expression by FACS, and stimulated with PMA and ionomycin in the presence of Golgi Stop for 4h to 
measure cytokine or transcription factor expression by intracellular staining.  Also, FACS-sorted 
populations were restimulated with anti-CD3 for 4h, after which cDNA was prepared and gene 
expression determined by real time RT-PCR (see below).    
 
Quantitative real-time PCR. Total RNA was extracted from activated or naïve T cells using TriZol 
reagent (Invitrogen). Then, cDNA was synthesized using Superscript reverse transcriptase and oligo(dT) 
primers (Invitrogen) and gene expression was examined with a Bio-Rad iCycler Optical System using 
iQTM SYBR green real-time PCR kit (Bio-Rad Laboratories, Inc.). The data were normalized to -actin 
reference. The list of primers utilized is shown in Table 2. 
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Table 2: List of real time PCR primers 
 
a) Transcription Factors 
Gene Primers sequence forward Primers sequence reverse Reference 
ROR CACGGCCCTGGTTCTCAT   CAGATGTTCCACTCTCCTCTTCTCT (Kang et al., 
2006) 
ROR TCCAAATCCCACCTGGAAAC   GGAAGGTCTGCCACGTTATCTG (Akashi and 
Takumi, 2005) 
T-bet CAACAACCCCTTTGCCAAAG TCCCCCAAGCAGTTGACAGT (Grogan et al., 
2001) 
GATA-3 AGAACCGGCCCCTTATGAA AGTTCGCGCAGGATGTCC (Grogan et al., 
2001) 
Foxp3 TACTTCAAGTTCCACAACATGCGACC CGCACAAAGCACTTGTGCAGACTCA
G 
(Chen et al., 
2008) 
IRF4 TCCTCTGGATGGCTCCAGATGG CACCAAAGCACAGAGTCACCTG (Chung et al., 
2009) 
AHR AGCATCATGAGGAACCTTGG GGATTTCGTCCGTTATGTCG (Reynolds et al., 
2010) 
Twist1 CGCACGCAGTCGCTGAACG GACGCGGACATGGACCAGG (Niesner et al., 
2008) 
Twist2 GCATCCTGGCCAACGTGC TCCATGCGCCACACGGAG (Niesner et al., 
2008) 
BATF AGTGAGGACCTGGAGAAAC GCTCAGCACTGATGTGAAGTA (Horisawa et al., 
2008) 
b) Cytokines and chemokines 
Gene Primers sequence forward Primers sequence reverse Reference 
IL-17A CTCCAGAAGGCCCTCAGACTAC AGCTTTCCCTCCGCATTGACACAG (Ivanov et al., 
2006) 
IL-17F CCCATGGGATTACAACATCACTC CACTGGGCCTCAGCGATC (Harrington et 
al., 2005) 
IL-21 TCATCATTGACCTCGTGGCCC ATCGTACTTCTCCACTTGCAATCCC (Nurieva et al., 
2007) 
IL-22 CATGCAGGAGGTGGTACCTT CAGACGCAAGCATTTCTCAG (Chung et al., 
2006) 
CCL20 ATGGCCTGCGGTGGCAAGCGTCTG TAGGCTGAGGAGGTTCACAGCCCT (Park et al., 
2005) 
IFN- GATGCATTCATGAGTATTGCCAAGT GTGGACCACTCGGATGAGCTC (Nurieva et al., 
2003) 
IL-4 AGATCACGGCATTTTGAACG TTTGGCACATCCATCTCCG (Grogan et al., 
2001) 
IL-5 CGCTCACCGAGCTCTGTTG CCAATGCATAGCTGGTGATTTTT (Grogan et al., 
2001) 
IL-13 GCTTATTGAGGAGCTGAGCAACA GGCCAGGTCCACACTCCATA (Grogan et al., 
2001) 
IL-10 ATAACTGCACCCACTTCCCAGTC CCCAAGTAACCCTTAAAGTCCTGC (Lang et al., 
2002) 
CCL2 CTCAGCCAGATGCAGTTAACGCCC GGTGCTGAAGACCTTAGGGCAGAT (Reynolds et al., 
2010) 
Gro- CGCTTCTCTGTGCAGCGCTGCTGCT AAGCCTCGCGACCATTCTTGAGTG (Park et al., 
2005) 
c) Cytokine and chemokine receptors 
Gene Primers sequence forward Primers sequence reverse Reference 
CCR6 CCTCACATTCTTAGGACTGGAGC GGCAATCAGAGCTCTCGGA (Yamazaki et al., 
2008) 
IL-23R GCCAAGAGAACCATTCCCGA TCAGTGCTACAATCTTCAGAGGACA (Harrington et 
al., 2005) 
CCR2 CCTTGGGAATGAGTAACTGTGTGAT ATGGAGAGATACCTTCGGAACTTCT (Ishibashi et al., 
2004) 
CXCR5 ACTCCTTACCACAGTGCACCT GGAAACGGGAGGTGAACCA (Wu and Hwang, 
2002) 
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d) Treg-associated markers 
Gene Primers sequence forward Primers sequence reverse Reference 
GPR83 GAAGATGCTGGTGCTTGTGGTAGTC AAGTGGTGATTAGGTAGTGGAGCCC (Sugimoto et al., 
2006) 
Glutaredoxin GGACATCACAGCCACTAACAACACC ATCTGCTTCAGCCGAGTCATCAG (Sugimoto et al., 
2006) 
Ecm1 ACTACCTGCTCCGACCCTGC CCTGTTCTGGATATGGAAGCTCG (Sugimoto et al., 
2006) 
Helios ACTCCTCAGAAGTTTGTGGGGG GCTGGGCTTTGTTTCCTCTTG (Sugimoto et al., 
2006) 
SOCS2 TCTGGGGACTGCCTTTACCAAC CCTCTGGGTTCTCTTTCACATAGC (Sugimoto et al., 
2006) 
GITR GACGGTCACTGCAGACTTTG GCCATGACCAGGAAGATGAC (Wang et al., 
2005) 
f) Housekeeping gene 
Gene Primer sequence forward Primer sequence reverse Reference 
-Actin TCCTTCGTTGCCGGTCCAC ACCAGCGCAGCGATATCGTC (Nurieva et al., 
2003) 
 
 
Bone marrow reconstitution. Female RAG1 KO mice were reconstituted with T cell-depleted bone 
marrow cells from different KO mice or their respective WT controls. Eight weeks later, appropriate 
reconstitution was determined by measuring CD4+ and CD8+ T cells and B cell populations in blood. 
Then, these mice were analyzed for immune cell populations in different tissues or used for in vivo 
animal experimental models (immunizations or EAE, see below) 
 
Myelin Oligodendrocyte Glycoprotein (MOG) or Keyhole Limpet Hemocyanin (KLH) immunization. 
Mice at 5-8 weeks of age were immunized subcutaneously at the dorsal flanks with 150 g MOG 
peptide (amino acids 35–55; MEVGWYRSPFSROVHLYRNGK) emulsified in 500 g Complete 
Freund’s Adjuvant (CFA) or 200 g KLH protein emulsified in 50 g CFA. Seven days later, cells from 
spleens and/or draining lymph nodes were isolated and restimulated with 25 g/ml MOG35-55 peptide or 
50 g/ml KLH protein or media alone for 24 hr. Golgi Stop and/or PMA and ionomycin was added the 
last 6h of culture, and cytokine expression in CD4+ T cells was determined by intracellular cytokine 
staining as previously described. Also, cells were restimulated with increasing concentrations of KLH 
protein or MOG35-55 peptide for three days, and cytokine production was determined in cell-free 
supernatants by ELISA (Pharmingen).  Also, after KLH protein or MOG35-55 peptide restimulation for 
three days, proliferation was determined by addition of [3H]-thymidine to the culture for the last 8h.  
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Experimental Autoimmune Encephalomyelitis (EAE). Female mice at 6-8 weeks of age were immunized 
subcutaneously at the dorsal flanks with 150 g MOG peptide (amino acids 35–55; 
MEVGWYRSPFSROVHLYRNGK) emulsified in 500 g Complete Freund’s Adjuvant (CFA) on day 0 
and day 7. Pertussis toxin (500 ng/mouse) was given intraperitoneally at day 1 and day 8.  Clinical signs 
of EAE were assigned scores on a scale of 1–5 as follows: 0, none; 1, limp tail or waddling gait with tail 
tonicity; 2, wobbly gait; 3, hind limb paralysis; 4, hind limb and forelimb paralysis; 5, death.  To 
analyze central nervous system infiltrates, mice were perfused with heparin 0.6%, brain and spinal cord 
were collected after perfussion, and mononuclear cells were prepared by percoll gradient.  
 
Co-Immunoprecipitation.  HEK 293T cells were transfected with expression vectors encoding Flag-
ROR, Flag-RORt, Myc-RORt (Yang et al., 2008c), 6xMyc-Smad3, 6xMyc-Smad2, 2xMyc-Smad4, 
Flag-Smad2, Flag-Smad3, His-TGF-RI T202D (Feng et al., 2000) and wild-type or mutant Foxp3.  
Fourty eight hours after transfection, cells were washed with cold-PBS and lysed with lysis buffer (50 
mM Tris-HCl [pH 8.0], 1% Nonidet P-40, 120 mM NaCl, 4 mM EDTA, 1 mM Na3VO4, 50 mM NaF, 1 
µg/ml leupeptin, 2 µg/ml aprotinin, 1 µg/ml pepstatin A).  Lysates were generated by centrifugation and 
pre-cleared with protein A/G-sepharose (Sigma-Aldrich) for 2 h. Then, immunoprecipitation was 
performed by incubating the pre-cleared lysate with 2 g of anti-FLAG-M2 or anti-Myc antibodies 
(Sigma-Aldrich) for 2h after which protein A/G-Sepharose was added.  Immunoprecipitates were finally 
obtained by centrifugation.  Similar protein concentration from whole cell lysates or immunoprecipitates 
were analyzed by Western blot using anti-FLAG-M2, anti-myc, anti-His (Sigma-Aldrich) or anti-
human/mouse Foxp3 (eBioscience) antibodies. 
 
Mammalian Two-hybrid reporter assay. Transfection of Chinese Hamster Ovary (CHO) cells was 
performed using Fugene 6 transfection reagent (Roche, Indianapolis, IN).  The following vectors were 
cotransfected: 0.1 g of (UAS)5-Luciferase reporter vector, which contains 5 copies of the GAL4 
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upstream-activating sequence (UAS), and 0.05 g of VP16-ROR, 0.1 g pM-EBIP96, encoding an 
LXXLL motif derived from SRC-1 (Kurebayashi et al., 2004), and Foxp3 expression vectors cloned 
into the pGFP-RV vectors as previously described. Cells were incubated for forty hours and luciferase 
activity was then determined with a luciferase kit (Promega). Transfection efficiency was normalized by 
-galactosidase activity. 
 
IL-17 transcription reporter assay. RORt (Yang et al., 2008c), ROR(Yang et al., 2008c), wild-type 
or mutant Foxp3 vectors were transfected into EL-4 cells with a luciferase reporter vector containing IL-
17 minimal promoter region together with CNS2 element  (Akimzhanov et al., 2007; Yang et al., 2008c).  
Luciferase activity was determined using the dual-luciferase reporter system (Promega) to assay Firefly 
and Renilla luciferase activity in each sample.  
 
RORE reporter assay. HEK 293T cells were co-transfected with 1-10 g of the (RORE)3-Luciferase 
reporter (provided by Dr. A. Jetten) in the presence or absence of 1-10 g of RORt-RV and increasing 
concentrations of Foxp3-RV or Smad3 2SD-RV. Cells were incubated for 16 h with complete medium, 
and then for 24 h with 0.5% FBS containing medium to reduce the endogenous TGF- concentration 
present in FBS.  Furthermore, transfection of Chinese Hamster Ovary (CHO) cells was performed using 
Fugene 6 transfection reagent (Roche, Indianapolis, IN).  CHO cells were co-transfected with (RORE)3-
Luciferase reporter and 0.05 g pZeoSV-ROR (provided by Dr. A. Jetten) in the presence or absence 
of Foxp3 wild-type or mutant expression vectors for fourty hours.  Luciferase activity was determined 
using the dual-luciferase reporter system (Promega) to assay Firefly and Renilla luciferase activity in 
each sample. Renilla luciferase or -galactosidase activities were used to normalize transfection 
efficiency.   
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